Column1,Comment.ID,Document.ID,Text,word.count,Page.Number,Docket.ID,Original.Document.ID,Attachments,RIN,Title,Document.Type,Document.Subtype,Include.Submitter.Information,Comment.on.Document.ID,Status,Status.Set.Date,Current.Assignee,Status.Set.By,Received.Date,Date.Posted,Posting.Restriction,Reason.Restricted,Restriction.Explanation,Component,File.Code,Tracking.Number,Page.Count,Total.Page.Count.Including.Attachments,Submission.Type,Number.of.Submissions,First.Name,Last.Name,City,Country,State.or.Province,ZIP.Postal.Code,Email.Address,Organization.Name,Category,Site_Key,Name,Address,Email,Organization,Type
175,CMS-2017-0156-1658,CMS-2017-0156-1658-0,"Comments for Part D proposed rule from Peter B. Bach, MD from Memorial Sloan Kettering Cancer Center, Stacie B. Dusetzina, Ph.D. from Vanderbilt University Medical Center, Rena Conti, Ph.D. from the University of Chicago
We appreciate the opportunity to comment on Medicare's proposed Part D rule (CMS-4182-P).  Our comments focus exclusively on the Request for Information regarding the possibility of implementing point-of-sale rebates within the benefit.  
Overview of our work on point-of-sale rebates for Medicare Part D
As a point of reference, we published an article in JAMA Internal Medicine  in 2017 detailing some important consequences for Medicare beneficiaries on high cost medications that resulted from a steadily widening gap between drug's 'list' prices and 'net' prices.  We noted that one way to ameliorate the consequences was to institute 'point of sale' rebates in Part D.
In our study we highlighted two important consequences for beneficiaries enrolled in Part D plans. First, for drugs requiring beneficiaries to pay deductibles or co-insurance, a drug with a higher list price (and larger rebate) under the standard benefit structure would have higher out of pocket costs for the beneficiary than the drug with the lower list price (and smaller rebate), even when net prices received by manufacturers are the same.  Second, due to the fact that beneficiaries move through the Part D benefit structure based on their own out of pocket spending, setting their out of pocket costs based on inflated list prices rather than net prices increases the number of patients reaching the catastrophic coverage / reinsurance phase of the benefit.  In addition, since plans are able to retain some rebates under the current benefit design, this may induce them to select more expensive products for Part D formularies.
On the first consequence of current plan benefit design, we provided an example of two competitive drugs for the treatment of HCV infection. Under current benefit design and using Medicare's own Part D planfinder for 2016 we showed that a full treatment course with Harvoni would cost a beneficiary nearly $2,000 more out of pocket than a similar treatment course with Merck's Zepatier, despite having similar net prices.  
(Please see attached file for full text of overview of our work.)
Actuary calculation included in the Proposed Rule: 
The CMS actuary incorporated estimates in the proposed rule that highlight the potential tradeoff introduced through point of sale rebates.  While we appreciate the actuary's work on this question, we propose some assumptions should be further specified to determine their impact as CMS considers the broader policy tradeoff.
How big is the rebate applied when determining the drug price for purposes of calculating beneficiary share?  
As we understand it, the CMS actuary applied a fixed rebate across all categories of drugs and across all plans in the benefit to assess point of sale rebates, we believe that the CMS actuary has plan and drug level data that would allow for more detailed modeling of point-of-sale rebates.  We are not sure the impact of applying these rebates in such a specific manner, but it is possible it could change some of the projections given that some specialty drugs have large rebate levels while others do not.   
We also appreciate the static nature of the actuary's projections, but think there may be merit in projecting forward 5 or 10 years to assess the aggregate impact of point-of-sale rebates in light of strong ongoing trends toward both higher list prices and widening gross-to-net differences.  
We also propose a variation on the actuary model, where the progression through the benefit is different for the beneficiary than it is for the pharmaceutical company, as follows:
1)	the beneficiary transitions to different stages of the Part D benefit based on the point-of-sale rebated price
2)	the pharmaceutical company discount provided in the coverage gap would be based on the list price (technically the WAC) of the dispensed drugs
Under this alternative scenario the pharmaceutical sponsor rebate would be triggered when list price based progression reached the coverage gap, and the rebate level during that subsequent period would be based on 50% of list price (technically the WAC) for those drugs for which rebates are required.  The rebate would terminate when the list price based progression reached the catastrophic phase.  
This modification would leave the pharmaceutical contribution consistent irrespective of the rebate level that CMS applies to the point of sale, and also increase their contribution in the current actuary models - a contribution that would reduce Medicare and beneficiary costs in the projections.   The WAC is also entirely under the control of the pharmaceutical company irrespective of rebate level, so pharmaceutical company decisions to raise WAC for instance would translate directly into larger rebates paid in the coverage gap.  
",795,1,CMS-2017-0156,CMS-2017-0156-DRAFT-1663,NA,0983-AT08,Peter B. Bach-NY,PUBLIC SUBMISSIONS,Public Comment,Yes,CMS-2017-0156-0046,Posted,01/18/2018,NA,"Hayes, Yolanda K (CMS)",01/16/2018,01/18/2018,No restrictions,NA,NA,NA,NA,1k2-90ys-a0me,1,1,3,1,Peter B.,Bach,NA,United States,NY,7932,NA,NA,NA,NA,Peter B. Bach,"NY, 07932",NA,NA,Other
85,CMS-2017-0156-1020,CMS-2017-0156-1020-0,"The Honorable Seema Verma
Administrator 
Centers for Medicare & Medicaid Services
Department of Health and Human Services
Attention:  CMS-4182-P

Dear Administrator Verma:

On behalf of CoverMyMeds, I am pleased to submit comments and recommendations on the proposed rule, ""Medicare Program; Contract Year 2019 Policy and Technical Changes to the Medicare Advantage, Medicare Cost Plan, Medicare Fee-for-Service, the Medicare Prescription Drug Benefit Programs, and the PACE Program (CMS-4182-P).""

CoverMyMeds is pleased to see the progress made by CMS in the proposed rules on several important issues that can have a significant, positive impact on Medicare patients, providers and other system stakeholders.  We are also pleased to share our industry experience and provide input to CMS on this important rule making.

CoverMyMeds is the nation's leading ePA technology partner.   CoverMyMeds streamlines the medication PA process, electronically connecting providers, pharmacists and plan/PBMs to improve time to therapy and decrease prescription abandonment with electronic prior authorization (ePA). Since our inception in 2008, we have helped over 80 million patients get their needed medications via our automated processes.   Nationwide, we bring our solutions to more than 700,000 providers, 62,000 pharmacies, 500+ EHRs and payers representing 80% of U.S. prescription volume.

Please see full comments within the attached file (CMS 4182-P-Part D Proposed Rule-CoverMyMeds Comments).  

In general, we concur that CMS should move forward with adopting the NCPDP SCRIPT Standard v2017071, but do not concur with the omission of the electronic prior authorization (""ePA"") transactions from the rule adoption.  CoverMyMeds ask that CMS reconsider this position and in the final rule adopt the ePA transactions.  

The industry began work on the ePA process over a decade ago because the current standardized frameworks (X12 278, 275, and PA attachments) were incomplete in providing a truly standardized end to end process for prior authorizations for prescription drugs.  In the same sense, NCPDP's Telecommunications standard permits payers to notify the pharmacist of a claim requiring prior authorization, or when a prior authorization was used to pay a claim; but does not account for the process by which an approved entity is able to request and obtain a prior authorization. 

""In 2004, the National Council for Prescription Drug Programs (NCPDP) organized a multi-industry, multi-Standards Development Organization task group to evaluate a prior authorization (PA) standard, particularly the medication prior authorization, that would support the needs for e-prescribing transactions and to develop a solution. Investigators found that the HIPAA-named PA standard (the X12N 278 v4010 or v5010), was not adequate to support medication PA because it was designed for procedures/services or durable medical equipment (DME) prior authorization and did not accommodate the information necessary to facilitate prior authorization. It also did not have a mechanism for providers to provide relevant information for e-prescribing. Consequently, the NCPDP developed and through its vetting process, received industry approval for e-Prescribing Prior Authorization transactions (included in the NCPDP SCRIPT Standard), which enables the healthcare industry to exchange prescriber-initiated prior-authorization requests for prescribed medications as part of the provider-patient encounter.""

In a May 2014 letter, NCVHS recommended to the Secretary of Health and Human Services that the prior authorization transactions found in NCPDP SCRIPT Version 2013101 be adopted for the exchange of prior authorization information between prescribers and processors for pharmacy benefits. They also recommend the standard be named in the most appropriate regulation and at the earliest possible time. 

CoverMyMeds aligns with NCPDP, and the industry's understanding that prior authorization transactions are named under HIPAA and not the MMA.  However, we also feel strongly that ePA be included in this Rule.  In the attached, full comment letter, we offer additional commentary to support our request of CMS to include the NCPDP SCRIPT Standard ePA transactions as a part of the final rule making. 

Also, because this would be a new process for Med D plans, the timing of the proposal and eventual passage of the new Med D regulations and standard IT implementation timeframes, we recommend a 24-month implementation of the NCPDP transactions from the date the final rule is published and additionally recommend that the effective date not occur on a national holiday.  

CoverMyMeds appreciates the opportunity to comment on this proposed rule and supports the efforts of CMS in improving the Medicare program. If you have questions or need further information, please contact me, Kim Boyd, Director of Industry Relations and Government Affairs at (615) 663-5579 or kdiehlboyd@covermymeds.com


",729,1,CMS-2017-0156,CMS-2017-0156-DRAFT-1021,NA,0983-AT08,CoverMyMeds-OH,PUBLIC SUBMISSIONS,Public Comment,Yes,CMS-2017-0156-0046,Posted,01/16/2018,NA,"Hayes, Yolanda K (CMS)",01/11/2018,01/16/2018,No restrictions,NA,NA,NA,NA,1k2-90v3-atlm,1,1,3,1,Kim,Diehl-Boyd,Columbus,United States,OH,43215,kdiehlboyd@covermymeds.com,CoverMyMeds,NA,covermymeds.com,Kim Diehl-Boyd,"Columbus, OH, 43215",kdiehlboyd@covermymeds.com,CoverMyMeds,Health Services
268,CMS-2017-0156-1617,CMS-2017-0156-1617-0,"See attached file(s)

January 16, 2018


Submitted Via Federal eRulemaking Portal 
	http://www.regulations.gov

Centers for Medicare and Medicaid Services
U.S. Department of Health and Human Services

Subject:   Comment on Proposed Policy Changes and Updates for Medicare Advantage and the Prescription Drug Benefit Program for Contract Year 2019 (CMS-4182-P)

To Whom It May Concern:

As CMS considers policy changes and updates for Medicare Advantage and the Prescription Drug Benefit Program for the 2019 contract year, we take this opportunity to remind those interested of the important role accreditation plays in the safe and effective dispensing of prescription medications in the United States.

We believe that accreditation by a CMS-approved national accrediting organization is a reliable indicator of quality and a high level of service being delivered to patients. As such, we further assert that CMS approval should be the only requirement for acceptance of accreditation in pharmacy networks. Specifically, pharmacy providers should be free to choose which CMS-approved accrediting organization(s) to engage with. We believe all stakeholders are best served if accrediting organizations are forced to earn their standing in the market, rather than have some networks mandate the use of a particular accrediting organization. Mandating the use of a particular accrediting organization, aside from providing that organization with no incentive to incorporate efficiencies or adapt to meet market need, creates unreasonable burdens on providers and restricts access to medications for patients, as well as allowing for artificial price inflation, which may ultimately be borne in part by patients.

Accreditation is a rigorous, transparent and comprehensive process in which a health care organization undergoes an examination of its policies, administration, human resources, provision of care, documentation, performance improvement and safety practices.  This impartial, independent evaluation provides for the assessment, education and improvement of processes and quality of care.  Accreditation standards set quality benchmarks that supersede regulatory requirements to promote improvement throughout all aspects of the organization.

We therefore believe that an accreditation requirement is consistent with CMS' stated goals of promoting innovation while improving quality and empowering Medicare Advantage and Part D sponsors with tools to improve quality of care and provide more choices for plan enrollees.

It is also significant to note that this rigorous, independent assessment of a pharmacy provider's fitness and qualifications to dispense medications in a safe and compliant manner occurs at no cost to the government or to the public.

Accreditation Commission for Health Care (ACHC) is an independent, private, not-for-profit Corporation established in 1986 and is tax-exempt under Section 501 (c) (3) of the Internal Revenue Code.  ACHC is committed to delivering solutions that improve patient safety and quality of care, meeting customer and regulatory requirements, enhancing employee skills and performance, and continuous improvement of its quality management systems and processes. ACHC is a nationally recognized Accrediting Organization (AO) with deeming authority for Home Health, Hospice and Durable Medical Equipment, Prosthetics, Orthotics and Supplies (DMEPOS).  In addition, ACHC provides accreditation programs for Ambulatory Infusion Centers, Infusion Nursing, Infusion Pharmacy, Specialty Pharmacy, Long Term Care Pharmacy, Sterile/Non-sterile Compounding, Private Duty Nursing/Aide/Companion, Sleep Centers and Behavioral Health Services.
We thank you for this opportunity to provide feedback on these important policy changes.
",517,1,CMS-2017-0156,CMS-2017-0156-DRAFT-1622,NA,0983-AT08,Accreditation Commission for Health Care--NC,PUBLIC SUBMISSIONS,Public Comment,Yes,CMS-2017-0156-0046,Posted,01/18/2018,NA,"Hayes, Yolanda K (CMS)",01/16/2018,01/18/2018,No restrictions,NA,NA,NA,NA,1k2-90ym-7h03,1,1,3,1,J Andrew,Maddigan,Cary,United States,NC,27513,amaddigan@achc.org,Accreditation Commission for Health Care,NA,achc.org,J Andrew Maddigan,"Cary, NC, 27513",amaddigan@achc.org,Accreditation Commission for Health Care,Trade Association
218,CMS-2017-0156-1426,CMS-2017-0156-1426-0,"January 16, 2018

Centers for Medicare and Medicaid Services
Department of Health and Human Services
P.O. Box 8013
Baltimore, MD  21244-8013

Attention:

CMS-4182-P Request for Information
Docket CMS-2017-0156


Citizens Against Government Waste (CAGW) is a private, nonpartisan, nonprofit, organization representing more than one million members and supporters nationwide.  CAGW's mission is to eliminate waste, fraud, abuse, mismanagement, and inefficiency in the federal government.  Founded in 1984 by the late industrialist J. Peter Grace and syndicated columnist Jack Anderson, CAGW was established to follow up on the work of the President's Private Sector Survey on Cost Control, also known as the Grace Commission.

Section 1860D-11(i), the non-interference clause in MMA, prohibits the federal government from interfering in the price negotiations among drug manufacturers, pharmacies, and prescription drug plan sponsors.  It also disallows creating a specific formulary or instituting a price structure for the reimbursement of covered Part D drugs.  Allowing private entities to negotiate drug prices has made Medicare Part D one of the few government programs to cost less than predicted.

Please find in the attached PDF CAGW's full comments to CMS-4182-P ""Request for Information"" (RFI) regarding the application of manufacturer rebates and pharmacy price concessions to Medicare enrollees at the point of sale and CMS's consideration of ""setting the minimum percentage of manufacturer rebates that must be passed through at the point of sale [POS] at a point less than 100 percent of the applicable average rebate amount for drugs in the same drug category or class.""

Regardless of which proposed methodology offered in the RFI is adopted, it would establish price controls and would set precedent for this and future administrations to determine other price structures within Medicare Part D.  It is also a clear violation of the non-interference clause.  CAGW urges CMS not to adopt this policy in a future rulemaking.

",300,1,CMS-2017-0156,CMS-2017-0156-DRAFT-1431,NA,0983-AT08,Citizens Against Government Waste-DC,PUBLIC SUBMISSIONS,Public Comment,Yes,CMS-2017-0156-0046,Posted,01/17/2018,NA,"Hayes, Yolanda K (CMS)",01/16/2018,01/17/2018,No restrictions,NA,NA,NA,NA,1k2-90yg-3ixp,1,1,3,1,Thomas,Schatz,Washington,United States,DC,20036,ewright@cagw.org,Citizens Against Government Waste,NA,cagw.org,Thomas Schatz,"Washington, DC, 20036",ewright@cagw.org,Citizens Against Government Waste,Policy and Research
179,CMS-2017-0156-1542,CMS-2017-0156-1542-0,"See attached file

The American Society of Consultant Pharmacists (ASCP), is pleased to have the opportunity to comment on select provisions of the Center for Medicare and Medicaid Services Proposed Policy Changes and Updates for Medicare Advantage and the Prescription Drug Benefit Program for Contact Year 2019 (CMS-4182-P). ASCP has a long history of advocating for the medical best interests of people who reside in long-term care facilities and those enrolled in hospice programs. We appreciate CMS' continued concern for the welfare of the frail elderly who rely on the Medicare drug benefit as a vital lifeline. Our comments are focused on the following sections:
1.	Implementation of the Comprehensive Addiction and Recovery Act of 2016 (CARA)
2.	Updating the Part D E-Prescribing Standards
3.	Preclusion List and eliminating the requirement for all prescribers writing Medicare Part D prescriptions to enroll or opt out as a Medicare Provider
4.	Flexibility in the Medicare Advantage Uniformity Requirements
5.	Establishing Limitations for the Part D Special Election Period (SEP) for Dually Eligible Beneficiaries
6.	Any Willing Pharmacy Standards Terms and Conditions and Better Define Pharmacy Types
7.	Changes to the Days' Supply Required by the Part D Transition Process
8.	Expedited Substitutions of Certain Generics and Other Midyear Formulary Changes 
9.	Request for Information Regarding the Application of Manufacturer Rebates and Pharmacy Price Concessions to Drug Prices at the Point of Sale

Our comment letter is attached and is 14 pages. If there is any problem in reading it, please contact me immediately and I can resend or email copy. Thank you.

Arnold E. Clayman, PD, FASCP 
VP of Pharmacy Practice & Government Affairs
American Society of Consultant Pharmacists | www.ascp.com 
aclayman@ascp.com | t: 703.739.1300 ext. 178 | f: 703.739.1321




",267,1,CMS-2017-0156,CMS-2017-0156-DRAFT-1549,NA,0983-AT08,Arnold Clayman-VA,PUBLIC SUBMISSIONS,Public Comment,Yes,CMS-2017-0156-0046,Posted,01/18/2018,NA,"Hayes, Yolanda K (CMS)",01/16/2018,01/18/2018,No restrictions,NA,NA,NA,NA,1k2-90yl-qyb7,1,1,3,1,Arnold,Clayman,Alexandria,United States,VA,22314,aclayman@ascp.com,NA,NA,ascp.com,Arnold Clayman,"Alexandria, VA, 22314",aclayman@ascp.com,NA,NA
260,CMS-2017-0156-1505,CMS-2017-0156-1505-0,"Dear Administrator Verma,

On behalf of the Cancer Support Community (CSC), an international nonprofit organization that provides support, education, and hope to cancer patients, survivors, and their loved ones, we appreciate the opportunity to submit the attached comments on the Centers for Medicare & Medicaid Services (CMS) Medicare Program; Contract Year 2019 Policy and Technical Changes to the Medicare Advantage, Medicare Cost Plan, Medicare Fee-for-Service, the Medicare Prescription Drug Benefit Programs, and the PACE Program [CMS-4182-P].

As the largest direct provider of social and emotional support services for people impacted by cancer, and the largest nonprofit employer of psychosocial oncology professionals in the United States, CSC has a unique understanding of the cancer patient experience. Each year, CSC serves more than one million people affected by cancer through its network of over 40 licensed affiliates, more than 120 satellite locations, and a dynamic online community of individuals receiving social support services. Overall, we deliver more than $40 million in free, personalized services each year to individuals and families affected by cancer nationwide and internationally. 

CSC thanks CMS for the opportunity to provide the attached comments on this proposed rule and we stand ready to serve as a resource to CMS as we work together to ensure that patients have affordable access to comprehensive coverage through Medicare. Please reach out to me at linda@cancersupportcommunity.org if you would like to discuss any of the above in more detail. 

Sincerely,
 
Linda House, RN, BSN, MSM
President 
Cancer Support Community Headquarters
",244,1,CMS-2017-0156,CMS-2017-0156-DRAFT-1511,NA,0983-AT08,Cancer Support Community-DC,PUBLIC SUBMISSIONS,Public Comment,Yes,CMS-2017-0156-0046,Posted,01/18/2018,NA,"Hayes, Yolanda K (CMS)",01/16/2018,01/18/2018,No restrictions,NA,NA,NA,NA,1k2-90yk-mx1u,1,1,4,1,Anonymous,Anonymous,Washington,United States,DC,20005,kristen@cancersupportcommunity.org,Cancer Support Community,NA,cancersupportcommunity.org,Anonymous Anonymous,"Washington, DC, 20005",kristen@cancersupportcommunity.org,Cancer Support Community,NA
271,CMS-2017-0156-1620,CMS-2017-0156-1620-0,"PerformRx is a pharmacy benefit manager (PBM) for Medicare Advantage Prescription Drug Plans (MAPDs) and Medicare-Medicaid Plans (MMPs) nationwide. Thank you for this opportunity to comment on CMS' proposed Contract Year 2019 Policy and Technical Changes to the Medicare Advantage, Medicare Cost Plan, Medicare Fee-for-Service, the
Medicare Prescription Drug Benefit Programs, and the PACE Program.

First, we would like to express our appreciation for CMS' partnership in administration of the Part D program on behalf of Medicare beneficiaries.

However, we are concerned that the proposed rule would result in additional regulation contrary to Presidential Executive Order # 13771 on Reducing Regulation and Controlling Regulatory Costs and Presidential Executive Order # 13777 on Enforcing the Regulatory Reform Agenda. While we appreciate CMS' efforts to reduce regulatory burden in some areas, such as elimination of the Medicare prescriber enrollment requirement, we see increased regulation through the proposed rule. Our attached comments point out specific areas. We ask CMS to please reconsider this rule in light of the aforementioned Executive Orders.

Further, we are concerned that implementation of all of the proposed changes, which are major in scope, could not be accomplished by January 1, 2019. First, the final rule would need to be issued. Second, CMS would need to provide any needed clarifications. Third, as explained throughout our comments, this ambitious timeline for implementation would not be feasible across the industry.

Please see the attached comments. Thank you for your consideration.
",234,1,CMS-2017-0156,CMS-2017-0156-DRAFT-1625,NA,0983-AT08,PerformRx--PA,PUBLIC SUBMISSIONS,Public Comment,Yes,CMS-2017-0156-0046,Posted,01/18/2018,NA,"Hayes, Yolanda K (CMS)",01/16/2018,01/18/2018,No restrictions,NA,NA,NA,NA,1k2-90ym-41qh,1,1,3,1,Michelle,Juhanson,Philadelphia,United States,PA,19113,mjuhanson@performrx.com,PerformRx,NA,performrx.com,Michelle Juhanson,"Philadelphia, PA, 19113",mjuhanson@performrx.com,PerformRx,PBM
224,CMS-2017-0156-1347,CMS-2017-0156-1347-0,"We support the CMS Medicare proposal to restore the freedom of senior citizens to access medication at the pharmacy of their choice.

Today, the choice of pharmacy for many senior citizens is limited. Many are forced to go to pharmacies that are approved by Pharmacy Benefit Managers (PBMs) under contract with Medicare Part D sponsors. Family owned or independent pharmacies are often excluded from these ""preferred"" pharmacies and patients can be forced to change pharmacies as a result. In lower population areas, patients may need to travel increasingly long distances to reach a pharmacy classified as ""preferred"" by the PBMs. Patients should have the choice to access medication at any pharmacy that accepts their payment regardless of coverage.

Opening up this market to any willing pharmacy also increases competition among pharmacies nationwide, which always benefits consumers. The ""Any Willing Pharmacy"" policy will greatly encourage price competition and lead to lower costs in the Medicare Part D program. Kickbacks to and between the PBMs and large pharmaceutical companies only add to the costs of the current system while doing nothing to help the patient...

(Please see attached document.)",184,1,CMS-2017-0156,CMS-2017-0156-DRAFT-1351,NA,0983-AT08,Citizens' Council for Health Freedom-MN,PUBLIC SUBMISSIONS,Public Comment,Yes,CMS-2017-0156-0046,Posted,01/17/2018,NA,"Hayes, Yolanda K (CMS)",01/15/2018,01/17/2018,No restrictions,NA,NA,NA,NA,1k2-90xy-l5n0,1,1,3,1,Twila,"Brase RN, President",Saint Paul,United States,MN,55103,info@cchfreedom.org,Citizens' Council for Health Freedom,NA,cchfreedom.org,"Twila Brase RN, President","Saint Paul, MN, 55103",info@cchfreedom.org,Citizens' Council for Health Freedom,Beneficiary Advocate
61,CMS-2017-0156-1669,CMS-2017-0156-1669-0,"To Whom It May Concern, 

PointClickCare is pleased to share these comments on select provisions of the Center for Medicare & Medicaid Services (CMS) Proposed Policy Changes and Updates for Medicare Advantage and the Prescription Drug Benefit Program for Contact Year 2019 (CMS-4182-P). 
PointClickCare is the leading provider of cloud-based software and services designed for the long-term and post-acute care (LTPAC) and senior living markets.  PointClickCare is helping over 15,000 long-term and post-acute care (LTPAC) providers meet the challenges of senior care by enabling them to achieve the business results that matter  enriching the lives of their residents and patients, improving financial and operational health, and mitigating risk.  PointClickCares cloud-based software platform is advancing senior care by enabling a person-centered approach to care, connecting healthcare providers across the care continuum with easy to use, regulatory compliant solutions for improved resident outcomes, enhanced financial performance, and staff optimization.  

Please see attached file.
Thank you,
Genice Hornberger
Senior Product Advisor
PointClickCare",159,1,CMS-2017-0156,CMS-2017-0156-DRAFT-1673,NA,0983-AT08,PointClickCare-OH,PUBLIC SUBMISSIONS,Public Comment,Yes,CMS-2017-0156-0046,Posted,01/25/2018,NA,"Hayes, Yolanda K (CMS)",01/16/2018,01/25/2018,No restrictions,NA,NA,NA,NA,1k2-90yk-dj0j,1,1,4,1,Genice,Hornberger,Milford,United States,OH,45150,genice.hornberger@pointclickcare.com,PointClickCare,NA,pointclickcare.com,NA,NA,NA,NA,NA
185,CMS-2017-0156-1466,CMS-2017-0156-1466-0,"SinfoniaRx strongly supports the inclusion of medication therapy management (MTM) services in the numerator of the medical loss ratio (MLR). 
As an industry leader in the delivery of MTM services, we have seen first hand the impact these valuable services have 
improving the health of the patients we serve. Specific outcomes include improved medication utilization, improved markers of
health (e.g. blood pressure, blood glucose), reduced hospitalizations, and patient reported improved quality of life. Additionally,
there is strong evidence that MTM services does reduce healthcare costs. In a 2017 study completed by HSAG, MTM 
services provided after hospital discharge resulted in close to an 80 to 1 return on investment (study attached). 

Additionally, we have heard from the payers we contract with to deliver services that a key limitation on expanding these 
services to more beneficiaries is the current MLR calculation. SinfoniaRx does believe this proposed change would support 
more beneficiaries while reducing overall healthcare spending. 
",154,1,CMS-2017-0156,CMS-2017-0156-DRAFT-1471,NA,0983-AT08,SinfoniaRx-AZ,PUBLIC SUBMISSIONS,Public Comment,Yes,CMS-2017-0156-0046,Posted,01/18/2018,NA,"Hayes, Yolanda K (CMS)",01/16/2018,01/18/2018,No restrictions,NA,NA,NA,NA,1k2-90yj-us8o,1,1,3,1,Jeniece,Roher,Tucson,United States,AZ,85701,jiroher@sinfoniarx.com,SinfoniaRx,NA,sinfoniarx.com,Jeniece Roher,"Tucson, AZ, 85701",jiroher@sinfoniarx.com,SinfoniaRx,Health Services
162,CMS-2017-0156-1534,CMS-2017-0156-1534-0,"The Association for Accessible Medicines (AAM) appreciates the opportunity to provide input on the Contract Year 2019 Policy and Technical Changes to the Medicare Advantage, Medicare Cost Plan, Medicare Fee-for-Service, the Medicare Prescription Drug Benefit, and the PACE Program proposed rule (CMS-4182-P). As manufacturers of nine out of every 10 prescription medicines dispensed in the United States, AAM members form an integral, and powerful, part of the healthcare system. Generic drugs have saved patients and the U.S. health care system $1.67 trillion in the last decade, generating $253 billion in savings in 2016 alone. Medicare savings amounted to $77 billion ($1,883 per enrollee) and Medicaid savings of $37.9 billion ($512 per enrollee).

AAM is pleased with several of the proposals included in the rule, which we believe will help to strengthen the Part D prescription drug benefit for patients, and help make the benefit itself sustainable for the future.

(Please see attached.)",150,1,CMS-2017-0156,CMS-2017-0156-DRAFT-1541,NA,0983-AT08,Association for Accessible Medicines-DC,PUBLIC SUBMISSIONS,Public Comment,Yes,CMS-2017-0156-0046,Posted,01/18/2018,NA,"Hayes, Yolanda K (CMS)",01/16/2018,01/18/2018,No restrictions,NA,NA,NA,NA,1k2-90yk-glli,1,1,3,1,Christine,Simmon,Washington,United States,DC,20001,joseph.stewart@accessiblemeds.org,NA,NA,accessiblemeds.org,Christine Simmon,"Washington, DC, 20001",joseph.stewart@accessiblemeds.org,NA,NA
163,CMS-2017-0156-1179,CMS-2017-0156-1179-0,"Dear Sir or Madam,

Cerner Corporation (Cerner), a leading supplier of electronic health record, clinical and revenue cycle information systems appreciates the opportunity to submit comments on certain of the provisions of the Medicare Program; Contract Year 2019 Policy and Technical Changes to the Medicare Advantage, Medicare Cost Plan, Medicare Fee-for-Service, the Medicare Prescription Drug Benefits Programs and the PACE Program, Proposed Rule CMS-4182-P. We offer comments specifically on section II.B.8. E-Prescribing and the Part D Prescription Drug Program; Updating Part D E-Prescribing Standards. 

Cerner hopes these comments will be of value to CMS in considering possible update to the CY 2019 Medicare Part C and D Program Updates NPRM. We are happy to help clarify any of the comments should CMS wish to pursue any such conversations with us during the period of public comment review.

See attached file for the Cerner comments in their entirety.",145,1,CMS-2017-0156,CMS-2017-0156-DRAFT-1181,NA,0983-AT08,Cerner Corporation-MO,PUBLIC SUBMISSIONS,Public Comment,Yes,CMS-2017-0156-0046,Posted,01/16/2018,NA,"Hayes, Yolanda K (CMS)",01/12/2018,01/16/2018,No restrictions,NA,NA,NA,NA,1k2-90vv-bu5o,1,1,3,1,John,Travis,Kansas City,United States,MO,64117,jtravis@cerner.com,Cerner Corporation,NA,cerner.com,John Travis,"Kansas City, MO, 64117",jtravis@cerner.com,Cerner Corporation,Health Services
148,CMS-2017-0156-1508,CMS-2017-0156-1508-0,"The National Home Infusion Association (NHIA), representing the nations providers of infusion therapy in home and alternate-site settings submits the attached comments on the Centers for Medicare and Medicaid Services (CMS) proposed rule published for comment on November 18, 2017 entitled Medicare Program; Contract Year 2019 Policy and Technical Changes to the Medicare Advantage, Medicare Cost Plan, Medicare Fee-for-Service, the Medicare Prescription Drug Benefit Programs and the PACE Program.

NHIA appreciates the opportunity to comment on the proposed rule and continuing to work with CMS to ensure Medicare beneficiaries have access to the drugs and services home infusion providers avail to them.  Please feel free to have your staff contact Kendall Van Pool, NHIA Vice President of Government Affairs, at (703) 838-2664 or kendallvanpool@nhia.org should you want to discuss our comments further.  Thank you for your consideration of NHIAs comments.",141,1,CMS-2017-0156,CMS-2017-0156-DRAFT-1514,NA,0983-AT08,National Home Infusion Association-VA,PUBLIC SUBMISSIONS,Public Comment,Yes,CMS-2017-0156-0046,Posted,01/18/2018,NA,"Hayes, Yolanda K (CMS)",01/16/2018,01/18/2018,No restrictions,NA,NA,NA,NA,1k2-90yk-d5ar,1,1,4,1,Kendall,Van Pool,Alexandria,United States,VA,22314,kendall.vanpool@nhia.org,National Home Infusion Association,NA,nhia.org,Kendall Van Pool,"Alexandria, VA, 22314",kendall.vanpool@nhia.org,National Home Infusion Association,Trade Association
180,CMS-2017-0156-1619,CMS-2017-0156-1619-0,"APhA is pleased to submit these comments regarding the proposed changes to the Part D program for CY 2019 (the ""Proposed Rule"").  APhA, founded in 1852 as the American Pharmaceutical Association, represents 64,000 pharmacists, pharmaceutical scientists, student pharmacists, pharmacy technicians, and others interested in improving medication use and advancing patient care. APhA members provide care in all practice settings, including community pharmacies, physicians' offices, hospitals, long-term care facilities, community health centers, managed care organizations, hospice settings and the uniformed services. (See, attached .PDF for full comments). 

If you have any questions or require additional information, please contact Michael Baxter, Director of Regulatory Affairs, at mbaxter@aphanet.org or by phone at (202) 429-7538.

Sincerely,
 
Thomas E. Menighan, BSPharm, MBA, ScD (Hon), FAPhA
Executive Vice President and CEO

cc:	Stacie S. Maass, RPh, JD, Senior Vice President, Pharmacy Practice and Government Affairs
	Anne Burns, Vice President, Professional Affairs


",141,1,CMS-2017-0156,CMS-2017-0156-DRAFT-1624,NA,0983-AT08,American Pharmacists Association--DC,PUBLIC SUBMISSIONS,Public Comment,Yes,CMS-2017-0156-0046,Posted,01/18/2018,NA,"Hayes, Yolanda K (CMS)",01/16/2018,01/18/2018,No restrictions,NA,NA,NA,NA,1k2-90ym-h7bp,1,1,3,1,Michael,Baxter,Washington,United States,DC,20037,mbaxter@aphanet.org,American Pharmacists Association,NA,aphanet.org,Michael Baxter,"Washington, DC, 20037",mbaxter@aphanet.org,American Pharmacists Association,Trade Association (Pharmacy)
198,CMS-2017-0156-1516,CMS-2017-0156-1516-0,"To:    The Honorable Eric D. Hargan, Acting HHS Secretary
        The Honorable Seema Verma, CMS Administrator
        Centers for Medicare & Medicaid Services 
        Department of Health and Human Services
        Baltimore, MD  21244

From:     The National Health Care Anti-Fraud Association (NHCAA)

RE:         File Code CMS-4182-P

Date:      January 16, 2018

Please accept the attached comments regarding the CMS proposed rule ""Medicare Program; Contract Year 2019 Policy and Technical Changes to the Medicare Advantage, Medicare Cost Plan, Medicare Fee-for-Service, the Medicare Prescription Drug Benefit Programs, and the PACE Program"" (CMS-4182-P) published in the Federal Register on November 28, 2017.
",140,1,CMS-2017-0156,CMS-2017-0156-DRAFT-1522,NA,0983-AT08,National Health Care Anti-Fraud Association-DC,PUBLIC SUBMISSIONS,Public Comment,Yes,CMS-2017-0156-0046,Posted,01/18/2018,NA,"Hayes, Yolanda K (CMS)",01/16/2018,01/18/2018,No restrictions,NA,NA,NA,NA,1k2-90yk-vd6a,1,1,3,1,Leigh,McKenna,Washington,United States,DC,20005,lmckenna@nhcaa.org,National Health Care Anti-Fraud Association (NHCAA),NA,nhcaa.org,Leigh McKenna,"Washington, DC, 20005",lmckenna@nhcaa.org,National Health Care Anti-Fraud Association (NHCAA),Trade Association
120,CMS-2017-0156-1158,CMS-2017-0156-1158-0,"Dear Administrator Verma,

Please see the attached comment letter. 

--

The undersigned members of the Abuse Deterrent Coalition (ADC) offer the following comments for consideration on Docket No. CMS-2017-0157, ""Medicare Program: Contract Year 2019 Policy and Technical Changes to the Medicare Advantage, Medicare Cost Plan, Medicare Fee-for-Service, the Medicare Prescription Drug Benefit Programs, and the PACE Program.""

The ADC is a forum of abuse-deterrent formulation technology innovators, patient and issue associations and pharmaceutical manufacturers created to educate the public, policy makers and related regulatory agencies on the importance of abuse-deterrent (AD) opioids technologies utilized in the fight against prescription drug abuse. The Coalition serves as a unified voice for legislative and regulatory initiatives that support the required use of AD technologies for prescription drugs that have a high potential for abuse.

",128,1,CMS-2017-0156,CMS-2017-0156-DRAFT-1159,NA,0983-AT08,Abuse Deterrent Coalition-DC,PUBLIC SUBMISSIONS,Public Comment,Yes,CMS-2017-0156-0046,Posted,01/16/2018,NA,"Hayes, Yolanda K (CMS)",01/12/2018,01/16/2018,No restrictions,NA,NA,NA,NA,1k2-90vu-6ea3,1,1,3,1,Will,Loeb,Washington,United States,DC,20010-3516,wloeb@mcginnandcompany.com,Abuse Deterrent Coalition,NA,mcginnandcompany.com,Will Loeb,"Washington, DC, 20010-3516",wloeb@mcginnandcompany.com,Abuse Deterrent Coalition,Trade Association
93,CMS-2017-0156-1395,CMS-2017-0156-1395-0,"We appreciate this opportunity to offer comments on the 2019 proposed policy and technical changes under the Prescription Drug Benefit (Part D) and Medicare Advantage (MA) programs, and certain provisions of the Comprehensive Addiction and Recovery Act (CARA) and of the 21st Century Cures Act.

Priority Health is a Michigan-based non-profit health plan nationally recognized for improving the health and lives of its members. Created nearly 30 years ago, we offer a broad portfolio of health benefit options for Medicare, Medicaid, employer group and individual plans. Currently we have more than 130,000 members in our Medicare Advantage plans in our 68-county service area in Michigan. 

We respectfully submit the comments on the attached document, all of which pertain to the Medicare Advantage and Part D program.
",125,1,CMS-2017-0156,CMS-2017-0156-DRAFT-1400,NA,0983-AT08,Priority Health-MI,PUBLIC SUBMISSIONS,Public Comment,Yes,CMS-2017-0156-0046,Posted,01/17/2018,NA,"Hayes, Yolanda K (CMS)",01/16/2018,01/17/2018,No restrictions,NA,NA,NA,NA,1k2-90yd-7zou,1,1,3,1,Michelle,Coberly,Grand Rapids,United States,MI,49525,michelle.coberly@priorityhealth.com,Priority Health,NA,priorityhealth.com,Michelle Coberly,"Grand Rapids, MI, 49525",michelle.coberly@priorityhealth.com,Priority Health,Health Plan
110,CMS-2017-0156-1529,CMS-2017-0156-1529-0,"See attached file(s)

Good afternoon,

On behalf of Meals on Wheels America and our President and CEO, Ellie Hollander, I am pleased to submit comments on the Centers for Medicare & Medicaid Services Contract Year 2019 Policy and Technical Changes to the Medicare Advantage, Medicare Cost Plan, Medicare Fee-for-Service, the Medicare Prescription Drug Benefit Programs, and the PACE Program Proposed Rule (CMS-4182-P). We appreciate the opportunity for public comments on these important issues. Please see attached files.

Thank you for your consideration of our comments. We look forward to working with you and are available as a resource for any questions you have or information you might need. Please do not hesitate to reach out to me (katie.jantzi@mealsonwheelsamerica.org/571-339-1622) or my colleague, Erika Kelly (erika@mealsonwheelsamerica.org/571-339-1604).

Sincerely,
Katie Jantzi",122,1,CMS-2017-0156,CMS-2017-0156-DRAFT-1536,NA,0983-AT08,Meals on Wheels America-VA,PUBLIC SUBMISSIONS,Public Comment,Yes,CMS-2017-0156-0046,Posted,01/18/2018,NA,"Hayes, Yolanda K (CMS)",01/16/2018,01/18/2018,No restrictions,NA,NA,NA,NA,1k2-90yk-31u5,1,1,3,1,Katie,Jantzi,Arlington,United States,VA,22202,katie.jantzi@mealsonwheelsamerica.org,Meals on Wheels America,NA,mealsonwheelsamerica.org,Katie Jantzi,"Arlington, VA, 22202",katie.jantzi@mealsonwheelsamerica.org,Meals on Wheels America,NA
98,CMS-2017-0156-1458,CMS-2017-0156-1458-0,"The American Cancer Society Cancer Action Network (ACS CAN) appreciates the opportunity to comment on the proposed rule implementing policy and technical changes to the Medicare Part C and D programs. ACS CAN is the nonprofit, nonpartisan advocacy affiliate of the American Cancer Society and supports evidence-based policy and legislative solutions designed to eliminate cancer as a major health problem. As the nation's leading advocate for public policies that are helping to defeat cancer, ACS CAN ensures that cancer patients, survivors, and their families have a voice in public policy matters at all levels of government.

See attached comment letter.",99,1,CMS-2017-0156,CMS-2017-0156-DRAFT-1463,NA,0983-AT08,American Cancer Society Cancer Action Network-DC,PUBLIC SUBMISSIONS,Public Comment,Yes,CMS-2017-0156-0046,Posted,01/18/2018,NA,"Hayes, Yolanda K (CMS)",01/16/2018,01/18/2018,No restrictions,NA,NA,NA,NA,1k2-90yi-tf3m,1,1,3,1,Christopher,Hansen,Washington,United States,DC,20005,anna.howard@cancer.org,American Cancer Society Cancer Action Network,NA,cancer.org,Christopher Hansen,"Washington, DC, 20005",anna.howard@cancer.org,American Cancer Society Cancer Action Network,Trade Association
49,CMS-2017-0156-1553,CMS-2017-0156-1553-0,"The American College of Rheumatology appreciates the opportunity to respond to the Medicare Program; Contract Year 2019 Policy and Technical Changes to the Medicare Advantage, Medicare Cost Plan, Medicare Fee-for-Service, the Medicare Prescription Drug Benefit Program, and the PACE Program proposed rule. We look forward to being a resource to you and to working with the agency as this rule is finalized. Please contact Kayla L. Amodeo, Ph.D., Director of Regulatory Affairs, at kamodeo@rheumatology.org or (202) 210-1797 if you have questions or if we can be of assistance. Please find our comments in the attached PDF document.",97,1,CMS-2017-0156,CMS-2017-0156-DRAFT-1560,NA,0983-AT08,American College of Rheumatology-GA,PUBLIC SUBMISSIONS,Public Comment,Yes,CMS-2017-0156-0046,Posted,01/18/2018,NA,"Hayes, Yolanda K (CMS)",01/16/2018,01/18/2018,No restrictions,NA,NA,NA,NA,1k2-90yl-5415,1,1,3,1,Kayla,Amodeo,Atlanta,United States,GA,30319,kamodeo@rheumatology.org,American College of Rheumatology,NA,rheumatology.org,Kayla Amodeo,"Atlanta, GA, 30319",kamodeo@rheumatology.org,American College of Rheumatology,Trade Association (Providers)
88,CMS-2017-0156-1493,CMS-2017-0156-1493-0,"The Honorable Seema Verma, Administrator
Centers for Medicare & Medicaid Services
Department of Health and Human Services 
Attention:  CMS-4182-P
P.O. Box 8013
Baltimore, MD  21244-8013

RE: CMS-4182-P; Medicare Program; Contract Year 2019 Policy and Technical Changes to the Medicare Advantage, Medicare Cost Plan, Medicare Fee-for-Service, the Medicare 
Prescription Drug Benefit Programs, and the PACE Program; Proposed Rule;
Medicare Part D E-Prescribing Program Standards Sections Only

Dear Administrator Verma:

Please find our comment letter with respect to this notice of proposed rulemaking attached along with one supporting document.

Sincerely,

Ken Whittemore, Jr., R.Ph., MBA
VP, Professional & Regulatory Affairs
Telephone: (703) 921-2114
Email: ken.whittemore@surescripts.com

",92,1,CMS-2017-0156,CMS-2017-0156-DRAFT-1499,NA,0983-AT08,"Surescripts, LLC-VA",PUBLIC SUBMISSIONS,Public Comment,Yes,CMS-2017-0156-0046,Posted,01/18/2018,NA,"Hayes, Yolanda K (CMS)",01/16/2018,01/18/2018,No restrictions,NA,NA,NA,NA,1k2-90yk-1g3j,1,1,3,1,Ken,Whittemore Jr.,Arlington,United States,VA,22202,ken.whittemore@surescripts.com,"Surescripts, LLC",NA,surescripts.com,Ken Whittemore Jr.,"Arlington, VA, 22202",ken.whittemore@surescripts.com,"Surescripts, LLC",PBM
204,CMS-2017-0156-1578,CMS-2017-0156-1578-0,"RxAnte, Inc, a predictive analytics and clinical services company, appreciates the opportunity to provide comments to the Centers for Medicare & Medicaid Services (CMS) on the proposed rule, Medicare Program; Contract Year 2019 Policy and Technical Changes to the Medicare Advantage, Medicare Cost Plan, Medicare Fee-for-Service, the Medicare Prescription Drug Benefit Programs, and the PACE Program [CMS-4182-P], released on November 16, 2017. Specifically, RxAnte offers comments on the section of the proposed rule focused on the Medicare Advantage (MA) and Part D Quality Ratings System. Please find RxAnte's comments attached.",90,1,CMS-2017-0156,CMS-2017-0156-DRAFT-1585,NA,0983-AT08,"RxAnte, Inc-ME",PUBLIC SUBMISSIONS,Public Comment,Yes,CMS-2017-0156-0046,Posted,01/18/2018,NA,"Hayes, Yolanda K (CMS)",01/16/2018,01/18/2018,No restrictions,NA,NA,NA,NA,1k2-90yl-jb6t,1,1,3,1,Joshua,Benner,Portland,United States,ME,4101,jbenner@rxante.com,NA,NA,rxante.com,Joshua Benner,"Portland, ME, 04101",jbenner@rxante.com,NA,Health Services
261,CMS-2017-0156-0870,CMS-2017-0156-0870-0,"At the request of Marilynn ""Lynn"" Malerba, Chief of the Mohegan Tribe and Chairwoman of the Tribal Self-Governance Advisory  Committee (TSGAC), attached are the official comments on ""Medicare Program; Contract Year 2019 Policy and Technical Changes to the Medicare Advantage, Medicare Cost Plan, Medicare Fee-for-Service, the Medicare Prescription Drug Benefit Programs, and the PACE Program (CMS-4182-P)"". If you have any questions, please contact Chief Malerba at (860) 862-6192 or email @ lmalerba@moheganmail.com. Thank you.",75,1,CMS-2017-0156,CMS-2017-0156-DRAFT-0870,NA,0983-AT08,IHS Tribal Self-Governance Advisory Committee- DC,PUBLIC SUBMISSIONS,Public Comment,Yes,CMS-2017-0156-0046,Posted,01/11/2018,NA,"Hayes, Yolanda K (CMS)",01/08/2018,01/11/2018,No restrictions,NA,NA,NA,NA,1k2-90ta-32at,1,1,3,1,Cyndi,Ferguson,Washington,United States,DC,20036,cyndif@senseinc.com,IHS Tribal Self-Governance Advisory Committee,NA,senseinc.com,Cyndi Ferguson,"Washington, DC, 20036",cyndif@senseinc.com,IHS Tribal Self-Governance Advisory Committee,Other - Gov
122,CMS-2017-0156-1590,CMS-2017-0156-1590-0,"Attached are the comments of Blue Cross of Idaho Health Service, Inc. and Blue Cross of Idaho Care Plus, Inc. with respect to CMS-4182-PMedicare Program: Contract Year 2019 Policy and Technical Changes to the Medicare Advantage, Medicare Cost Plan, Medicare Fee-for-Service, the Medicare Prescription Drug Benefit Programs and the PACE Program Proposed Rule (82 Federal Register 56336 (Nov. 28, 2017) and 82 Federal Register 61519 (Dec. 28, 2017)).",68,1,CMS-2017-0156,CMS-2017-0156-DRAFT-1597,NA,0983-AT08,Blue Cross of Idaho-ID,PUBLIC SUBMISSIONS,Public Comment,Yes,CMS-2017-0156-0046,Posted,01/18/2018,NA,"Hayes, Yolanda K (CMS)",01/16/2018,01/18/2018,No restrictions,NA,NA,NA,NA,1k2-90yl-3y7b,1,1,3,1,Blue Cross of Idaho,Blue Cross of Idaho,NA,United States,ID,83642,NA,"Blue Cross of Idaho Health Service, Inc. and Blue Cross of Idaho Care Plus, Inc.",NA,NA,Blue Cross of Idaho Blue Cross of Idaho,"ID, 83642",NA,"Blue Cross of Idaho Health Service, Inc. and Blue Cross of Idaho Care Plus, Inc.",Health Plan
96,CMS-2017-0156-1592,CMS-2017-0156-1592-0,"Attached please find InnovaCare, Inc.  / MMM Healthcare, LLC (Contracts H4003, H4004, H7522)  comments  to CMS with respect to the proposed rule CMS- 41 82- P  ""Medicare Program; Contract Year 2019 Policy and Technical Changes to the Medicare Advantage, Medicare Cost Plan, Medicare Fee-for-Service, the Medicare Prescription Drug Benefit Programs, and the PACE Program.""

Thanks!

Myra Plumey
Compliance Officer
",60,1,CMS-2017-0156,CMS-2017-0156-DRAFT-1600,NA,0983-AT08,"InnovaCare, Inc./ MMM Healthcare, LLC-PR",PUBLIC SUBMISSIONS,Public Comment,Yes,CMS-2017-0156-0046,Posted,01/18/2018,NA,"Hayes, Yolanda K (CMS)",01/16/2018,01/18/2018,No restrictions,NA,NA,NA,NA,1k2-90yl-s5r0,1,1,3,1,Myra,Plumey,San Juan,United States,PR,918,myra.plumey@mmmhc.com,"InnovaCare, Inc./ MMM Healthcare, LLC",NA,mmmhc.com,Myra Plumey,"San Juan, PR, 00918",myra.plumey@mmmhc.com,"InnovaCare, Inc./ MMM Healthcare, LLC",Health Plan
132,CMS-2017-0156-1594,CMS-2017-0156-1594-0,"Attached please find the Biotechnology Innovation Organization's (BIO) comments on the Medicare Program; Contract Year 2019 Policy and Technical Changes to the Medicare Advantage, Medicare Cost Plan, Medicare Fee-for-Service, the Medicare Prescription Drug Benefit Programs and the PACE Program Proposed Rule [CMS-4182-P]. BIO appreciates the opportunity to comment on this Proposed Rule. Thank you for your consideration of our comments.",60,1,CMS-2017-0156,CMS-2017-0156-DRAFT-1602,NA,0983-AT08,Biotechnology Innovation Organization-DC,PUBLIC SUBMISSIONS,Public Comment,Yes,CMS-2017-0156-0046,Posted,01/18/2018,NA,"Hayes, Yolanda K (CMS)",01/16/2018,01/18/2018,No restrictions,NA,NA,NA,NA,1k2-90yl-vund,1,1,3,1,Anonymous,Anonymous,Washington,United States,DC,20024,moconnor@bio.org,Biotechnology Innovation Organization,NA,bio.org,Anonymous Anonymous,"Washington, DC, 20024",moconnor@bio.org,Biotechnology Innovation Organization,Trade Association (Manufacturers)
272,CMS-2017-0156-1512,CMS-2017-0156-1512-0,"The Pharmaceutical Care Management Association (PCMA) appreciates the opportunity to submit the attached comments on the Medicare Program Contract Year 2019 Policy and Technical Changes to the Medicare Advantage, Medicare Cost Plan, Medicare Fee-For-Service, the Medicare Prescription Drug Benefit Programs, and the PACE Program Proposed Rule and Request for Information as published in the Federal Register on November 28, 2017.",60,1,CMS-2017-0156,CMS-2017-0156-DRAFT-1518,NA,0983-AT08,Pharmaceutical Care Management Association-DC,PUBLIC SUBMISSIONS,Public Comment,Yes,CMS-2017-0156-0046,Posted,01/18/2018,NA,"Hayes, Yolanda K (CMS)",01/16/2018,01/18/2018,No restrictions,NA,NA,NA,NA,1k2-90yk-frtm,1,1,3,1,Mona,Mahmoud,Washington DC,United States,DC,20004,mmahmoud@pcmanet.org,PCMA,NA,pcmanet.org,Mona Mahmoud,"Washington DC, DC, 20004",mmahmoud@pcmanet.org,PCMA,Trade Association
73,CMS-2017-0156-1433,CMS-2017-0156-1433-0,"Please find attached comments by The AIDS Institute in strong support of requiring plan sponsors to pass on at least a certain percentage of manufacturer rebates at the point-of-sale (POS) to the beneficiary. Doing so will decrease patient cost-sharing, reduce the incentive for plans to choose high priced, high rebates drugs, and increase patient adherence to medications.  
",59,1,CMS-2017-0156,CMS-2017-0156-DRAFT-1438,NA,0983-AT08,The AIDS Institute-DC,PUBLIC SUBMISSIONS,Public Comment,Yes,CMS-2017-0156-0046,Posted,01/17/2018,NA,"Hayes, Yolanda K (CMS)",01/16/2018,01/17/2018,No restrictions,NA,NA,NA,NA,1k2-90yg-7iyg,1,1,3,1,Carl,Schmid,Washington,United States,DC,20036,cschmid@theaidsinstitute.org,The AIDS Institute,NA,theaidsinstitute.org,Carl Schmid,"Washington, DC, 20036",cschmid@theaidsinstitute.org,The AIDS Institute,Beneficiary Advocate
280,CMS-2017-0156-1526,CMS-2017-0156-1526-0,"On behalf of the Association of Women in Rheumatology (AWIR), we are pleased to submit the attached comments on the Medicare Program; Contract Year 2019 Policy and Technical Changes to the Medicare Advantage, Medicare Cost Plan, Medicare Fee-for-Service, the Medicare Prescription Drug Benefit Programs, and the PACE Program, and wish to thank CMS for the opportunity to contribute.",58,1,CMS-2017-0156,CMS-2017-0156-DRAFT-1533,NA,0983-AT08,Association of Women in Rheumatology-IL,PUBLIC SUBMISSIONS,Public Comment,Yes,CMS-2017-0156-0046,Posted,01/18/2018,NA,"Hayes, Yolanda K (CMS)",01/16/2018,01/18/2018,No restrictions,NA,NA,NA,NA,1k2-90yk-otkn,1,1,3,1,Anonymous,Anonymous,Schaumburg,United States,IL,60173,ally@wjweiser.com,Association of Women in Rheumatology,NA,wjweiser.com,Anonymous Anonymous,"Schaumburg, IL, 60173",ally@wjweiser.com,Association of Women in Rheumatology,Trade Association (Providers)
1,CMS-2017-0156-1563,CMS-2017-0156-1563-0,"On behalf of the American Health Care Association and National Center for Assisted Living (AHCA/NCAL), attached please find a comment letter in response to the proposed rule, Medicare Program; Contract Year 2019 Policy and Technical Changes to the Medicare Advantage, Medicare Cost Plan, Medicare Fee-for-Service, the Medicare Prescription Drug Benefit Programs, and the PACE Program (CMS-4182-P).
",56,1,CMS-2017-0156,CMS-2017-0156-DRAFT-1570,NA,0983-AT08,American Health Care Assn and National Ctr for Assisted Living-DC,PUBLIC SUBMISSIONS,Public Comment,Yes,CMS-2017-0156-0046,Posted,01/18/2018,NA,"Hayes, Yolanda K (CMS)",01/16/2018,01/18/2018,No restrictions,NA,NA,NA,NA,1k2-90yl-bxpv,1,1,3,1,Narda,Ipakchi,Washington,United States,DC,20005,nipakchi@ahca.org,AHCA/NCAL,NA,ahca.org,Narda Ipakchi,"Washington, DC, 20005",nipakchi@ahca.org,AHCA/NCAL,Trade Association (LTC)
40,CMS-2017-0156-1581,CMS-2017-0156-1581-0,"On behalf of the American Health Care Association and National Center for Assisted Living (AHCA/NCAL), attached please find a comment letter in response to the proposed rule, Medicare Program; Contract Year 2019 Policy and Technical Changes to the Medicare Advantage, Medicare Cost Plan, Medicare Fee-for-Service, the Medicare Prescription Drug Benefit Programs, and the PACE Program (CMS-4182-P).",56,1,CMS-2017-0156,CMS-2017-0156-DRAFT-1588,NA,0983-AT08,American Health Care Assn and National Ctr for Assisted Living-DC,PUBLIC SUBMISSIONS,Public Comment,Yes,CMS-2017-0156-0046,Posted,01/18/2018,NA,"Hayes, Yolanda K (CMS)",01/16/2018,01/18/2018,No restrictions,NA,NA,NA,NA,1k2-90yl-vuq0,1,1,3,1,Narda,Ipakchi,Washington,United States,DC,20005,nipakchi@ahca.org,AHCA/NCAL,NA,ahca.org,Narda Ipakchi,"Washington, DC, 20005",nipakchi@ahca.org,AHCA/NCAL,Trade Association (LTC)
123,CMS-2017-0156-1656,CMS-2017-0156-1656-0,"Please find attached comments from the Academy of Managed Care Pharmacy (AMCP) in response to the proposed rule ""Medicare Program; Contract Year 2019 Policy and Technical Changes to the Medicare Advantage, Medicare Cost Plan, Medicare Fee-for-Service, the Medicare Prescription Drug Benefit Programs, and the PACE Program [CMS-4182-P]"" published in the Federal Register on November 28, 2017.",56,1,CMS-2017-0156,CMS-2017-0156-DRAFT-1661,NA,0983-AT08,Academy of Managed Care Pharmacy-VA,PUBLIC SUBMISSIONS,Public Comment,Yes,CMS-2017-0156-0046,Posted,01/18/2018,NA,"Hayes, Yolanda K (CMS)",01/16/2018,01/18/2018,No restrictions,NA,NA,NA,NA,1k2-90ys-cqs2,1,1,3,1,Anonymous,Anonymous,Alexandria,United States,VA,22314,ssaha@amcp.org,Academy of Managed Care Pharmacy (AMCP),NA,amcp.org,Anonymous Anonymous,"Alexandria, VA, 22314",ssaha@amcp.org,Academy of Managed Care Pharmacy (AMCP),Trade Association
50,CMS-2017-0156-1548,CMS-2017-0156-1548-0,"Thank you for the opportunity to provide our attached comments on the CY2019 Proposed Changes to the Medicare Advantage and Part D programs released on November 16, 2017.

If you have questions with regard to our comments and recommendations, please contact me at (212) 453-4457 or mhusmann@healthfirst.org.

Sincerely,

Michael Husmann
Director, Regulatory Affairs
Healthfirst Health Plan, Inc.
Contracts H3359 and H5441
",55,1,CMS-2017-0156,CMS-2017-0156-DRAFT-1555,NA,0983-AT08,"Healthfirst Health Plan, Inc.-NY",PUBLIC SUBMISSIONS,Public Comment,Yes,CMS-2017-0156-0046,Posted,01/18/2018,NA,"Hayes, Yolanda K (CMS)",01/16/2018,01/18/2018,No restrictions,NA,NA,NA,NA,1k2-90yl-e8ia,1,1,3,1,Michael,Husmann,New York,United States,NY,10007,mhusmann@healthfirst.org,NA,NA,healthfirst.org,Michael Husmann,"New York, NY, 10007",mhusmann@healthfirst.org,NA,Health Plan
45,CMS-2017-0156-1468,CMS-2017-0156-1468-0,"Anthem, Inc. appreciates the opportunity to provide comments in response to the Contract Year 2019 Policy and Technical Changes to the Medicare Advantage, Medicare Cost Plan, Medicare Fee-for-Service, the Medicare Prescription Drug Benefit Programs, and the PACE Program proposed rule, released on November 16, 2017.

Our detailed comments are included in the attached.",52,1,CMS-2017-0156,CMS-2017-0156-DRAFT-1473,NA,0983-AT08,"Anthem, Inc.-NY",PUBLIC SUBMISSIONS,Public Comment,Yes,CMS-2017-0156-0046,Posted,01/18/2018,NA,"Hayes, Yolanda K (CMS)",01/16/2018,01/18/2018,No restrictions,NA,NA,NA,NA,1k2-90yj-hbph,1,1,3,1,Christine,Harhaj,New York,United States,NY,10005,christine.harhaj@anthem.com,"Anthem, Inc.",NA,anthem.com,Christine Harhaj,"New York, NY, 10005",christine.harhaj@anthem.com,"Anthem, Inc.",Health Plan
274,CMS-2017-0156-0961,CMS-2017-0156-0961-0,"The Medicare Cost Contractors Alliance (""Cost Alliance"") is submitting these attached comments
 in response to the notice of proposed rulemaking, dated November 28, 2017, ""Medicare Program; 
Contract Year 2019 Policy and Technical Changes to the Medicare Advantage, Medicare Cost Plan, 
Medicare Fee-for-Service, the Medicare Prescription Drug Benefit Programs, and the PACE Program.""",52,1,CMS-2017-0156,CMS-2017-0156-DRAFT-0961,NA,0983-AT08,Medicare Cost Contractors Alliance-MD,PUBLIC SUBMISSIONS,Public Comment,Yes,CMS-2017-0156-0046,Posted,01/16/2018,NA,"Hayes, Yolanda K (CMS)",01/10/2018,01/16/2018,No restrictions,NA,NA,NA,NA,1k2-90ui-umvh,1,1,3,1,Mark,Joffe,Rockville,United States,MD,20852,marksjoffe@gmail.com,Medicare Cost Contractors Alliance,NA,gmail.com,Mark Joffe,"Rockville, MD, 20852",marksjoffe@gmail.com,Medicare Cost Contractors Alliance,Trade Association
269,CMS-2017-0156-1533,CMS-2017-0156-1533-0,"On behalf of the Coalition of State Rheumatology Organizations (CSRO), we are pleased to submit the attached comments on the Medicare Program; Contract Year 2019 Policy and Technical Changes to the Medicare Advantage, Medicare Cost Plan, Medicare Fee-for-Service, the Medicare Prescription Drug Benefit Programs, and the PACE Program.",48,1,CMS-2017-0156,CMS-2017-0156-DRAFT-1540,NA,0983-AT08,Coalition of State Rheumatology Organizations-IL,PUBLIC SUBMISSIONS,Public Comment,Yes,CMS-2017-0156-0046,Posted,01/18/2018,NA,"Hayes, Yolanda K (CMS)",01/16/2018,01/18/2018,No restrictions,NA,NA,NA,NA,1k2-90yk-obyt,1,1,3,1,Anonymous,Anonymous,Schaumburg,United States,IL,60173,ally@wjweiser.com,Coalition of State Rheumatology Organizations,NA,wjweiser.com,Anonymous Anonymous,"Schaumburg, IL, 60173",ally@wjweiser.com,Coalition of State Rheumatology Organizations,Trade Association
282,CMS-2017-0156-0993,CMS-2017-0156-0993-0,"See attached file(s); I am writing to express my serious concerns with several provisions included in CMS' proposed rulemaking titled: ""Medicare Program; Contract Year 2019 Policy and Technical Changes to the Medicare Advantage, Medicare Cost Plan, Medicare Fee-for-Service, the Medicare Prescription Drug Benefit Programs, and the PACE Program.""
",48,1,CMS-2017-0156,CMS-2017-0156-DRAFT-0994,NA,0983-AT08,Susan Peppers-OH,PUBLIC SUBMISSIONS,Public Comment,Yes,CMS-2017-0156-0046,Posted,01/16/2018,NA,"Hayes, Yolanda K (CMS)",01/11/2018,01/16/2018,No restrictions,NA,NA,NA,NA,1k2-90v2-e6oo,1,1,3,1,Susan,Peppers,Middletown,United States,OH,45044,susan_peppers@express-scripts.com,NA,NA,express-scripts.com,Susan Peppers,"Middletown, OH, 45044",susan_peppers@express-scripts.com,NA,PBM
3,CMS-2017-0156-1285,CMS-2017-0156-1285-0,Please accept the attached comments from the Minnesota Dental Association. The Minnesota Dental Association welcomes the improvements to the enrollment requirements for Medicare Part C and Part D programs for providers who are not otherwise required to enroll and who do not submit claims to Medicare.,46,1,CMS-2017-0156,CMS-2017-0156-DRAFT-1288,NA,0983-AT08,Daniel Lightfoot-MN,PUBLIC SUBMISSIONS,Public Comment,Yes,CMS-2017-0156-0046,Posted,01/17/2018,NA,"Hayes, Yolanda K (CMS)",01/15/2018,01/17/2018,No restrictions,NA,NA,NA,NA,1k2-90xt-zo19,1,1,3,1,Daniel,Lightfoot,Minneapolis,United States,MN,55413,dlightfoot@mndental.org,Minnesota Dental Association,NA,mndental.org,Daniel Lightfoot,"Minneapolis, MN, 55413",dlightfoot@mndental.org,Minnesota Dental Association,Trade Association (Dental)
25,CMS-2017-0156-1622,CMS-2017-0156-1622-0,"Comment (attached) on behalf of Dialysis Clinic Inc. (DCI) on the following:
Re: CMS-4182-P: Medicare Program; Contract Year 2019 Policy and Technical Changes to the Medicare Advantage, 
Medicare Cost Plan, Medicare Fee-for-Service, the Medicare Prescription Drug Benefit Programs, and the PACE Program,
November 28, 2017.",43,1,CMS-2017-0156,CMS-2017-0156-DRAFT-1627,NA,0983-AT08,Dialysis Clinic Inc. (DCI)--DC,PUBLIC SUBMISSIONS,Public Comment,Yes,CMS-2017-0156-0046,Posted,01/18/2018,NA,"Hayes, Yolanda K (CMS)",01/16/2018,01/18/2018,No restrictions,NA,NA,NA,NA,1k2-90ym-5e1q,1,1,3,1,Martin,Corry,Washington,United States,DC,20004,mcorry@health-law.com,Dialysis Clinic Inc. (DCI),NA,health-law.com,Martin Corry,"Washington, DC, 20004",mcorry@health-law.com,Dialysis Clinic Inc. (DCI),Provider
60,CMS-2017-0156-1443,CMS-2017-0156-1443-0,"On behalf of Providence Health Assurance (PHA) I would like to thank you for the opportunity to provide comments on the CY 2019 Medicare Program Proposed Rules. Please find our comment letter attached for your review.

Sincerely,
Keri Steege
Medicare Compliance Officer
Providence Health Assurance - H9047",43,1,CMS-2017-0156,CMS-2017-0156-DRAFT-1448,NA,0983-AT08,Providence Health Assurance-OR,PUBLIC SUBMISSIONS,Public Comment,Yes,CMS-2017-0156-0046,Posted,01/17/2018,NA,"Hayes, Yolanda K (CMS)",01/16/2018,01/17/2018,No restrictions,NA,NA,NA,NA,1k2-90yh-p37f,1,1,3,1,Keri,Steege,Beaverton,United States,OR,97005,keri.steege@providence.org,NA,NA,providence.org,Keri Steege,"Beaverton, OR, 97005",keri.steege@providence.org,NA,NA
188,CMS-2017-0156-1453,CMS-2017-0156-1453-0,"On behalf on SCAN Health Plan, please find attached comments on the proposed ""Medicare Program; Contract Year 2019 Policy and Technical Changes to the Medicare Advantage, Medicare Cost Plan, Medicare Fee-for-Service, the Medicare Prescription Drug Benefit Programs, and the PACE Program.""

Thank you,

Dan Elling",43,1,CMS-2017-0156,CMS-2017-0156-DRAFT-1458,NA,0983-AT08,SCAN Health Plan-DC,PUBLIC SUBMISSIONS,Public Comment,Yes,CMS-2017-0156-0046,Posted,01/17/2018,NA,"Hayes, Yolanda K (CMS)",01/16/2018,01/17/2018,No restrictions,NA,NA,NA,NA,1k2-90yi-fcjx,1,1,3,1,Dan,Elling,Washington,United States,DC,20001,dan@lpgdc.com,SCAN Health Plan,NA,lpgdc.com,Dan Elling,"Washington, DC, 20001",dan@lpgdc.com,SCAN Health Plan,Health Plan
217,CMS-2017-0156-0841,CMS-2017-0156-0841-0,"Attached please find comments from the American Association of Nurse Anesthetists on CMS-4812-P - Medicare Program; Contract Year 2019 Policy and Technical Changes to the Medicare Advantage, Medicare Cost Plan, Medicare Fee-for-Service, the Medicare Prescription Drug Benefit Programs, and the PACE Program",42,1,CMS-2017-0156,CMS-2017-0156-DRAFT-0840,NA,0983-AT08,American Association of Nurse Anesthetists-DC,PUBLIC SUBMISSIONS,Public Comment,Yes,CMS-2017-0156-0046,Posted,01/10/2018,NA,"Braxton, Shawn L (CMS)",01/08/2018,01/10/2018,No restrictions,NA,NA,NA,NA,1k2-90t7-wfxn,1,1,3,1,Anonymous,Anonymous,NA,United States,DC,20001,NA,American Association of Nurse Anesthetists,NA,NA,Anonymous Anonymous,"DC, 20001",NA,American Association of Nurse Anesthetists,Trade Association (Providers)
237,CMS-2017-0156-1650,CMS-2017-0156-1650-0,"Please see attached comments from Justice in Aging regarding the Proposed Rule: Medicare Program; Contract Year 2019 Policy and Technical Changes to the Medicare Advantage, Medicare Cost Plan, Medicare Fee-for-Service, the Medicare Prescription Drug Benefit Programs, and the PACE Program, CMS-4182-P.",41,1,CMS-2017-0156,CMS-2017-0156-DRAFT-1655,NA,0983-AT08,Justice in Aging-DC,PUBLIC SUBMISSIONS,Public Comment,Yes,CMS-2017-0156-0046,Posted,01/18/2018,NA,"Hayes, Yolanda K (CMS)",01/16/2018,01/18/2018,No restrictions,NA,NA,NA,NA,1k2-90yq-64na,1,1,3,1,Jennifer,Goldberg,Washington,United States,DC,20005,jgoldberg@justiceinaging.org,Justice in Aging,NA,justiceinaging.org,Jennifer Goldberg,"Washington, DC, 20005",jgoldberg@justiceinaging.org,Justice in Aging,Beneficiary Advocate
78,CMS-2017-0156-1478,CMS-2017-0156-1478-0,"Attached please find a comment letter on Medicare Program; Contract Year 2019 Policy and Technical Changes to the Medicare Advantage, Medicare Cost Plan, Medicare Fee-for-Service, the Medicare Prescription Drug Benefit Programs, and the PACE Program, filed on behalf of Cigna.",40,1,CMS-2017-0156,CMS-2017-0156-DRAFT-1483,NA,0983-AT08,Cigna-DC,PUBLIC SUBMISSIONS,Public Comment,Yes,CMS-2017-0156-0046,Posted,01/18/2018,NA,"Hayes, Yolanda K (CMS)",01/16/2018,01/18/2018,No restrictions,NA,NA,NA,NA,1k2-90yj-k258,1,1,3,1,Anonymous,Anonymous,Washington,United States,DC,20004,lynn.nonnemaker@cigna.com,Cigna,NA,cigna.com,Anonymous Anonymous,"Washington, DC, 20004",lynn.nonnemaker@cigna.com,Cigna,Health Plan
249,CMS-2017-0156-1524,CMS-2017-0156-1524-0,"On behalf of Tufts Health Plan, we appreciate the opportunity to provide the attached comments on the proposed Medicare Advantage program regulations and Prescription Drug Benefit program regulations, released by the Centers for Medicare and Medicaid on November 28, 2017.",40,1,CMS-2017-0156,CMS-2017-0156-DRAFT-1531,NA,0983-AT08,Tufts Health Plan-MA,PUBLIC SUBMISSIONS,Public Comment,Yes,CMS-2017-0156-0046,Posted,01/18/2018,NA,"Hayes, Yolanda K (CMS)",01/16/2018,01/18/2018,No restrictions,NA,NA,NA,NA,1k2-90yk-fc4s,1,1,4,1,Nicole,Waickman,Watertown,United States,MA,2472,nicole_waickman@tufts-health.com,Tufts Health Plan,NA,tufts-health.com,Nicole Waickman,"Watertown, MA, 02472",nicole_waickman@tufts-health.com,Tufts Health Plan,Health Plan
258,CMS-2017-0156-1575,CMS-2017-0156-1575-0,"Please find the attached comments from Premier, Inc for the Medicare Program; Contract Year 2019 Policy and Technical Changes to the Medicare Advantage, Medicare Cost Plan, Medicare Fee-for-Service, the Medicare Prescription Drug Benefit Programs, and the PACE Program proposed rule.",40,1,CMS-2017-0156,CMS-2017-0156-DRAFT-1582,NA,0983-AT08,"Premier, Inc-DC",PUBLIC SUBMISSIONS,Public Comment,Yes,CMS-2017-0156-0046,Posted,01/18/2018,NA,"Hayes, Yolanda K (CMS)",01/16/2018,01/18/2018,No restrictions,NA,NA,NA,NA,1k2-90yl-sgou,1,1,3,1,Blair,Childs,NA,United States,DC,20001,Blair_Childs@PremierInc.com,"Premier, Inc",NA,PremierInc.com,Blair Childs,"DC, 20001",Blair_Childs@PremierInc.com,"Premier, Inc",Health Services
216,CMS-2017-0156-1625,CMS-2017-0156-1625-0,"Please find attached Astellas' comments related to the proposed rule:  Medicare Program; Contract Year 2019 Policy and Technical Changes to the Medicare Advantage, Medicare Cost Plan, Medicare Fee-for-Service, the Medicare Prescription Drug Benefit Programs, and the PACE Program.
",39,1,CMS-2017-0156,CMS-2017-0156-DRAFT-1630,NA,0983-AT08,Astellas--DC,PUBLIC SUBMISSIONS,Public Comment,Yes,CMS-2017-0156-0046,Posted,01/18/2018,NA,"Hayes, Yolanda K (CMS)",01/16/2018,01/18/2018,No restrictions,NA,NA,NA,NA,1k2-90yn-v49g,1,1,3,1,Anonymous,Anonymous,NA,United States,DC,20001,emily.wheeler@astellas.com,Astellas,NA,astellas.com,Anonymous Anonymous,"DC, 20001",emily.wheeler@astellas.com,Astellas,Manufacturer
291,CMS-2017-0156-1623,CMS-2017-0156-1623-0,"Please find attached MEDITECH's comments on the proposed rule for Medicare Program; Contract Year 2019 Policy and Technical Changes to the Medicare Advantage, Medicare Cost Plan, Medicare Fee-for-Service, the Medicare Prescription Drug Benefit Programs, and the PACE Program.",38,1,CMS-2017-0156,CMS-2017-0156-DRAFT-1628,NA,0983-AT08,MEDITECH--MA,PUBLIC SUBMISSIONS,Public Comment,Yes,CMS-2017-0156-0046,Posted,01/18/2018,NA,"Hayes, Yolanda K (CMS)",01/16/2018,01/18/2018,No restrictions,NA,NA,NA,NA,1k2-90ym-eyoj,1,1,4,1,Kari,Gordon,Westwood,United States,MA,2090,kgordon@meditech.com,MEDITECH,NA,meditech.com,Kari Gordon,"Westwood, MA, 02090",kgordon@meditech.com,MEDITECH,Health Services
105,CMS-2017-0156-1570,CMS-2017-0156-1570-0,"Dear Representatives of the Centers for Medicare and Medicaid Services: 

In the attached Excel spreadsheet we include our comments to the Medicare Program Proposed Rule. 
Thank you for the opportunity to submit the same.  

",36,1,CMS-2017-0156,CMS-2017-0156-DRAFT-1577,NA,0983-AT08,Abarca Health-PR,PUBLIC SUBMISSIONS,Public Comment,Yes,CMS-2017-0156-0046,Posted,01/18/2018,NA,"Hayes, Yolanda K (CMS)",01/16/2018,01/18/2018,No restrictions,NA,NA,NA,NA,1k2-90yl-n1fy,1,1,3,1,Angeles,Monroig,San Juan,United States,PR,918,angeles.monroig@abarcahealth.com,Abarca Health,NA,abarcahealth.com,Angeles Monroig,"San Juan, PR, 00918",angeles.monroig@abarcahealth.com,Abarca Health,PBM
209,CMS-2017-0156-1582,CMS-2017-0156-1582-0,"Attached, please find AARP's comments on Medicare Program; Contract Year 2019 Policy and Technical Changes to the Medicare Advantage, Medicare Cost Plan, Medicare Fee-for-Service, the Medicare Prescription Drug Benefit Programs, and the PACE Program.",34,1,CMS-2017-0156,CMS-2017-0156-DRAFT-1589,NA,0983-AT08,AARP-DC,PUBLIC SUBMISSIONS,Public Comment,Yes,CMS-2017-0156-0046,Posted,01/18/2018,NA,"Hayes, Yolanda K (CMS)",01/16/2018,01/18/2018,No restrictions,NA,NA,NA,NA,1k2-90yl-qjcj,1,1,3,1,Amy,Kelbick,Washington,United States,DC,20049,akelbick@aarp.org,AARP,NA,aarp.org,Amy Kelbick,"Washington, DC, 20049",akelbick@aarp.org,AARP,Beneficiary Advocate
279,CMS-2017-0156-1495,CMS-2017-0156-1495-0,Attached are comments from the Blue Cross and Blue Shield Association on the proposed rule related to Medicare Advantage and Part D with a response also to the RFI on Point of Sale Rebates,34,1,CMS-2017-0156,CMS-2017-0156-DRAFT-1501,NA,0983-AT08,Blue Cross Blue Shield Association-DC,PUBLIC SUBMISSIONS,Public Comment,Yes,CMS-2017-0156-0046,Posted,01/18/2018,NA,"Hayes, Yolanda K (CMS)",01/16/2018,01/18/2018,No restrictions,NA,NA,NA,NA,1k2-90yk-u16f,1,1,3,1,Jane,Galvin,Washington,United States,DC,20005,Jane.Galvin@bcbsa.com,Blue Cross Blue Shield Association,NA,bcbsa.com,Jane Galvin,"Washington, DC, 20005",Jane.Galvin@bcbsa.com,Blue Cross Blue Shield Association,Trade Association (Health Plans)
289,CMS-2017-0156-1554,CMS-2017-0156-1554-0,"Please find attached comments from the National Association of Medicaid Directors, focused on proposed changes to Medicare Advantage Duals Special Needs Plans (D-SNP) default enrollment options, passive enrollment, and special election period modifications.",33,1,CMS-2017-0156,CMS-2017-0156-DRAFT-1561,NA,0983-AT08,National Association of Medicaid Directors-DC,PUBLIC SUBMISSIONS,Public Comment,Yes,CMS-2017-0156-0046,Posted,01/18/2018,NA,"Hayes, Yolanda K (CMS)",01/16/2018,01/18/2018,No restrictions,NA,NA,NA,NA,1k2-90yl-w075,1,1,3,1,Jack,Rollins,Washington,United States,DC,20001,jack.rollins@medicaiddirectors.org,National Association of Medicaid Directors,NA,medicaiddirectors.org,Jack Rollins,"Washington, DC, 20001",jack.rollins@medicaiddirectors.org,National Association of Medicaid Directors,Trade Association
102,CMS-2017-0156-1654,CMS-2017-0156-1654-0,Please find the attached comment concerning the timeline for the new standard changes. Nebraska Medicine believes it prudent to extend the date in which the new NCPDP standards will take effect.,31,1,CMS-2017-0156,CMS-2017-0156-DRAFT-1659,NA,0983-AT08,Nebraska Medicine-NE,PUBLIC SUBMISSIONS,Public Comment,Yes,CMS-2017-0156-0046,Posted,01/18/2018,NA,"Hayes, Yolanda K (CMS)",01/16/2018,01/18/2018,No restrictions,NA,NA,NA,NA,1k2-90ys-aztw,1,1,4,1,David,Cloyed,Omaha,United States,NE,68198,dacloyed@nebraskamed.com,Nebraska Medicine,NA,nebraskamed.com,David Cloyed,"Omaha, NE, 68198",dacloyed@nebraskamed.com,Nebraska Medicine,Provider
264,CMS-2017-0156-1421,CMS-2017-0156-1421-0,"Attached is the Campaign for Sustainable Rx Pricings response to CMS-4182-P.  If you have any questions concerning our comments, please do not hesitate to call Lauren Aronson at 202-585-0255.",30,1,CMS-2017-0156,CMS-2017-0156-DRAFT-1426,NA,0983-AT08,Campaign for Sustainable Rx Pricing-DC,PUBLIC SUBMISSIONS,Public Comment,Yes,CMS-2017-0156-0046,Posted,01/17/2018,NA,"Hayes, Yolanda K (CMS)",01/16/2018,01/17/2018,No restrictions,NA,NA,NA,NA,1k2-90yg-2i1c,1,1,4,1,Lauren,Aronson,"Washington, DC",United States,DC,20005,laronson@mc-dc.com,Campaign for Sustainable Rx Pricing (CSRxP),NA,mc-dc.com,Lauren Aronson,"Washington, DC, DC, 20005",laronson@mc-dc.com,Campaign for Sustainable Rx Pricing (CSRxP),NA
244,CMS-2017-0156-1504,CMS-2017-0156-1504-0,"I am submitting the attached comments on behalf of the HIV Health Care Access Working Group.  Please feel free to contact me at 703-299-0915 with questions.  

Andrea",29,1,CMS-2017-0156,CMS-2017-0156-DRAFT-1510,NA,0983-AT08,HIV Health Care Access Working Group-VA,PUBLIC SUBMISSIONS,Public Comment,Yes,CMS-2017-0156-0046,Posted,01/18/2018,NA,"Hayes, Yolanda K (CMS)",01/16/2018,01/18/2018,No restrictions,NA,NA,NA,NA,1k2-90yk-dmj8,1,1,3,1,Andrea,Weddle,Arlington,United States,VA,22209,aweddle@idsociety.org,NA,NA,idsociety.org,Andrea Weddle,"Arlington, VA, 22209",aweddle@idsociety.org,NA,NA
108,CMS-2017-0156-1452,CMS-2017-0156-1452-0,"Please find attached the comment letter from Blue Cross Blue Shield of Michigan. Please contact me if you have any questions.
Thank you for the opportunity to submit comments.",28,1,CMS-2017-0156,CMS-2017-0156-DRAFT-1457,NA,0983-AT08,Blue Cross Blue Shield of Michigan-MI,PUBLIC SUBMISSIONS,Public Comment,Yes,CMS-2017-0156-0046,Posted,01/17/2018,NA,"Hayes, Yolanda K (CMS)",01/16/2018,01/17/2018,No restrictions,NA,NA,NA,NA,1k2-90yi-7b3g,1,1,3,1,Lauren,Benbow,NA,United States,MI,48226,lbenbow@bcbsm.com,Blue Cross Blue Shield of Michigan,NA,bcbsm.com,Lauren Benbow,"MI, 48226",lbenbow@bcbsm.com,Blue Cross Blue Shield of Michigan,Health Plan
144,CMS-2017-0156-1099,CMS-2017-0156-1099-0,"Dear Administrator, 

Good Afternoon! On behalf of Northeast Pharmacy Service Corporation (NPSC), I would like to submit our attached comments on CMS-4182-P. 

Best Regards,
Dave Benoit
VP, Patient Care Service
NPSC",28,1,CMS-2017-0156,CMS-2017-0156-DRAFT-1100,NA,0983-AT08,Northeast Pharmacy Service Corporation-MA,PUBLIC SUBMISSIONS,Public Comment,Yes,CMS-2017-0156-0046,Posted,01/16/2018,NA,"Hayes, Yolanda K (CMS)",01/11/2018,01/16/2018,No restrictions,NA,NA,NA,NA,1k2-90v9-svid,1,1,3,1,Dave,Benoit,Framingham,United States,MA,1701,dave@northeastpharmacy.com,Northeast Pharmacy Service Corporation,NA,northeastpharmacy.com,Dave Benoit,"Framingham, MA, 01701",dave@northeastpharmacy.com,Northeast Pharmacy Service Corporation,NA
9,CMS-2017-0156-1540,CMS-2017-0156-1540-0,Attached please find Centene Corporation's 25 page comment letter to CMS regarding the CY2019 Proposed Policy and Technical Changes to the MA Program CMS-4182-P.  Thank you.,27,1,CMS-2017-0156,CMS-2017-0156-DRAFT-1547,NA,0983-AT08,Centene Corporation-DC,PUBLIC SUBMISSIONS,Public Comment,Yes,CMS-2017-0156-0046,Posted,01/18/2018,NA,"Hayes, Yolanda K (CMS)",01/16/2018,01/18/2018,No restrictions,NA,NA,NA,NA,1k2-90yl-amfe,1,1,3,1,Joseph,Musker,Washington,United States,DC,20036,jmusker@centene.com,Centene Corporation,NA,centene.com,Joseph Musker,"Washington, DC, 20036",jmusker@centene.com,Centene Corporation,Health Plan
211,CMS-2017-0156-1511,CMS-2017-0156-1511-0,"On behalf of the National Psoriasis Foundation, attached please find comments on the proposed changes to the Medicare Part D program for contract year 2019. Thank you.",27,1,CMS-2017-0156,CMS-2017-0156-DRAFT-1517,NA,0983-AT08,National Psoriasis Foundation-VA,PUBLIC SUBMISSIONS,Public Comment,Yes,CMS-2017-0156-0046,Posted,01/18/2018,NA,"Hayes, Yolanda K (CMS)",01/16/2018,01/18/2018,No restrictions,NA,NA,NA,NA,1k2-90yk-2vzb,1,1,3,1,Anonymous,Anonymous,Alexandria,United States,VA,22314,jnagro@psoriasis.org,National Psoriasis Foundation,NA,psoriasis.org,Anonymous Anonymous,"Alexandria, VA, 22314",jnagro@psoriasis.org,National Psoriasis Foundation,Beneficiary Advocate
11,CMS-2017-0156-0964,CMS-2017-0156-0964-0,"To Whom It May Concern,

Please see the New York City Department of Health and Mental Hygiene's comments, attached. We thank you for the opportunity to contribute.",26,1,CMS-2017-0156,CMS-2017-0156-DRAFT-0964,NA,0983-AT08,New York City Department of Health and Mental Hygiene-NY,PUBLIC SUBMISSIONS,Public Comment,Yes,CMS-2017-0156-0046,Posted,01/16/2018,NA,"Hayes, Yolanda K (CMS)",01/10/2018,01/16/2018,No restrictions,NA,NA,NA,NA,1k2-90uk-3v05,1,1,3,1,Zachary,Withers,New York,United States,NY,11101,zwithers@health.nyc.gov,New York City Department of Health and Mental Hygiene,NA,health.nyc.gov,Zachary Withers,"New York, NY, 11101",zwithers@health.nyc.gov,New York City Department of Health and Mental Hygiene,Other - Gov
246,CMS-2017-0156-1541,CMS-2017-0156-1541-0,The Smarter Health Care Coalition is pleased to submit the attached comments in response to this proposed rule and specifically on the Medicare Advantage uniformity requirements.,26,1,CMS-2017-0156,CMS-2017-0156-DRAFT-1548,NA,0983-AT08,Smarter Health Care Coalition-DC,PUBLIC SUBMISSIONS,Public Comment,Yes,CMS-2017-0156-0046,Posted,01/18/2018,NA,"Hayes, Yolanda K (CMS)",01/16/2018,01/18/2018,No restrictions,NA,NA,NA,NA,1k2-90yl-hm19,1,1,3,1,Priya,Lamba,Washington,United States,DC,20004,plamba@healthsperien.com,Smarter Health Care Coalition,NA,healthsperien.com,Priya Lamba,"Washington, DC, 20004",plamba@healthsperien.com,Smarter Health Care Coalition,NA
253,CMS-2017-0156-1207,CMS-2017-0156-1207-0,Thank you for the opportunity to provide comments on this proposed rule. Please see the attached document for the National MLTSS Health Plan Association's comments.,25,1,CMS-2017-0156,CMS-2017-0156-DRAFT-1210,NA,0983-AT08,The National MLTSS Health Plan Association-DC,PUBLIC SUBMISSIONS,Public Comment,Yes,CMS-2017-0156-0046,Posted,01/16/2018,NA,"Hayes, Yolanda K (CMS)",01/12/2018,01/16/2018,No restrictions,NA,NA,NA,NA,1k2-90vz-o193,1,1,3,1,Lawrence,Atkins,Washington,United States,DC,20006,latkins@mltss.org,National MLTSS Health Plan Association,NA,mltss.org,Lawrence Atkins,"Washington, DC, 20006",latkins@mltss.org,National MLTSS Health Plan Association,Trade Association
276,CMS-2017-0156-1639,CMS-2017-0156-1639-0,Kaiser Permanente appreciates the opportunity to comment on the 2019 MA and Part D Policy and Technical Changes Proposed Rule. Please see the attached document.,25,1,CMS-2017-0156,CMS-2017-0156-DRAFT-1644,NA,0983-AT08,Kaiser Permanente --CA,PUBLIC SUBMISSIONS,Public Comment,Yes,CMS-2017-0156-0046,Posted,01/18/2018,NA,"Hayes, Yolanda K (CMS)",01/16/2018,01/18/2018,No restrictions,NA,NA,NA,NA,1k2-90yo-q1rn,1,1,3,1,Anonymous,Anonymous,Oakland,United States,CA,94612,NA,Kaiser Permanente,NA,NA,Anonymous Anonymous,"Oakland, CA, 94612",NA,Kaiser Permanente,Health Plan
48,CMS-2017-0156-1424,CMS-2017-0156-1424-0,"See attached file. If there are any questions or concerns, please contact, Anne Hubbard, Director of Health Policy, at 703-839-7394 or Anne.Hubbard@ASTRO.org.",22,1,CMS-2017-0156,CMS-2017-0156-DRAFT-1429,NA,0983-AT08,American Society for Radiation Oncology-VA,PUBLIC SUBMISSIONS,Public Comment,Yes,CMS-2017-0156-0046,Posted,01/17/2018,NA,"Hayes, Yolanda K (CMS)",01/16/2018,01/17/2018,No restrictions,NA,NA,NA,NA,1k2-90yg-sts1,1,1,3,1,Anne,Hubbard,Arlington,United States,VA,22202,anne.hubbard@astro.org,American Society for Radiation Oncology (ASTRO),NA,astro.org,Anne Hubbard,"Arlington, VA, 22202",anne.hubbard@astro.org,American Society for Radiation Oncology (ASTRO),Trade Association (Providers)
245,CMS-2017-0156-1646,CMS-2017-0156-1646-0,See attached comment letter from the Council for Affordable Health Coverage in support of policies to lower health costs and improve affordability.,22,1,CMS-2017-0156,CMS-2017-0156-DRAFT-1651,NA,0983-AT08,Council for Affordable Health Coverage--DE,PUBLIC SUBMISSIONS,Public Comment,Yes,CMS-2017-0156-0046,Posted,01/18/2018,NA,"Hayes, Yolanda K (CMS)",01/16/2018,01/18/2018,No restrictions,NA,NA,NA,NA,1k2-90yq-t5xd,1,1,3,1,Joel,White,Washington,United States,DE,20001,joel.white@cahc.net,CAHC,NA,cahc.net,Joel White,"Washington, DE, 20001",joel.white@cahc.net,CAHC,NA
118,CMS-2017-0156-1518,CMS-2017-0156-1518-0,"See attached file containing a letter from Alan G. Rosenbloom, President & CEO, Senior Care Pharmacy Coalition, Washington, DC.

Thank you.",20,1,CMS-2017-0156,CMS-2017-0156-DRAFT-1524,NA,0983-AT08,Senior Care Pharmacy Coalition-DC,PUBLIC SUBMISSIONS,Public Comment,Yes,CMS-2017-0156-0046,Posted,01/18/2018,NA,"Hayes, Yolanda K (CMS)",01/16/2018,01/18/2018,No restrictions,NA,NA,NA,NA,1k2-90yk-m47s,1,1,3,1,Alan,Rosenbloom,Washington,United States,DC,20006,ARosenbloom@seniorcarepharmacies.org,Senior Care Pharmacy Coalition,NA,seniorcarepharmacies.org,Alan Rosenbloom,"Washington, DC, 20006",ARosenbloom@seniorcarepharmacies.org,Senior Care Pharmacy Coalition,NA
124,CMS-2017-0156-0532,CMS-2017-0156-0532-0,Attached are Independence's comments to the proposed 2019 Part C & D Regulation. Thank you for your time and consideration.,20,1,CMS-2017-0156,CMS-2017-0156-DRAFT-0531,NA,0983-AT08,Kate Keenan-PA,PUBLIC SUBMISSIONS,Public Comment,Yes,CMS-2017-0156-0046,Posted,01/02/2018,NA,"Hayes, Yolanda K (CMS)",12/28/2017,01/02/2018,No restrictions,NA,NA,NA,NA,1k1-90lr-er8g,1,1,3,1,Kate,Keenan,Philadelphia,United States,PA,19103,kate.keenan@ibx.com,Independence Blue Cross,NA,ibx.com,Kate Keenan,"Philadelphia, PA, 19103",kate.keenan@ibx.com,Independence Blue Cross,Health Plan
131,CMS-2017-0156-1547,CMS-2017-0156-1547-0,Please see attached document for the American College of Physician's comments on CMS' Medicare Advantage and Part D Proposed Rule.,20,1,CMS-2017-0156,CMS-2017-0156-DRAFT-1554,NA,0983-AT08,American College of Physicians-DC,PUBLIC SUBMISSIONS,Public Comment,Yes,CMS-2017-0156-0046,Posted,01/18/2018,NA,"Hayes, Yolanda K (CMS)",01/16/2018,01/18/2018,No restrictions,NA,NA,NA,NA,1k2-90yl-1el9,1,1,3,1,Brooke,Rockwern,Washington,United States,DC,20001,brockwern@acponline.org,American College of Physicians,NA,acponline.org,Brooke Rockwern,"Washington, DC, 20001",brockwern@acponline.org,American College of Physicians,Trade Association (Providers)
142,CMS-2017-0156-1644,CMS-2017-0156-1644-0,Thank you for the opportunity to provide comment. Please see the attached file for comments on behalf of Molina Healthcare.,20,1,CMS-2017-0156,CMS-2017-0156-DRAFT-1649,NA,0983-AT08,Molina Healthcare--CA,PUBLIC SUBMISSIONS,Public Comment,Yes,CMS-2017-0156-0046,Posted,01/18/2018,NA,"Hayes, Yolanda K (CMS)",01/16/2018,01/18/2018,No restrictions,NA,NA,NA,NA,1k2-90yp-2e7j,1,1,3,1,Brianna,Ensslin,Long Beach,United States,CA,90802,brianna.ensslin@molinahealthcare.com,Molina Healthcare,NA,molinahealthcare.com,Brianna Ensslin,"Long Beach, CA, 90802",brianna.ensslin@molinahealthcare.com,Molina Healthcare,Health Plan
145,CMS-2017-0156-1611,CMS-2017-0156-1611-0,Please see the attached comments from the Pennsylvania Department of Aging and the Pennsylvania Department of Human Services.,18,1,CMS-2017-0156,CMS-2017-0156-DRAFT-1616,NA,0983-AT08,Pennsylvania Department of Aging and Pennsylvania Department of Human Services--PA,PUBLIC SUBMISSIONS,Public Comment,Yes,CMS-2017-0156-0046,Posted,01/18/2018,NA,"Hayes, Yolanda K (CMS)",01/16/2018,01/18/2018,No restrictions,NA,NA,NA,NA,1k2-90ym-kyd7,1,1,4,1,Caitlin,Palmer,Harrisburg,United States,PA,17120,caipalmer@pa.gov,Pennsylvania Department of Human Services,NA,pa.gov,Caitlin Palmer,"Harrisburg, PA, 17120",caipalmer@pa.gov,Pennsylvania Department of Human Services,Other - Gov
159,CMS-2017-0156-1507,CMS-2017-0156-1507-0,Please accept the attached AMGA comments in response to this proposed MA/Part D rule (CMS-4182-P).  Thank you.,18,1,CMS-2017-0156,CMS-2017-0156-DRAFT-1513,NA,0983-AT08,Advanced High Performance Health-VA,PUBLIC SUBMISSIONS,Public Comment,Yes,CMS-2017-0156-0046,Posted,01/18/2018,NA,"Hayes, Yolanda K (CMS)",01/16/2018,01/18/2018,No restrictions,NA,NA,NA,NA,1k2-90yk-jf5k,1,1,4,1,david,introcaso,Alexandria,United States,VA,22314,dintrocaso@amga.org,AMGA,NA,amga.org,david introcaso,"Alexandria, VA, 22314",dintrocaso@amga.org,AMGA,NA
71,CMS-2017-0156-1598,CMS-2017-0156-1598-0,Please see attached for the collective comments of UPMC Health Plan and the UPMC Insurance Services Division.,17,1,CMS-2017-0156,CMS-2017-0156-DRAFT-1606,NA,0983-AT08,UPMC Health Plan-PA,PUBLIC SUBMISSIONS,Public Comment,Yes,CMS-2017-0156-0046,Posted,01/18/2018,NA,"Hayes, Yolanda K (CMS)",01/16/2018,01/18/2018,No restrictions,NA,NA,NA,NA,1k2-90yl-f5zz,1,1,3,1,Caleb,Wallace,NA,United States,PA,15219,wallacecb@upmc.edu,UPMC Health Plan,NA,upmc.edu,Caleb Wallace,"PA, 15219",wallacecb@upmc.edu,UPMC Health Plan,Health Plan
99,CMS-2017-0156-1488,CMS-2017-0156-1488-0,"Please see the attached comments from EmblemHealth, a Medicare Advantage Organization operating in New York and Connecticut.",17,1,CMS-2017-0156,CMS-2017-0156-DRAFT-1494,NA,0983-AT08,EmblemHealth-NY,PUBLIC SUBMISSIONS,Public Comment,Yes,CMS-2017-0156-0046,Posted,01/18/2018,NA,"Hayes, Yolanda K (CMS)",01/16/2018,01/18/2018,No restrictions,NA,NA,NA,NA,1k2-90yk-cxtq,1,1,3,1,Anonymous,Anonymous,New York,United States,NY,10041,hweiss@emblemhealth.com,EmblemHealtth,NA,emblemhealth.com,Anonymous Anonymous,"New York, NY, 10041",hweiss@emblemhealth.com,EmblemHealtth,Health Plan
106,CMS-2017-0156-1603,CMS-2017-0156-1603-0,"Attached please find Aetna, Inc.'s comments on the Medicare Part C and D Proposed Rule.

Thank you.",16,1,CMS-2017-0156,CMS-2017-0156-DRAFT-1611,NA,0983-AT08,Aetna-CT,PUBLIC SUBMISSIONS,Public Comment,Yes,CMS-2017-0156-0046,Posted,01/18/2018,NA,"Hayes, Yolanda K (CMS)",01/16/2018,01/18/2018,No restrictions,NA,NA,NA,NA,1k2-90ym-5iwq,1,1,3,1,Steven,Kelmar,NA,United States,CT,6156,llowenstein@groom.com,NA,NA,groom.com,Steven Kelmar,"CT, 06156",llowenstein@groom.com,NA,NA
109,CMS-2017-0156-0919,CMS-2017-0156-0919-0,Attached are comments submitted on behalf of Wolters Kluwer Health. Thanks for the opportunity to comment.,16,1,CMS-2017-0156,CMS-2017-0156-DRAFT-0919,NA,0983-AT08,Wolters Kluwer Health-MN,PUBLIC SUBMISSIONS,Public Comment,Yes,CMS-2017-0156-0046,Posted,01/16/2018,NA,"Hayes, Yolanda K (CMS)",01/09/2018,01/16/2018,No restrictions,NA,NA,NA,NA,1k2-90tu-tle9,1,1,3,1,Robert,Hussey,NA,United States,MN,55439,NA,Wolters Kluwer Health,NA,NA,Robert Hussey,"MN, 55439",NA,Wolters Kluwer Health,NA
207,CMS-2017-0156-1480,CMS-2017-0156-1480-0,"VIVA Health, Inc. appreciates the opportunity to comment on the proposed rule. Our comments are attached.",16,1,CMS-2017-0156,CMS-2017-0156-DRAFT-1485,NA,0983-AT08,"VIVA Health, Inc.-AL",PUBLIC SUBMISSIONS,Public Comment,Yes,CMS-2017-0156-0046,Posted,01/18/2018,NA,"Hayes, Yolanda K (CMS)",01/16/2018,01/18/2018,No restrictions,NA,NA,NA,NA,1k2-90yj-ev6x,1,1,3,1,Nancy,Beasley,Birmingham,United States,AL,35203,nbeasley@uabmc.edu,"VIVA Health, Inc.",NA,uabmc.edu,Nancy Beasley,"Birmingham, AL, 35203",nbeasley@uabmc.edu,"VIVA Health, Inc.",Health Plan
117,CMS-2017-0156-0048,CMS-2017-0156-0048-0,"On behalf of the American Physical Therapy Association, please find attached our comments. Thank you.",15,1,CMS-2017-0156,CMS-2017-0156-DRAFT-0047,NA,0983-AT08,American Physical Therapy Association-VA,PUBLIC SUBMISSIONS,Public Comment,Yes,CMS-2017-0156-0046,Posted,12/26/2017,NA,"Hayes, Yolanda K (CMS)",12/18/2017,12/26/2017,No restrictions,NA,NA,NA,NA,1k1-90f3-xl3b,1,1,3,1,Kara,Gainer,Alexandria,United States,VA,22314,karagainer@apta.org,American Physical Therapy Association,NA,apta.org,Kara Gainer,"Alexandria, VA, 22314",karagainer@apta.org,American Physical Therapy Association,Trade Association (Providers)
177,CMS-2017-0156-1614,CMS-2017-0156-1614-0,Please find the attached comments submitted on behalf of the National Alliance on Mental Illness.,15,1,CMS-2017-0156,CMS-2017-0156-DRAFT-1619,NA,0983-AT08,National Alliance on Mental Illness--VA,PUBLIC SUBMISSIONS,Public Comment,Yes,CMS-2017-0156-0046,Posted,01/18/2018,NA,"Hayes, Yolanda K (CMS)",01/16/2018,01/18/2018,No restrictions,NA,NA,NA,NA,1k2-90ym-dwhf,1,1,3,1,Andrew,Sperling,Arlington,United States,VA,22203,asperling@nami.org,National Alliance on Mental Illness,NA,nami.org,Andrew Sperling,"Arlington, VA, 22203",asperling@nami.org,National Alliance on Mental Illness,Beneficiary Advocate
192,CMS-2017-0156-1501,CMS-2017-0156-1501-0,Thank you for the opportunity to comment on Proposed Rule CMS-4182-P. Our comments are attached.,15,1,CMS-2017-0156,CMS-2017-0156-DRAFT-1507,NA,0983-AT08,"MII Life, Incorporated-MN",PUBLIC SUBMISSIONS,Public Comment,Yes,CMS-2017-0156-0046,Posted,01/18/2018,NA,"Hayes, Yolanda K (CMS)",01/16/2018,01/18/2018,No restrictions,NA,NA,NA,NA,1k2-90yk-6nk1,1,1,3,1,Amy,Luhmann,Eagan,United States,MN,55121,amy.luhmann@ClearStoneSolutions.com,"MII Life, Incorporated",NA,ClearStoneSolutions.com,Amy Luhmann,"Eagan, MN, 55121",amy.luhmann@ClearStoneSolutions.com,"MII Life, Incorporated",NA
254,CMS-2017-0156-1587,CMS-2017-0156-1587-0,"On behalf of Mallinckrodt Pharmaceuticals, please see attached for our comments to the Proposed Rule.

",15,1,CMS-2017-0156,CMS-2017-0156-DRAFT-1594,NA,0983-AT08,Mallinckrodt Pharmaceuticals-DC,PUBLIC SUBMISSIONS,Public Comment,Yes,CMS-2017-0156-0046,Posted,01/18/2018,NA,"Hayes, Yolanda K (CMS)",01/16/2018,01/18/2018,No restrictions,NA,NA,NA,NA,1k2-90yl-vz3h,1,1,3,1,Beth,Kolbe,NA,United States,DC,20001,NA,Mallinckrodt Pharmaceuticals,NA,NA,Beth Kolbe,"DC, 20001",NA,Mallinckrodt Pharmaceuticals,Manufacturer
47,CMS-2017-0156-1521,CMS-2017-0156-1521-0,Attached please find the Paramount Health Care Comments relative to the CMS-4182-P Proposed Rule.,14,1,CMS-2017-0156,CMS-2017-0156-DRAFT-1527,NA,0983-AT08,Paramount Health Care-OH,PUBLIC SUBMISSIONS,Public Comment,Yes,CMS-2017-0156-0046,Posted,01/18/2018,NA,"Hayes, Yolanda K (CMS)",01/16/2018,01/18/2018,No restrictions,NA,NA,NA,NA,1k2-90yk-dah1,1,1,3,1,Nicole,Beadle,Maumee,United States,OH,43537,nicole.beadle@promedica.org,NA,NA,promedica.org,Nicole Beadle,"Maumee, OH, 43537",nicole.beadle@promedica.org,NA,Provider
173,CMS-2017-0156-0896,CMS-2017-0156-0896-0,See attached file(s) for a comment letter from the National Renal Administrators Association (NRAA).,14,1,CMS-2017-0156,CMS-2017-0156-DRAFT-0896,NA,0983-AT08,The National Renal Administrators Association-PA,PUBLIC SUBMISSIONS,Public Comment,Yes,CMS-2017-0156-0046,Posted,01/11/2018,NA,"Hayes, Yolanda K (CMS)",01/09/2018,01/11/2018,No restrictions,NA,NA,NA,NA,1k2-90tr-7xxk,1,1,4,1,Marc,Chow,Philadelphia,United States,PA,19103,mchow@nraa.org,National Renal Administrators Association (NRAA),NA,nraa.org,Marc Chow,"Philadelphia, PA, 19103",mchow@nraa.org,National Renal Administrators Association (NRAA),Trade Association
233,CMS-2017-0156-1605,CMS-2017-0156-1605-0,"Please see the attached file for comments from the MAPRx Coalition.
Sincerely,
Bonnie Duffy, Convener
MAPRx Coalition",14,1,CMS-2017-0156,CMS-2017-0156-DRAFT-1613,NA,0983-AT08,MAPRx Coalition-DC,PUBLIC SUBMISSIONS,Public Comment,Yes,CMS-2017-0156-0046,Posted,01/18/2018,NA,"Hayes, Yolanda K (CMS)",01/16/2018,01/18/2018,No restrictions,NA,NA,NA,NA,1k2-90ym-vhcb,1,1,3,1,Bonnie,Duffy,Washington,United States,DC,20036,Bduffy@nvgllc.com,MAPRx Coalition,NA,nvgllc.com,Bonnie Duffy,"Washington, DC, 20036",Bduffy@nvgllc.com,MAPRx Coalition,Beneficiary Advocate
14,CMS-2017-0156-1515,CMS-2017-0156-1515-0,HealthPartners submits the attached comments to CMS-4182-P.  We appreciate the comment opportunity.,13,1,CMS-2017-0156,CMS-2017-0156-DRAFT-1521,NA,0983-AT08,"HealthPartners, Inc-MN",PUBLIC SUBMISSIONS,Public Comment,Yes,CMS-2017-0156-0046,Posted,01/18/2018,NA,"Hayes, Yolanda K (CMS)",01/16/2018,01/18/2018,No restrictions,NA,NA,NA,NA,1k2-90yk-1k31,1,1,3,1,Jennifer,Colosimo,Bloomington,United States,MN,55425,jennifer.a.colosimo@healthpartners.com,"HealthPartners, Inc",NA,healthpartners.com,Jennifer Colosimo,"Bloomington, MN, 55425",jennifer.a.colosimo@healthpartners.com,"HealthPartners, Inc",Health Plan
116,CMS-2017-0156-1045,CMS-2017-0156-1045-0,The UAW Retiree Medical Benefits Trust respectfully submits the attached comments for consideration.,13,1,CMS-2017-0156,CMS-2017-0156-DRAFT-1046,NA,0983-AT08,UAW Retiree Medical Benefits Trust-MI,PUBLIC SUBMISSIONS,Public Comment,Yes,CMS-2017-0156-0046,Posted,01/16/2018,NA,"Hayes, Yolanda K (CMS)",01/11/2018,01/16/2018,No restrictions,NA,NA,NA,NA,1k2-90v4-ktgi,1,1,3,1,Aaron,Champney,Detroit,United States,MI,48214,achampney@rhac.com,UAW Retiree Medical Benefits Trust,NA,rhac.com,Aaron Champney,"Detroit, MI, 48214",achampney@rhac.com,UAW Retiree Medical Benefits Trust,Health Plan
127,CMS-2017-0156-1187,CMS-2017-0156-1187-0,Please find the attached comments of the National Association of Chain Drug Stores.,13,1,CMS-2017-0156,CMS-2017-0156-DRAFT-1190,NA,0983-AT08,National Association of Chain Drug Stores-VA,PUBLIC SUBMISSIONS,Public Comment,Yes,CMS-2017-0156-0046,Posted,01/16/2018,NA,"Hayes, Yolanda K (CMS)",01/12/2018,01/16/2018,No restrictions,NA,NA,NA,NA,1k2-90vx-jhyt,1,1,3,1,Eric,Juhl,Arlington,United States,VA,22009,ejuhl@nacds.org,National Association of Chain Drug Stores,NA,nacds.org,Eric Juhl,"Arlington, VA, 22009",ejuhl@nacds.org,National Association of Chain Drug Stores,Trade Association (Pharmacy)
140,CMS-2017-0156-0889,CMS-2017-0156-0889-0,Please see the attached letter from the American Society of Addiction Medicine (ASAM).,13,1,CMS-2017-0156,CMS-2017-0156-DRAFT-0889,NA,0983-AT08,American Society of Addiction Medicine-MD,PUBLIC SUBMISSIONS,Public Comment,Yes,CMS-2017-0156-0046,Posted,01/11/2018,NA,"Hayes, Yolanda K (CMS)",01/09/2018,01/11/2018,No restrictions,NA,NA,NA,NA,1k2-90tr-k269,1,1,4,1,Anonymous,Anonymous,NA,United States,MD,20852,NA,American Society of Addiction Medicine,NA,NA,Anonymous Anonymous,"MD, 20852",NA,American Society of Addiction Medicine,Trade Association
182,CMS-2017-0156-1551,CMS-2017-0156-1551-0,Please see the attached comments regarding the 2019 Proposed rule.  Thank you.,13,1,CMS-2017-0156,CMS-2017-0156-DRAFT-1558,NA,0983-AT08,Envision Insurance Company-CA,PUBLIC SUBMISSIONS,Public Comment,Yes,CMS-2017-0156-0046,Posted,01/18/2018,NA,"Hayes, Yolanda K (CMS)",01/16/2018,01/18/2018,No restrictions,NA,NA,NA,NA,1k2-90yl-62x1,1,1,3,1,Dan,O'Donnell,El Dorado Hills,United States,CA,95762,dodonnell@envisionrx.com,Envision Insurnace Company,NA,envisionrx.com,Dan O'Donnell,"El Dorado Hills, CA, 95762",dodonnell@envisionrx.com,Envision Insurnace Company,Health Plan
219,CMS-2017-0156-1432,CMS-2017-0156-1432-0,Please find attached comments from the Alliance for Transparent and Affordable Prescriptions (ATAP).,13,1,CMS-2017-0156,CMS-2017-0156-DRAFT-1437,NA,0983-AT08,Alliance for Transparent and Affordable Prescriptions-DC,PUBLIC SUBMISSIONS,Public Comment,Yes,CMS-2017-0156-0046,Posted,01/17/2018,NA,"Hayes, Yolanda K (CMS)",01/16/2018,01/17/2018,No restrictions,NA,NA,NA,NA,1k2-90yg-aqbw,1,1,3,1,Judith,Gorsuch,Washington,United States,DC,20016,jgorsuch@hhs.com,Alliance for Transparent and Affordable Prescriptions,NA,hhs.com,Judith Gorsuch,"Washington, DC, 20016",jgorsuch@hhs.com,Alliance for Transparent and Affordable Prescriptions,Beneficiary Advocate
228,CMS-2017-0156-1423,CMS-2017-0156-1423-0,Please read the attached letter with my comments regarding the proposed DIR Rule.,13,1,CMS-2017-0156,CMS-2017-0156-DRAFT-1428,NA,0983-AT08,ValuCare Center Health Mart Pharmacy-WI,PUBLIC SUBMISSIONS,Public Comment,Yes,CMS-2017-0156-0046,Posted,01/17/2018,NA,"Hayes, Yolanda K (CMS)",01/16/2018,01/17/2018,No restrictions,NA,NA,NA,NA,1k2-90yg-c0un,1,1,3,1,Stephen,Wilke,Marinette,United States,WI,54143,steve@valucarecenter.com,NA,NA,valucarecenter.com,Stephen Wilke,"Marinette, WI, 54143",steve@valucarecenter.com,NA,NA
53,CMS-2017-0156-1659,CMS-2017-0156-1659-0,Please see attached stakeholder letter submitted by the National Community Pharmacists Association.,12,1,CMS-2017-0156,CMS-2017-0156-DRAFT-1175,NA,0983-AT08,National Community Pharmacists Association-VA (form letter-121),PUBLIC SUBMISSIONS,Public Comment,Yes,CMS-2017-0156-0046,Posted,01/19/2018,NA,"Hayes, Yolanda K (CMS)",01/12/2018,01/19/2018,No restrictions,NA,NA,NA,NA,1k2-90vv-3ld6,1,1,3,121,Michael,Rule,Alexandria,United States,VA,22314,michael.rule@ncpanet.org,National Community Pharmacists Association,NA,ncpanet.org,Michael Rule,"Alexandria, VA, 22314",michael.rule@ncpanet.org,National Community Pharmacists Association,Trade Association (Pharmacy)
201,CMS-2017-0156-1475,CMS-2017-0156-1475-0,"CMS-4182-P

Please see comments on proposed rule in the attached document.

See attached file(s)",12,1,CMS-2017-0156,CMS-2017-0156-DRAFT-1480,NA,0983-AT08,MedImpact-CA,PUBLIC SUBMISSIONS,Public Comment,Yes,CMS-2017-0156-0046,Posted,01/18/2018,NA,"Hayes, Yolanda K (CMS)",01/16/2018,01/18/2018,No restrictions,NA,NA,NA,NA,1k2-90yj-d00m,1,1,3,1,Colleen,Matoon,San Diego,United States,CA,92131,colleen.matoon@medimpact.com,MedImpact,NA,medimpact.com,Colleen Matoon,"San Diego, CA, 92131",colleen.matoon@medimpact.com,MedImpact,PBM
241,CMS-2017-0156-1589,CMS-2017-0156-1589-0,Please see the attached comments submitted by the Center for Medicare Advocacy,12,1,CMS-2017-0156,CMS-2017-0156-DRAFT-1596,NA,0983-AT08,Center for Medicare Advocacy-DC,PUBLIC SUBMISSIONS,Public Comment,Yes,CMS-2017-0156-0046,Posted,01/18/2018,NA,"Hayes, Yolanda K (CMS)",01/16/2018,01/18/2018,No restrictions,NA,NA,NA,NA,1k2-90yl-spoq,1,1,3,1,David,Lipschutz,Washington,United States,DC,20036,dlipschutz@medicareadvocacy.org,Center for Medicare Advocacy,NA,medicareadvocacy.org,David Lipschutz,"Washington, DC, 20036",dlipschutz@medicareadvocacy.org,Center for Medicare Advocacy,Beneficiary Advocate
32,CMS-2017-0156-1126,CMS-2017-0156-1126-0,Attached please find URAC's comments in response to the proposed rule.,11,1,CMS-2017-0156,CMS-2017-0156-DRAFT-1127,NA,0983-AT08,Utilization Review Accreditation Commission-DC,PUBLIC SUBMISSIONS,Public Comment,Yes,CMS-2017-0156-0046,Posted,01/16/2018,NA,"Hayes, Yolanda K (CMS)",01/12/2018,01/16/2018,No restrictions,NA,NA,NA,NA,1k2-90vr-8qs5,1,1,4,1,Aaron,Turner-{jofer,Washington DC,United States,DC,20005,aturner-phifer@urac.org,URAC,NA,urac.org,Aaron Turner-{jofer,"Washington DC, DC, 20005",aturner-phifer@urac.org,URAC,NA
104,CMS-2017-0156-1282,CMS-2017-0156-1282-0,Please see the attached letter.  Thank you for your consideration.,11,1,CMS-2017-0156,CMS-2017-0156-DRAFT-1285,NA,0983-AT08,Brian Wilson-NE,PUBLIC SUBMISSIONS,Public Comment,Yes,CMS-2017-0156-0046,Posted,01/17/2018,NA,"Hayes, Yolanda K (CMS)",01/15/2018,01/17/2018,No restrictions,NA,NA,NA,NA,1k2-90xt-tdwh,1,1,3,1,Brian,Wilson,Ogallala,United States,NE,69153,brianwilson@usaverx.com,NA,NA,usaverx.com,Brian Wilson,"Ogallala, NE, 69153",brianwilson@usaverx.com,NA,NA
164,CMS-2017-0156-1477,CMS-2017-0156-1477-0,"On behalf of Smith & Nephew, please see our attached comments.",11,1,CMS-2017-0156,CMS-2017-0156-DRAFT-1482,NA,0983-AT08,"Smith & Nephew, Inc.-DC",PUBLIC SUBMISSIONS,Public Comment,Yes,CMS-2017-0156-0046,Posted,01/18/2018,NA,"Hayes, Yolanda K (CMS)",01/16/2018,01/18/2018,No restrictions,NA,NA,NA,NA,1k2-90yj-rq17,1,1,3,1,Scott,Reid,Washington,United States,DC,20001,scott.reid@smith-nephew.com,Smith & Nephew,NA,smith-nephew.com,Scott Reid,"Washington, DC, 20001",scott.reid@smith-nephew.com,Smith &amp; Nephew,NA
193,CMS-2017-0156-1444,CMS-2017-0156-1444-0,Please see comment letter from Medical Transportation Access Coalition (MTAC) attached.,11,1,CMS-2017-0156,CMS-2017-0156-DRAFT-1449,NA,0983-AT08,Medical Transportation Access Coalition-DC,PUBLIC SUBMISSIONS,Public Comment,Yes,CMS-2017-0156-0046,Posted,01/17/2018,NA,"Hayes, Yolanda K (CMS)",01/16/2018,01/17/2018,No restrictions,NA,NA,NA,NA,1k2-90yh-6fm3,1,1,3,1,Anonymous,Anonymous,NA,United States,DC,20001,NA,Medical Transportation Access Coalition,NA,NA,Anonymous Anonymous,"DC, 20001",NA,Medical Transportation Access Coalition,Trade Association
200,CMS-2017-0156-1634,CMS-2017-0156-1634-0,"Please see the attached comment letter.

Thank you,
Joel White
Executive Director
Health IT Now",11,1,CMS-2017-0156,CMS-2017-0156-DRAFT-1639,NA,0983-AT08,Health IT Now--DC,PUBLIC SUBMISSIONS,Public Comment,Yes,CMS-2017-0156-0046,Posted,01/18/2018,NA,"Hayes, Yolanda K (CMS)",01/16/2018,01/18/2018,No restrictions,NA,NA,NA,NA,1k2-90yo-batd,1,1,3,1,Joel,White,Washington,United States,DC,20001,jwhite@healthitnow.org,Health IT Now,NA,healthitnow.org,Joel White,"Washington, DC, 20001",jwhite@healthitnow.org,Health IT Now,Policy and Research
232,CMS-2017-0156-1492,CMS-2017-0156-1492-0,Please see the attached comment letter from the Healthcare Leadership Council.,11,1,CMS-2017-0156,CMS-2017-0156-DRAFT-1498,NA,0983-AT08,Healthcare Leadership Council-DC,PUBLIC SUBMISSIONS,Public Comment,Yes,CMS-2017-0156-0046,Posted,01/18/2018,NA,"Hayes, Yolanda K (CMS)",01/16/2018,01/18/2018,No restrictions,NA,NA,NA,NA,1k2-90yk-k1l0,1,1,3,1,Roxanne,Yaghoubi,Washington,United States,DC,20001,ryaghoubi@hlc.org,Healthcare Leadership Council,NA,hlc.org,Roxanne Yaghoubi,"Washington, DC, 20001",ryaghoubi@hlc.org,Healthcare Leadership Council,NA
154,CMS-2017-0156-1299,CMS-2017-0156-1299-0,"Please see the attached document from DST Pharmacy Solutions, Inc.",10,1,CMS-2017-0156,CMS-2017-0156-DRAFT-1303,NA,0983-AT08,"DST Pharmacy Solutions, Inc.-MO",PUBLIC SUBMISSIONS,Public Comment,Yes,CMS-2017-0156-0046,Posted,01/17/2018,NA,"Hayes, Yolanda K (CMS)",01/15/2018,01/17/2018,No restrictions,NA,NA,NA,NA,1k2-90xv-drtx,1,1,3,1,Felicia,Dawson,Kansas City,United States,MO,64105,fdawson@dstsystems.com,"DST Pharmacy Solutions, Inc.",NA,dstsystems.com,Felicia Dawson,"Kansas City, MO, 64105",fdawson@dstsystems.com,"DST Pharmacy Solutions, Inc.",NA
288,CMS-2017-0156-1392,CMS-2017-0156-1392-0,Attached are comments from The Coalition to Transform Advanced Care,10,1,CMS-2017-0156,CMS-2017-0156-DRAFT-1397,NA,0983-AT08,Coalition to Transform Advanced Care-DC,PUBLIC SUBMISSIONS,Public Comment,Yes,CMS-2017-0156-0046,Posted,01/17/2018,NA,"Hayes, Yolanda K (CMS)",01/16/2018,01/17/2018,No restrictions,NA,NA,NA,NA,1k2-90yd-c4h7,1,1,3,1,Marian,Grant,NA,United States,DC,20004,mgrant@thectac.org,CTAC,NA,thectac.org,Marian Grant,"DC, 20004",mgrant@thectac.org,CTAC,Trade Association
15,CMS-2017-0156-1538,CMS-2017-0156-1538-0,The American Diabetes Association respectfully submits the attached comments.,9,1,CMS-2017-0156,CMS-2017-0156-DRAFT-1545,NA,0983-AT08,American Diabetes Association-VA,PUBLIC SUBMISSIONS,Public Comment,Yes,CMS-2017-0156-0046,Posted,01/18/2018,NA,"Hayes, Yolanda K (CMS)",01/16/2018,01/18/2018,No restrictions,NA,NA,NA,NA,1k2-90yl-qaga,1,1,3,1,LaShawn,McIver,NA,United States,VA,22202,kmaier@diabetes.org,American Diabetes Association,NA,diabetes.org,LaShawn McIver,"VA, 22202",kmaier@diabetes.org,American Diabetes Association,Beneficiary Advocate
56,CMS-2017-0156-1545,CMS-2017-0156-1545-0,"Please find attached comments from the Food Marketing Institute.

",9,1,CMS-2017-0156,CMS-2017-0156-DRAFT-1552,NA,0983-AT08,Food Marketing Institute-VA,PUBLIC SUBMISSIONS,Public Comment,Yes,CMS-2017-0156-0046,Posted,01/18/2018,NA,"Hayes, Yolanda K (CMS)",01/16/2018,01/18/2018,No restrictions,NA,NA,NA,NA,1k2-90yl-i7bl,1,1,4,1,Dana,Graber,Arlington,United States,VA,22201,NA,Food Marketing Institute,NA,NA,Dana Graber,"Arlington, VA, 22201",NA,Food Marketing Institute,Research and Policy
84,CMS-2017-0156-1405,CMS-2017-0156-1405-0,See attached file from the American Society of Hematology.,9,1,CMS-2017-0156,CMS-2017-0156-DRAFT-1410,NA,0983-AT08,American Society of Hematology-DC,PUBLIC SUBMISSIONS,Public Comment,Yes,CMS-2017-0156-0046,Posted,01/17/2018,NA,"Hayes, Yolanda K (CMS)",01/16/2018,01/17/2018,No restrictions,NA,NA,NA,NA,1k2-90yf-ab7p,1,1,3,1,Katherine,Stark,Washington,United States,DC,20039,kstark@hematology.org,American Society of Hematology,NA,hematology.org,Katherine Stark,"Washington, DC, 20039",kstark@hematology.org,American Society of Hematology,Trade Association (Providers)
126,CMS-2017-0156-1517,CMS-2017-0156-1517-0,"See attached for comments from Boehringer Ingelheim Pharmaceuticals, Inc.",9,1,CMS-2017-0156,CMS-2017-0156-DRAFT-1523,NA,0983-AT08,Boehringer Ingelheim Pharmaceuticals-CT,PUBLIC SUBMISSIONS,Public Comment,Yes,CMS-2017-0156-0046,Posted,01/18/2018,NA,"Hayes, Yolanda K (CMS)",01/16/2018,01/18/2018,No restrictions,NA,NA,NA,NA,1k2-90yk-2ltf,1,1,3,1,Molly,Burich,Ridgefield,United States,CT,6810,molly.burich@boehringer-ingelheim.com,Boehringer Ingelheim Pharmaceuticals,NA,boehringer-ingelheim.com,Molly Burich,"Ridgefield, CT, 06810",molly.burich@boehringer-ingelheim.com,Boehringer Ingelheim Pharmaceuticals,Manufacturer
143,CMS-2017-0156-1258,CMS-2017-0156-1258-0,Attached please find comments from the American Heart Association.,9,1,CMS-2017-0156,CMS-2017-0156-DRAFT-1261,NA,0983-AT08,American Heart Association-DC,PUBLIC SUBMISSIONS,Public Comment,Yes,CMS-2017-0156-0046,Posted,01/17/2018,NA,"Hayes, Yolanda K (CMS)",01/14/2018,01/17/2018,No restrictions,NA,NA,NA,NA,1k2-90xf-gbnh,1,1,3,1,Madeleine,Konig,"1150 Connecticut Avenue, NW, Suite 300",United States,DC,20036,madeleine.konig@heart.org,American Heart Association,NA,heart.org,Madeleine Konig,"1150 Connecticut Avenue, NW, Suite 300, DC, 20036",madeleine.konig@heart.org,American Heart Association,Beneficiary Advocate
215,CMS-2017-0156-1439,CMS-2017-0156-1439-0,Please see attached file. Thank you for your consideration.,9,1,CMS-2017-0156,CMS-2017-0156-DRAFT-1444,NA,0983-AT08,Blue Cross and Blue Shield of Minnesota-MN,PUBLIC SUBMISSIONS,Public Comment,Yes,CMS-2017-0156-0046,Posted,01/17/2018,NA,"Hayes, Yolanda K (CMS)",01/16/2018,01/17/2018,No restrictions,NA,NA,NA,NA,1k2-90yh-mjmj,1,1,3,1,Scott,Keefer,Eagan,United States,MN,55121,scott.keefer@bluecrossmn.com,Blue Cross and Blue Shield of Minnesota,NA,bluecrossmn.com,Scott Keefer,"Eagan, MN, 55121",scott.keefer@bluecrossmn.com,Blue Cross and Blue Shield of Minnesota,Health Plan
12,CMS-2017-0156-1451,CMS-2017-0156-1451-0,Please accept the attached comments for your review.,8,1,CMS-2017-0156,CMS-2017-0156-DRAFT-1456,NA,0983-AT08,SinfoniaRx-AZ,PUBLIC SUBMISSIONS,Public Comment,Yes,CMS-2017-0156-0046,Posted,01/17/2018,NA,"Hayes, Yolanda K (CMS)",01/16/2018,01/17/2018,No restrictions,NA,NA,NA,NA,1k2-90yi-y80i,1,1,3,1,Jeniece,Roher,Tucson,United States,AZ,85712,jiroher@sinfoniarx.com,SinfoniaRx,NA,sinfoniarx.com,Jeniece Roher,"Tucson, AZ, 85712",jiroher@sinfoniarx.com,SinfoniaRx,Health Services
36,CMS-2017-0156-1509,CMS-2017-0156-1509-0,Please see attached document for comments on CMS-4182-P,8,1,CMS-2017-0156,CMS-2017-0156-DRAFT-1515,NA,0983-AT08,"PDX, Inc.-TX",PUBLIC SUBMISSIONS,Public Comment,Yes,CMS-2017-0156-0046,Posted,01/18/2018,NA,"Hayes, Yolanda K (CMS)",01/16/2018,01/18/2018,No restrictions,NA,NA,NA,NA,1k2-90yk-ljj6,1,1,3,1,Leann,Lewis,Fort Worth,United States,TX,76108,llewis@pdxinc.com,"PDX, Inc.",NA,pdxinc.com,Leann Lewis,"Fort Worth, TX, 76108",llewis@pdxinc.com,"PDX, Inc.",Health Services
150,CMS-2017-0156-1543,CMS-2017-0156-1543-0,Please see the attached comment letter from HANYS.,8,1,CMS-2017-0156,CMS-2017-0156-DRAFT-1550,NA,0983-AT08,Healthcare Association of New York State-NY,PUBLIC SUBMISSIONS,Public Comment,Yes,CMS-2017-0156-0046,Posted,01/18/2018,NA,"Hayes, Yolanda K (CMS)",01/16/2018,01/18/2018,No restrictions,NA,NA,NA,NA,1k2-90yl-yu67,1,1,3,1,Victoria,Aufiero,Rensselaer,United States,NY,12144,vaufiero@hanys.org,Healthcare Association of New York State,NA,hanys.org,Victoria Aufiero,"Rensselaer, NY, 12144",vaufiero@hanys.org,Healthcare Association of New York State,Trade Association
283,CMS-2017-0156-1522,CMS-2017-0156-1522-0,Please see attached document for comments on CMS-4182-P,8,1,CMS-2017-0156,CMS-2017-0156-DRAFT-1529,NA,0983-AT08,"PDX, Inc-TX",PUBLIC SUBMISSIONS,Public Comment,Yes,CMS-2017-0156-0046,Posted,01/18/2018,NA,"Hayes, Yolanda K (CMS)",01/16/2018,01/18/2018,No restrictions,NA,NA,NA,NA,1k2-90yk-bzut,1,1,3,1,Leann,Lewis,Fort Worth,United States,TX,76108,llewis@pdxinc.com,"PDX, Inc",NA,pdxinc.com,Leann Lewis,"Fort Worth, TX, 76108",llewis@pdxinc.com,"PDX, Inc",Health Services
87,CMS-2017-0156-1189,CMS-2017-0156-1189-0,Attached please find A-S Medication Solutions' comments.,7,1,CMS-2017-0156,CMS-2017-0156-DRAFT-1192,NA,0983-AT08,A-S Medication Solutions-IL,PUBLIC SUBMISSIONS,Public Comment,Yes,CMS-2017-0156-0046,Posted,01/16/2018,NA,"Hayes, Yolanda K (CMS)",01/12/2018,01/16/2018,No restrictions,NA,NA,NA,NA,1k2-90vx-jtrd,1,1,3,1,Walter,Hoff,NA,United States,IL,60048,stephanie.curtis@alston.com,A-S Medication Solutions,NA,alston.com,Walter Hoff,"IL, 60048",stephanie.curtis@alston.com,A-S Medication Solutions,NA
97,CMS-2017-0156-1472,CMS-2017-0156-1472-0,Please find the full comment letter attached.,7,1,CMS-2017-0156,CMS-2017-0156-DRAFT-1477,NA,0983-AT08,Amgen Inc.-DC,PUBLIC SUBMISSIONS,Public Comment,Yes,CMS-2017-0156-0046,Posted,01/18/2018,NA,"Hayes, Yolanda K (CMS)",01/16/2018,01/18/2018,No restrictions,NA,NA,NA,NA,1k2-90yj-inl0,1,1,3,1,Josh,Ofman,Washington,United States,DC,20005,NA,NA,NA,NA,Josh Ofman,"Washington, DC, 20005",NA,NA,Other
115,CMS-2017-0156-1566,CMS-2017-0156-1566-0,See attached comments from America's Physician Groups.,7,1,CMS-2017-0156,CMS-2017-0156-DRAFT-1573,NA,0983-AT08,America's Physician Groups-DC,PUBLIC SUBMISSIONS,Public Comment,Yes,CMS-2017-0156-0046,Posted,01/18/2018,NA,"Hayes, Yolanda K (CMS)",01/16/2018,01/18/2018,No restrictions,NA,NA,NA,NA,1k2-90yl-r03a,1,1,3,1,Mara,McDermott,Washington,United States,DC,20005,mmcdermott@apg.org,NA,NA,apg.org,Mara McDermott,"Washington, DC, 20005",mmcdermott@apg.org,NA,Trade Assocation (Provider)
129,CMS-2017-0156-1479,CMS-2017-0156-1479-0,Please see attached document for written comments.,7,1,CMS-2017-0156,CMS-2017-0156-DRAFT-1484,NA,0983-AT08,TennCare Long-Term Services and Supports-TN,PUBLIC SUBMISSIONS,Public Comment,Yes,CMS-2017-0156-0046,Posted,01/18/2018,NA,"Hayes, Yolanda K (CMS)",01/16/2018,01/18/2018,No restrictions,NA,NA,NA,NA,1k2-90yj-falp,1,1,3,1,Patti,Killingsworth,Nashville,United States,TN,37243,patti.killingsworth@tn.gov,TennCare Long-Term Services and Supports,NA,tn.gov,Patti Killingsworth,"Nashville, TN, 37243",patti.killingsworth@tn.gov,TennCare Long-Term Services and Supports,Other - Gov
281,CMS-2017-0156-1303,CMS-2017-0156-1303-0,Please see attached letter.  Thank You,7,1,CMS-2017-0156,CMS-2017-0156-DRAFT-1307,NA,0983-AT08,Victor's Regent Pharmacy-NM,PUBLIC SUBMISSIONS,Public Comment,Yes,CMS-2017-0156-0046,Posted,01/17/2018,NA,"Hayes, Yolanda K (CMS)",01/15/2018,01/17/2018,No restrictions,NA,NA,NA,NA,1k2-90xv-hq4w,1,1,3,1,John Victor,Castillo,Albuquerque,United States,NM,87105,victorspharmacy@aol.com,Victor's Regent Pharmacy,NA,aol.com,John Victor Castillo,"Albuquerque, NM, 87105",victorspharmacy@aol.com,Victor's Regent Pharmacy,Pharmacy
286,CMS-2017-0156-1391,CMS-2017-0156-1391-0,Please see attached comment letter from Sunovion.,7,1,CMS-2017-0156,CMS-2017-0156-DRAFT-1396,NA,0983-AT08,Sunovion-DC,PUBLIC SUBMISSIONS,Public Comment,Yes,CMS-2017-0156-0046,Posted,01/17/2018,NA,"Hayes, Yolanda K (CMS)",01/16/2018,01/17/2018,No restrictions,NA,NA,NA,NA,1k2-90yd-367f,1,1,3,1,Bela,Sastry,NA,United States,DC,20004,NA,Sunovion,NA,NA,Bela Sastry,"DC, 20004",NA,Sunovion,NA
19,CMS-2017-0156-1496,CMS-2017-0156-1496-0,Please see attached AHIP comment letter.,6,1,CMS-2017-0156,CMS-2017-0156-DRAFT-1502,NA,0983-AT08,America's Health Insurance Plans-DC,PUBLIC SUBMISSIONS,Public Comment,Yes,CMS-2017-0156-0046,Posted,01/18/2018,NA,"Hayes, Yolanda K (CMS)",01/16/2018,01/18/2018,No restrictions,NA,NA,NA,NA,1k2-90yk-ookq,1,1,3,1,Anonymous,Anonymous,Washington,United States,DC,20004,NA,America's Health Insurance Plans,NA,NA,Anonymous Anonymous,"Washington, DC, 20004",NA,America's Health Insurance Plans,Trade Association (Health Plans)
94,CMS-2017-0156-1539,CMS-2017-0156-1539-0,Please see attached comments from PhRMA.,6,1,CMS-2017-0156,CMS-2017-0156-DRAFT-1546,NA,0983-AT08,Pharmaceutical Research and Manufacturers of America-DC,PUBLIC SUBMISSIONS,Public Comment,Yes,CMS-2017-0156-0046,Posted,01/18/2018,NA,"Hayes, Yolanda K (CMS)",01/16/2018,01/18/2018,No restrictions,NA,NA,NA,NA,1k2-90yl-q5q4,1,1,3,1,Megan,Hickey,Washington,United States,DC,20036,mhickey@phrma.org,PhRMA,NA,phrma.org,Megan Hickey,"Washington, DC, 20036",mhickey@phrma.org,PhRMA,Trade Association (Manufacturers)
111,CMS-2017-0156-1615,CMS-2017-0156-1615-0,Please see attached letter from Pfizer.,6,1,CMS-2017-0156,CMS-2017-0156-DRAFT-1620,NA,0983-AT08,Pfizer--NY,PUBLIC SUBMISSIONS,Public Comment,Yes,CMS-2017-0156-0046,Posted,01/18/2018,NA,"Hayes, Yolanda K (CMS)",01/16/2018,01/18/2018,No restrictions,NA,NA,NA,NA,1k2-90ym-7yx0,1,1,3,1,Margaret,Davis,New York,United States,NY,10017,margaret.davis@pfizer.com,Pfizer Inc,NA,pfizer.com,Margaret Davis,"New York, NY, 10017",margaret.davis@pfizer.com,Pfizer Inc,Manufacturer
137,CMS-2017-0156-1560,CMS-2017-0156-1560-0,Please see attached NPAF comment letter.,6,1,CMS-2017-0156,CMS-2017-0156-DRAFT-1567,NA,0983-AT08,National Patient Advocate Foundation-DC,PUBLIC SUBMISSIONS,Public Comment,Yes,CMS-2017-0156-0046,Posted,01/18/2018,NA,"Hayes, Yolanda K (CMS)",01/16/2018,01/18/2018,No restrictions,NA,NA,NA,NA,1k2-90yl-347i,1,1,3,1,Nicole,Braccio,Washington,United States,DC,20005,nicole.braccio@npaf.org,National Patient Advocate Foundation,NA,npaf.org,Nicole Braccio,"Washington, DC, 20005",nicole.braccio@npaf.org,National Patient Advocate Foundation,Beneficiary Advocate
153,CMS-2017-0156-1467,CMS-2017-0156-1467-0,See attached letter from Advantage MD,6,1,CMS-2017-0156,CMS-2017-0156-DRAFT-1472,NA,0983-AT08,Advantage MD-MD,PUBLIC SUBMISSIONS,Public Comment,Yes,CMS-2017-0156-0046,Posted,01/18/2018,NA,"Hayes, Yolanda K (CMS)",01/16/2018,01/18/2018,No restrictions,NA,NA,NA,NA,1k2-90yj-spl3,1,1,3,1,Marja,Wilson,Glen Burnie,United States,MD,21060,mwilson@jhhc.com,Advantage MD,NA,jhhc.com,Marja Wilson,"Glen Burnie, MD, 21060",mwilson@jhhc.com,Advantage MD,Health Plan
172,CMS-2017-0156-1557,CMS-2017-0156-1557-0,Please see the comment letter attached,6,1,CMS-2017-0156,CMS-2017-0156-DRAFT-1564,NA,0983-AT08,AstraZeneca-DC,PUBLIC SUBMISSIONS,Public Comment,Yes,CMS-2017-0156-0046,Posted,01/18/2018,NA,"Hayes, Yolanda K (CMS)",01/16/2018,01/18/2018,No restrictions,NA,NA,NA,NA,1k2-90yl-fs6s,1,1,3,1,Laura,Okpala,Washington,United States,DC,20004,laura.okpala@astrazeneca.com,AstraZeneca,NA,astrazeneca.com,Laura Okpala,"Washington, DC, 20004",laura.okpala@astrazeneca.com,AstraZeneca,Manufacturer
186,CMS-2017-0156-1359,CMS-2017-0156-1359-0,Please see attached comments. Thank you.,6,1,CMS-2017-0156,CMS-2017-0156-DRAFT-1363,NA,0983-AT08,National Association of Dental Plans-TX,PUBLIC SUBMISSIONS,Public Comment,Yes,CMS-2017-0156-0046,Posted,01/17/2018,NA,"Hayes, Yolanda K (CMS)",01/15/2018,01/17/2018,No restrictions,NA,NA,NA,NA,1k2-90xz-fr72,1,1,3,1,Emeline,Augustini,Dallas,United States,TX,75251,eaugustini@nadp.org,National Association of Dental Plans (NADP),NA,nadp.org,Emeline Augustini,"Dallas, TX, 75251",eaugustini@nadp.org,National Association of Dental Plans (NADP),Trade Association (Dental)
2,CMS-2017-0156-1576,CMS-2017-0156-1576-0,Please see the attached document.,5,1,CMS-2017-0156,CMS-2017-0156-DRAFT-1583,NA,0983-AT08,Novo Nordisk-DC,PUBLIC SUBMISSIONS,Public Comment,Yes,CMS-2017-0156-0046,Posted,01/18/2018,NA,"Hayes, Yolanda K (CMS)",01/16/2018,01/18/2018,No restrictions,NA,NA,NA,NA,1k2-90yl-m4jp,1,1,4,1,Laura,Tolosa-Leiva,Washington,United States,DC,20001,lutv@novonordisk.com,Novo Nordisk,NA,novonordisk.com,Laura Tolosa-Leiva,"Washington, DC, 20001",lutv@novonordisk.com,Novo Nordisk,Manufacturer
152,CMS-2017-0156-1567,CMS-2017-0156-1567-0,See attached file(s). Thank you.,5,1,CMS-2017-0156,CMS-2017-0156-DRAFT-1574,NA,0983-AT08,Martin's Point Generations Advantage-ME,PUBLIC SUBMISSIONS,Public Comment,Yes,CMS-2017-0156-0046,Posted,01/18/2018,NA,"Hayes, Yolanda K (CMS)",01/16/2018,01/18/2018,No restrictions,NA,NA,NA,NA,1k2-90yl-pb77,1,1,3,1,Jaclyn,Jacobson,Portland,United States,ME,4072,jaclyn.jacobson@martinspoint.org,Martin's Point Generations Advantage,NA,martinspoint.org,Jaclyn Jacobson,"Portland, ME, 04072",jaclyn.jacobson@martinspoint.org,Martin's Point Generations Advantage,Health Plan
37,CMS-2017-0156-1428,CMS-2017-0156-1428-0,Please see attached file.,4,1,CMS-2017-0156,CMS-2017-0156-DRAFT-1433,NA,0983-AT08,Medical Group Management Association-DC,PUBLIC SUBMISSIONS,Public Comment,Yes,CMS-2017-0156-0046,Posted,01/17/2018,NA,"Hayes, Yolanda K (CMS)",01/16/2018,01/17/2018,No restrictions,NA,NA,NA,NA,1k2-90yg-a3mq,1,1,3,1,Suzanne,Falk,Washington,United States,DC,20006,sfalk@mgma.org,Medical Group Management Association,NA,mgma.org,Suzanne Falk,"Washington, DC, 20006",sfalk@mgma.org,Medical Group Management Association,Trade Association
42,CMS-2017-0156-1572,CMS-2017-0156-1572-0,Please see attached file.,4,1,CMS-2017-0156,CMS-2017-0156-DRAFT-1579,NA,0983-AT08,ExactCare-OH,PUBLIC SUBMISSIONS,Public Comment,Yes,CMS-2017-0156-0046,Posted,01/18/2018,NA,"Hayes, Yolanda K (CMS)",01/16/2018,01/18/2018,No restrictions,NA,NA,NA,NA,1k2-90yl-mg58,1,1,3,1,Dale,Wollschleger,NA,United States,OH,44125,NA,NA,NA,NA,Dale Wollschleger,"OH, 44125",NA,NA,Pharmacy
51,CMS-2017-0156-0957,CMS-2017-0156-0957-0,Please see the attached.,4,1,CMS-2017-0156,CMS-2017-0156-DRAFT-0957,NA,0983-AT08,Jesse Bushman-DC,PUBLIC SUBMISSIONS,Public Comment,Yes,CMS-2017-0156-0046,Posted,01/16/2018,NA,"Hayes, Yolanda K (CMS)",01/10/2018,01/16/2018,No restrictions,NA,NA,NA,NA,1k2-90uh-dtw6,1,1,3,1,Jesse,Bushman,Washington,United States,DC,20005,jbushman@jdrf.org,JDRF,NA,jdrf.org,Jesse Bushman,"Washington, DC, 20005",jbushman@jdrf.org,JDRF,NA
82,CMS-2017-0156-1562,CMS-2017-0156-1562-0,Novartis comment letter attached,4,1,CMS-2017-0156,CMS-2017-0156-DRAFT-1569,NA,0983-AT08,Novartis-DC,PUBLIC SUBMISSIONS,Public Comment,Yes,CMS-2017-0156-0046,Posted,01/18/2018,NA,"Hayes, Yolanda K (CMS)",01/16/2018,01/18/2018,No restrictions,NA,NA,NA,NA,1k2-90yl-5d54,1,1,3,1,Anonymous,Anonymous,NA,United States,DC,20004,NA,Novartis,NA,NA,Anonymous Anonymous,"DC, 20004",NA,Novartis,Manufacturer
100,CMS-2017-0156-0039,CMS-2017-0156-0039-0,See attached file(s): commentonregttyler,4,1,CMS-2017-0156,CMS-2017-0157-DRAFT-0004,NA,0983-AT08,Tana-Michelle Tyler-OR,PUBLIC SUBMISSIONS,Public Comment,Yes,CMS-2017-0156-0001,Posted,12/11/2017,NA,"Hayes, Yolanda K (CMS)",11/29/2017,12/11/2017,No restrictions,NA,NA,NA,NA,1k1-902j-h756,1,1,3,1,Tana-Michelle,Tyler,Portland,United States,OR,97202,ttyler@gwu.edu,NA,NA,gwu.edu,Tana-Michelle Tyler,"Portland, OR, 97202",ttyler@gwu.edu,NA,NA
101,CMS-2017-0156-1626,CMS-2017-0156-1626-0,Please see attached file(s).,4,1,CMS-2017-0156,CMS-2017-0156-DRAFT-1631,NA,0983-AT08,Ryan White Clinics-340B--DC,PUBLIC SUBMISSIONS,Public Comment,Yes,CMS-2017-0156-0046,Posted,01/18/2018,NA,"Hayes, Yolanda K (CMS)",01/16/2018,01/18/2018,No restrictions,NA,NA,NA,NA,1k2-90yn-tql0,1,1,3,1,Anonymous,Anonymous,Washington,United States,DC,20005,brad.lang@powerslaw.com,RWC-340B,NA,powerslaw.com,Anonymous Anonymous,"Washington, DC, 20005",brad.lang@powerslaw.com,RWC-340B,NA
156,CMS-2017-0156-1449,CMS-2017-0156-1449-0,Please see attached letter.,4,1,CMS-2017-0156,CMS-2017-0156-DRAFT-1454,NA,0983-AT08,Cleveland Clinic-OH,PUBLIC SUBMISSIONS,Public Comment,Yes,CMS-2017-0156-0046,Posted,01/17/2018,NA,"Hayes, Yolanda K (CMS)",01/16/2018,01/17/2018,No restrictions,NA,NA,NA,NA,1k2-90yi-lzzn,1,1,3,1,Marie-Joy,Paredes,Cleveland Clinic,United States,OH,44195,paredem@ccf.org,Cleveland Clinic,NA,ccf.org,Marie-Joy Paredes,"Cleveland Clinic, OH, 44195",paredem@ccf.org,Cleveland Clinic,Provider
161,CMS-2017-0156-1645,CMS-2017-0156-1645-0,See attached comment letter.,4,1,CMS-2017-0156,CMS-2017-0156-DRAFT-1650,NA,0983-AT08,CalOptima--CA,PUBLIC SUBMISSIONS,Public Comment,Yes,CMS-2017-0156-0046,Posted,01/18/2018,NA,"Hayes, Yolanda K (CMS)",01/16/2018,01/18/2018,No restrictions,NA,NA,NA,NA,1k2-90yp-qo9i,1,1,3,1,Sanaya,Lim,Orange,United States,CA,92868,slim@caloptima.org,CalOptima,NA,caloptima.org,Sanaya Lim,"Orange, CA, 92868",slim@caloptima.org,CalOptima,Health Plan
191,CMS-2017-0156-1393,CMS-2017-0156-1393-0,Novartis comment letter attached,4,1,CMS-2017-0156,CMS-2017-0156-DRAFT-1398,NA,0983-AT08,Novartis-DC,PUBLIC SUBMISSIONS,Public Comment,Yes,CMS-2017-0156-0046,Posted,01/17/2018,NA,"Hayes, Yolanda K (CMS)",01/16/2018,01/17/2018,No restrictions,NA,NA,NA,NA,1k2-90yd-abri,1,1,3,1,Anonymous,Anonymous,NA,United States,DC,20004,NA,Novartis,NA,NA,Anonymous Anonymous,"DC, 20004",NA,Novartis,Manufacturer
4,CMS-2017-0156-1642,CMS-2017-0156-1642-0,See attached file(s),3,1,CMS-2017-0156,CMS-2017-0156-DRAFT-1647,NA,0983-AT08,Tennessee Pharmacists Association--TN,PUBLIC SUBMISSIONS,Public Comment,Yes,CMS-2017-0156-0046,Posted,01/18/2018,NA,"Hayes, Yolanda K (CMS)",01/16/2018,01/18/2018,No restrictions,NA,NA,NA,NA,1k2-90yp-p7ql,1,1,4,1,Micah,Cost,Nashville,United States,TN,37179,micah@tnpharm.org,Tennessee Pharmacists Association,NA,tnpharm.org,Micah Cost,"Nashville, TN, 37179",micah@tnpharm.org,Tennessee Pharmacists Association,Trade Association
5,CMS-2017-0156-0843,CMS-2017-0156-0843-0,See attached file(s),3,1,CMS-2017-0156,CMS-2017-0156-DRAFT-0842,NA,0983-AT08,Collegium Pharmaceuticals -MA,PUBLIC SUBMISSIONS,Public Comment,Yes,CMS-2017-0156-0046,Posted,01/10/2018,NA,"Braxton, Shawn L (CMS)",01/08/2018,01/10/2018,No restrictions,NA,NA,NA,NA,1k2-90t7-3ctk,1,1,4,1,Steven,Passik,Canton,United States,MA,2021,spassik@collegiumpharma.com,Collegium Pharmaceuticals,NA,collegiumpharma.com,Steven Passik,"Canton, MA, 02021",spassik@collegiumpharma.com,Collegium Pharmaceuticals,NA
6,CMS-2017-0156-1279,CMS-2017-0156-1279-0,See attached file(s),3,1,CMS-2017-0156,CMS-2017-0156-DRAFT-1282,NA,0983-AT08,Multipurpose Senior Services Program Site Association-CA,PUBLIC SUBMISSIONS,Public Comment,Yes,CMS-2017-0156-0046,Posted,01/17/2018,NA,"Hayes, Yolanda K (CMS)",01/15/2018,01/17/2018,No restrictions,NA,NA,NA,NA,1k2-90xt-bbom,1,1,3,1,Janet,Heath,Sacramento,United States,CA,95816,mssp.association@gmail.com,Multipurpose Senior Services Program Site Association,NA,gmail.com,Janet Heath,"Sacramento, CA, 95816",mssp.association@gmail.com,Multipurpose Senior Services Program Site Association,Trade Association
7,CMS-2017-0156-1174,CMS-2017-0156-1174-0,See attached file(s),3,1,CMS-2017-0156,CMS-2017-0156-DRAFT-1176,NA,0983-AT08,MARC Coalition-DC,PUBLIC SUBMISSIONS,Public Comment,Yes,CMS-2017-0156-0046,Posted,01/16/2018,NA,"Hayes, Yolanda K (CMS)",01/12/2018,01/16/2018,No restrictions,NA,NA,NA,NA,1k2-90vv-4me1,1,1,3,1,Anonymous,Anonymous,WASHINGTON,United States,DC,20006-4707,dfarber@kslaw.com,MARC Coalition,NA,kslaw.com,Anonymous Anonymous,"WASHINGTON, DC, 20006-4707",dfarber@kslaw.com,MARC Coalition,NA
10,CMS-2017-0156-1288,CMS-2017-0156-1288-0,See attached file(s),3,1,CMS-2017-0156,CMS-2017-0156-DRAFT-1291,NA,0983-AT08,Prime Therapeutics-MN,PUBLIC SUBMISSIONS,Public Comment,Yes,CMS-2017-0156-0046,Posted,01/17/2018,NA,"Hayes, Yolanda K (CMS)",01/15/2018,01/17/2018,No restrictions,NA,NA,NA,NA,1k2-90xt-ba5h,1,1,3,1,Sara,McDermid,Edina,United States,MN,55435,sara.mcdermid@primetherapeutics.com,NA,NA,primetherapeutics.com,Sara McDermid,"Edina, MN, 55435",sara.mcdermid@primetherapeutics.com,NA,PBM
16,CMS-2017-0156-1411,CMS-2017-0156-1411-0,See attached file(s),3,1,CMS-2017-0156,CMS-2017-0156-DRAFT-1416,NA,0983-AT08,Froedtert Health-WI,PUBLIC SUBMISSIONS,Public Comment,Yes,CMS-2017-0156-0046,Posted,01/17/2018,NA,"Hayes, Yolanda K (CMS)",01/16/2018,01/17/2018,No restrictions,NA,NA,NA,NA,1k2-90yf-e5p5,1,1,3,1,Rhonda,Joseph,Milwaukee,United States,WI,53226,rhonda.joseph@froedtert.com,Froedtert Health,NA,froedtert.com,Rhonda Joseph,"Milwaukee, WI, 53226",rhonda.joseph@froedtert.com,Froedtert Health,NA
17,CMS-2017-0156-1464,CMS-2017-0156-1464-0,See attached file(s),3,1,CMS-2017-0156,CMS-2017-0156-DRAFT-1469,NA,0983-AT08,MAXIMUS Federal-VA,PUBLIC SUBMISSIONS,Public Comment,Yes,CMS-2017-0156-0046,Posted,01/18/2018,NA,"Hayes, Yolanda K (CMS)",01/16/2018,01/18/2018,No restrictions,NA,NA,NA,NA,1k2-90yj-vsi3,1,1,3,1,Elizabeth,Molina,Virginia,United States,VA,22042,elizabethmolina@maximus.com,MAXIMUS Federal,NA,maximus.com,Elizabeth Molina,"Virginia, VA, 22042",elizabethmolina@maximus.com,MAXIMUS Federal,NA
18,CMS-2017-0156-1205,CMS-2017-0156-1205-0,See attached file(s),3,1,CMS-2017-0156,CMS-2017-0156-DRAFT-1208,NA,0983-AT08,Wilson Krezdorn-TX,PUBLIC SUBMISSIONS,Public Comment,Yes,CMS-2017-0156-0046,Posted,01/16/2018,NA,"Hayes, Yolanda K (CMS)",01/12/2018,01/16/2018,No restrictions,NA,NA,NA,NA,1k2-90vz-8bvz,1,1,3,1,Wilson,Krezdorn,Tyler,United States,TX,75703,management@rosecityrx.net,Rose City Pharmacy LLC,NA,rosecityrx.net,Wilson Krezdorn,"Tyler, TX, 75703",management@rosecityrx.net,Rose City Pharmacy LLC,Pharmacy
20,CMS-2017-0156-0359,CMS-2017-0156-0359-0,See attached file(s),3,1,CMS-2017-0156,CMS-2017-0156-DRAFT-0359,NA,0983-AT08,Michael Magrath-IL,PUBLIC SUBMISSIONS,Public Comment,Yes,CMS-2017-0156-0046,Posted,12/26/2017,NA,"Hayes, Yolanda K (CMS)",12/22/2017,12/26/2017,No restrictions,NA,NA,NA,NA,1k1-90hs-ouku,1,1,3,1,Michael,Magrath,Oakbrook Terrace,United States,IL,60181,michael.magrath@vasco.com,"VASCO Data Security, Inc.",NA,vasco.com,Michael Magrath,"Oakbrook Terrace, IL, 60181",michael.magrath@vasco.com,"VASCO Data Security, Inc.",Health Services
21,CMS-2017-0156-1404,CMS-2017-0156-1404-0,See attached file(s),3,1,CMS-2017-0156,CMS-2017-0156-DRAFT-1409,NA,0983-AT08,Johnson & Johnson-DC,PUBLIC SUBMISSIONS,Public Comment,Yes,CMS-2017-0156-0046,Posted,01/17/2018,NA,"Hayes, Yolanda K (CMS)",01/16/2018,01/17/2018,No restrictions,NA,NA,NA,NA,1k2-90yf-xrmf,1,1,3,1,Robert,Donnelly,NA,United States,DC,20005,NA,Johnson & Johnson,NA,NA,Robert Donnelly,"DC, 20005",NA,Johnson &amp; Johnson,Manufacturer
22,CMS-2017-0156-1616,CMS-2017-0156-1616-0,See attached file(s),3,1,CMS-2017-0156,CMS-2017-0156-DRAFT-1621,NA,0983-AT08,American Acedemy of Physical Medicine and Rehabilitation--IL,PUBLIC SUBMISSIONS,Public Comment,Yes,CMS-2017-0156-0046,Posted,01/18/2018,NA,"Hayes, Yolanda K (CMS)",01/16/2018,01/18/2018,No restrictions,NA,NA,NA,NA,1k2-90ym-ucht,1,1,3,1,Mary,Stinneford,Rosemont,United States,IL,60018,kstinneford@aapmt.org,American Acedemy of Physical Medicine and Rehabilitation,NA,aapmt.org,Mary Stinneford,"Rosemont, IL, 60018",kstinneford@aapmt.org,American Acedemy of Physical Medicine and Rehabilitation,Trade Association (Providers)
23,CMS-2017-0156-1579,CMS-2017-0156-1579-0,See attached file(s),3,1,CMS-2017-0156,CMS-2017-0156-DRAFT-1586,NA,0983-AT08,Federation of American Hospitals-DC,PUBLIC SUBMISSIONS,Public Comment,Yes,CMS-2017-0156-0046,Posted,01/18/2018,NA,"Hayes, Yolanda K (CMS)",01/16/2018,01/18/2018,No restrictions,NA,NA,NA,NA,1k2-90yl-bxo3,1,1,3,1,Erin,Richardson,Washington,United States,DC,20001,erichardson@fah.org,Federation of American Hospitals,NA,fah.org,Erin Richardson,"Washington, DC, 20001",erichardson@fah.org,Federation of American Hospitals,Trade Association (Provider)
24,CMS-2017-0156-1531,CMS-2017-0156-1531-0,See attached file(s),3,1,CMS-2017-0156,CMS-2017-0156-DRAFT-1538,NA,0983-AT08,Ascension-DC,PUBLIC SUBMISSIONS,Public Comment,Yes,CMS-2017-0156-0046,Posted,01/18/2018,NA,"Hayes, Yolanda K (CMS)",01/16/2018,01/18/2018,No restrictions,NA,NA,NA,NA,1k2-90yk-63kx,1,1,3,1,Anonymous,Anonymous,NA,United States,DC,20002,NA,Ascension,NA,NA,Anonymous Anonymous,"DC, 20002",NA,Ascension,NA
26,CMS-2017-0156-1425,CMS-2017-0156-1425-0,See attached file(s),3,1,CMS-2017-0156,CMS-2017-0156-DRAFT-1430,NA,0983-AT08,American Clinical Laboratory Association-DC,PUBLIC SUBMISSIONS,Public Comment,Yes,CMS-2017-0156-0046,Posted,01/17/2018,NA,"Hayes, Yolanda K (CMS)",01/16/2018,01/17/2018,No restrictions,NA,NA,NA,NA,1k2-90yg-ezm5,1,1,3,1,Sharon,West,Washington,United States,DC,20005,swest@acla.com,American Clinical Laboratory Association,NA,acla.com,Sharon West,"Washington, DC, 20005",swest@acla.com,American Clinical Laboratory Association,Trade Association
27,CMS-2017-0156-1163,CMS-2017-0156-1163-0,See attached file(s),3,1,CMS-2017-0156,CMS-2017-0156-DRAFT-1164,NA,0983-AT08,Charles Calati-MI,PUBLIC SUBMISSIONS,Public Comment,Yes,CMS-2017-0156-0046,Posted,01/16/2018,NA,"Hayes, Yolanda K (CMS)",01/12/2018,01/16/2018,No restrictions,NA,NA,NA,NA,1k2-90vu-mekf,1,1,3,1,Charles,Calati,Lansing,United States,MI,48933,ccalati@aol.com,NA,NA,aol.com,Charles Calati,"Lansing, MI, 48933",ccalati@aol.com,NA,Other
28,CMS-2017-0156-0971,CMS-2017-0156-0971-0,Comments are attached.,3,1,CMS-2017-0156,CMS-2017-0156-DRAFT-0971,NA,0983-AT08,Vermont State Dental Society-VT,PUBLIC SUBMISSIONS,Public Comment,Yes,CMS-2017-0156-0046,Posted,01/16/2018,NA,"Hayes, Yolanda K (CMS)",01/10/2018,01/16/2018,No restrictions,NA,NA,NA,NA,1k2-90ul-z40l,1,1,3,1,Vaughn,Collins,South Burlington,United States,VT,5403,NA,Vermont State Dental Society,NA,NA,Vaughn Collins,"South Burlington, VT, 05403",NA,Vermont State Dental Society,Trade Association (Dental)
29,CMS-2017-0156-1302,CMS-2017-0156-1302-0,See attached file(s),3,1,CMS-2017-0156,CMS-2017-0156-DRAFT-1306,NA,0983-AT08,Bayer Corporation-NJ,PUBLIC SUBMISSIONS,Public Comment,Yes,CMS-2017-0156-0046,Posted,01/17/2018,NA,"Hayes, Yolanda K (CMS)",01/15/2018,01/17/2018,No restrictions,NA,NA,NA,NA,1k2-90xv-9r1f,1,1,3,1,Christopher,Piazza,Whippany,United States,NJ,7981,christopher.piazza@bayer.com,Bayer Corporation,NA,bayer.com,Christopher Piazza,"Whippany, NJ, 07981",christopher.piazza@bayer.com,Bayer Corporation,Manufacturer
30,CMS-2017-0156-1241,CMS-2017-0156-1241-0,See attached file(s),3,1,CMS-2017-0156,CMS-2017-0156-DRAFT-1245,NA,0983-AT08,Mark Kinney-CO,PUBLIC SUBMISSIONS,Public Comment,Yes,CMS-2017-0156-0046,Posted,01/16/2018,NA,"Hayes, Yolanda K (CMS)",01/13/2018,01/16/2018,No restrictions,NA,NA,NA,NA,1k2-90wg-77os,1,1,3,1,Mark,Kinney,Louisville,United States,CO,80027,mark.kinney@ipcrx.com,Independent Pharmacy Cooperative,NA,ipcrx.com,Mark Kinney,"Louisville, CO, 80027",mark.kinney@ipcrx.com,Independent Pharmacy Cooperative,Trade Association
31,CMS-2017-0156-1549,CMS-2017-0156-1549-0,See attached file(s),3,1,CMS-2017-0156,CMS-2017-0156-DRAFT-1556,NA,0983-AT08,Arizona Health Care Cost Containment System-AZ,PUBLIC SUBMISSIONS,Public Comment,Yes,CMS-2017-0156-0046,Posted,01/18/2018,NA,"Hayes, Yolanda K (CMS)",01/16/2018,01/18/2018,No restrictions,NA,NA,NA,NA,1k2-90yl-1cv9,1,1,3,1,Tom,Betlach,Phoenix,United States,AZ,85034,kyle.sawyer@azahcccs.gov,AHCCCS,NA,azahcccs.gov,Tom Betlach,"Phoenix, AZ, 85034",kyle.sawyer@azahcccs.gov,AHCCCS,Other - Gov
33,CMS-2017-0156-1652,CMS-2017-0156-1652-0,See attached file(s),3,1,CMS-2017-0156,CMS-2017-0156-DRAFT-1657,NA,0983-AT08,Drug Max Inc.-MI,PUBLIC SUBMISSIONS,Public Comment,Yes,CMS-2017-0156-0046,Posted,01/18/2018,NA,"Hayes, Yolanda K (CMS)",01/16/2018,01/18/2018,No restrictions,NA,NA,NA,NA,1k2-90yr-ol2h,1,1,3,1,Leila,Fawaz,Dearborn,United States,MI,48126,drugmaxpharmacy@gmail.com,Drug Max Inc.,NA,gmail.com,Leila Fawaz,"Dearborn, MI, 48126",drugmaxpharmacy@gmail.com,Drug Max Inc.,NA
34,CMS-2017-0156-1418,CMS-2017-0156-1418-0,See attached file(s),3,1,CMS-2017-0156,CMS-2017-0156-DRAFT-1423,NA,0983-AT08,SNP Alliance-DC,PUBLIC SUBMISSIONS,Public Comment,Yes,CMS-2017-0156-0046,Posted,01/17/2018,NA,"Hayes, Yolanda K (CMS)",01/16/2018,01/17/2018,No restrictions,NA,NA,NA,NA,1k2-90yf-uexd,1,1,3,1,Cheryl,"Phillips, M.D.",Washington,United States,DC,20001,cphillips@snpalliance.org,SNP Alliance,NA,snpalliance.org,"Cheryl Phillips, M.D.","Washington, DC, 20001",cphillips@snpalliance.org,SNP Alliance,Policy and Research
35,CMS-2017-0156-1506,CMS-2017-0156-1506-0,See attached file(s),3,1,CMS-2017-0156,CMS-2017-0156-DRAFT-1512,NA,0983-AT08,American Academy of Dermatology Association-DC,PUBLIC SUBMISSIONS,Public Comment,Yes,CMS-2017-0156-0046,Posted,01/18/2018,NA,"Hayes, Yolanda K (CMS)",01/16/2018,01/18/2018,No restrictions,NA,NA,NA,NA,1k2-90yk-uect,1,1,4,1,Anonymous,Anonymous,NA,United States,DC,20005,ajohn@aad.org,American Academy of Dermatology Association,NA,aad.org,Anonymous Anonymous,"DC, 20005",ajohn@aad.org,American Academy of Dermatology Association,Trade Association (Providers)
38,CMS-2017-0156-1311,CMS-2017-0156-1311-0,See attached file(s),3,1,CMS-2017-0156,CMS-2017-0156-DRAFT-1315,NA,0983-AT08,Patrick Gleason-MN,PUBLIC SUBMISSIONS,Public Comment,Yes,CMS-2017-0156-0046,Posted,01/17/2018,NA,"Hayes, Yolanda K (CMS)",01/15/2018,01/17/2018,No restrictions,NA,NA,NA,NA,1k2-90xv-qe9b,1,1,3,1,Patrick,Gleason,Bloomington,United States,MN,55437,pgleason@primetherapeutics.com,NA,NA,primetherapeutics.com,Patrick Gleason,"Bloomington, MN, 55437",pgleason@primetherapeutics.com,NA,PBM
39,CMS-2017-0156-1310,CMS-2017-0156-1310-0,See attached file(s),3,1,CMS-2017-0156,CMS-2017-0156-DRAFT-1314,NA,0983-AT08,Medicine Chest Pharmacy-NM,PUBLIC SUBMISSIONS,Public Comment,Yes,CMS-2017-0156-0046,Posted,01/17/2018,NA,"Hayes, Yolanda K (CMS)",01/15/2018,01/17/2018,No restrictions,NA,NA,NA,NA,1k2-90xv-w4gh,1,1,3,1,Kenneth,Corazza,Albuquerque,United States,NM,87107,medicinejeffe@gmail.com,Medicine Chest Pharmacy,NA,gmail.com,Kenneth Corazza,"Albuquerque, NM, 87107",medicinejeffe@gmail.com,Medicine Chest Pharmacy,Pharmacy
41,CMS-2017-0156-1446,CMS-2017-0156-1446-0,See attached file(s),3,1,CMS-2017-0156,CMS-2017-0156-DRAFT-1451,NA,0983-AT08,The SCAN Foundation-CA,PUBLIC SUBMISSIONS,Public Comment,Yes,CMS-2017-0156-0046,Posted,01/17/2018,NA,"Hayes, Yolanda K (CMS)",01/16/2018,01/17/2018,No restrictions,NA,NA,NA,NA,1k2-90yh-fbhp,1,1,4,1,Megan,Burke,Long Beach,United States,CA,90806,mburke@thescanfoundation.org,The SCAN Foundation,NA,thescanfoundation.org,Megan Burke,"Long Beach, CA, 90806",mburke@thescanfoundation.org,The SCAN Foundation,NA
43,CMS-2017-0156-1574,CMS-2017-0156-1574-0,See attached file(s),3,1,CMS-2017-0156,CMS-2017-0156-DRAFT-1581,NA,0983-AT08,Independent Health-NY,PUBLIC SUBMISSIONS,Public Comment,Yes,CMS-2017-0156-0046,Posted,01/18/2018,NA,"Hayes, Yolanda K (CMS)",01/16/2018,01/18/2018,No restrictions,NA,NA,NA,NA,1k2-90yl-ye0r,1,1,4,1,Jeremy,Laubacker,Buffalo,United States,NY,14221,Jeremy.Laubacker@independenthealth.com,Independent Health,NA,independenthealth.com,Jeremy Laubacker,"Buffalo, NY, 14221",Jeremy.Laubacker@independenthealth.com,Independent Health,Health Plan
44,CMS-2017-0156-1535,CMS-2017-0156-1535-0,see attached file,3,1,CMS-2017-0156,CMS-2017-0156-DRAFT-1542,NA,0983-AT08,delraypharmacy-VA,PUBLIC SUBMISSIONS,Public Comment,Yes,CMS-2017-0156-0046,Posted,01/18/2018,NA,"Hayes, Yolanda K (CMS)",01/16/2018,01/18/2018,No restrictions,NA,NA,NA,NA,1k2-90yk-qc6e,1,1,3,1,Stacey,Swartz,Alexandria,United States,VA,22301,stacey@delraypharmacy.com,NA,NA,delraypharmacy.com,Stacey Swartz,"Alexandria, VA, 22301",stacey@delraypharmacy.com,NA,NA
46,CMS-2017-0156-1641,CMS-2017-0156-1641-0,See attached file(s),3,1,CMS-2017-0156,CMS-2017-0156-DRAFT-1646,NA,0983-AT08,Olivehurst Drug Store--CA,PUBLIC SUBMISSIONS,Public Comment,Yes,CMS-2017-0156-0046,Posted,01/18/2018,NA,"Hayes, Yolanda K (CMS)",01/16/2018,01/18/2018,No restrictions,NA,NA,NA,NA,1k2-90yp-hkth,1,1,3,1,Hector,Camacho,Olivehurst,United States,CA,95961,olivehurst4897@yahoo.com,Olivehurst Drug Store,NA,yahoo.com,Hector Camacho,"Olivehurst, CA, 95961",olivehurst4897@yahoo.com,Olivehurst Drug Store,Pharmacy
52,CMS-2017-0156-1556,CMS-2017-0156-1556-0,See attached file(s),3,1,CMS-2017-0156,CMS-2017-0156-DRAFT-1563,NA,0983-AT08,Sempre Health-CA,PUBLIC SUBMISSIONS,Public Comment,Yes,CMS-2017-0156-0046,Posted,01/18/2018,NA,"Hayes, Yolanda K (CMS)",01/16/2018,01/18/2018,No restrictions,NA,NA,NA,NA,1k2-90yl-oma4,1,1,3,1,Anonymous,Anonymous,NA,United States,CA,94107,NA,Sempre Health,NA,NA,Anonymous Anonymous,"CA, 94107",NA,Sempre Health,Health Services
54,CMS-2017-0156-1240,CMS-2017-0156-1240-0,See attached file(s),3,1,CMS-2017-0156,CMS-2017-0156-DRAFT-1244,NA,0983-AT08,Lucas Smith-CO,PUBLIC SUBMISSIONS,Public Comment,Yes,CMS-2017-0156-0046,Posted,01/16/2018,NA,"Hayes, Yolanda K (CMS)",01/13/2018,01/16/2018,No restrictions,NA,NA,NA,NA,1k2-90we-d302,1,1,3,1,Lucas,Smith,Buena Vista,United States,CO,81211,lucas.smith@bvdrug.net,NA,NA,bvdrug.net,Lucas Smith,"Buena Vista, CO, 81211",lucas.smith@bvdrug.net,NA,NA
55,CMS-2017-0156-1307,CMS-2017-0156-1307-0,See attached file(s),3,1,CMS-2017-0156,CMS-2017-0156-DRAFT-1311,NA,0983-AT08,Meals on Wheels San Diego County-CA,PUBLIC SUBMISSIONS,Public Comment,Yes,CMS-2017-0156-0046,Posted,01/17/2018,NA,"Hayes, Yolanda K (CMS)",01/15/2018,01/17/2018,No restrictions,NA,NA,NA,NA,1k2-90xv-w20x,1,1,3,1,Debbie,Case,San Diego,United States,CA,92110,dcase@meals-on-wheels.org,Meals on Wheels San Diego County,NA,meals-on-wheels.org,Debbie Case,"San Diego, CA, 92110",dcase@meals-on-wheels.org,Meals on Wheels San Diego County,NA
57,CMS-2017-0156-1476,CMS-2017-0156-1476-0,Please see attached.,3,1,CMS-2017-0156,CMS-2017-0156-DRAFT-1481,NA,0983-AT08,Michigan Pharmacists Association-MI,PUBLIC SUBMISSIONS,Public Comment,Yes,CMS-2017-0156-0046,Posted,01/18/2018,NA,"Hayes, Yolanda K (CMS)",01/16/2018,01/18/2018,No restrictions,NA,NA,NA,NA,1k2-90yj-jkzy,1,1,3,1,Larry,Wagenknecht,Lansing,United States,MI,48933,Larry@MichiganPharmacists.org,Michigan Pharmacists Association,NA,MichiganPharmacists.org,Larry Wagenknecht,"Lansing, MI, 48933",Larry@MichiganPharmacists.org,Michigan Pharmacists Association,Trade Association (Pharmacy)
58,CMS-2017-0156-1301,CMS-2017-0156-1301-0,See attached file(s),3,1,CMS-2017-0156,CMS-2017-0156-DRAFT-1305,NA,0983-AT08,Primetherapeutics-MN,PUBLIC SUBMISSIONS,Public Comment,Yes,CMS-2017-0156-0046,Posted,01/17/2018,NA,"Hayes, Yolanda K (CMS)",01/15/2018,01/17/2018,No restrictions,NA,NA,NA,NA,1k2-90xv-h2rt,1,1,3,1,Richard,Zabinski,Bloomington,United States,MN,55437,rzabinski@primetherapeutics.com,NA,NA,primetherapeutics.com,Richard Zabinski,"Bloomington, MN, 55437",rzabinski@primetherapeutics.com,NA,PBM
62,CMS-2017-0156-1135,CMS-2017-0156-1135-0,See attached file(s),3,1,CMS-2017-0156,CMS-2017-0156-DRAFT-1136,NA,0983-AT08,National Comprehensive Cancer Network-PA,PUBLIC SUBMISSIONS,Public Comment,Yes,CMS-2017-0156-0046,Posted,01/16/2018,NA,"Hayes, Yolanda K (CMS)",01/12/2018,01/16/2018,No restrictions,NA,NA,NA,NA,1k2-90vs-h5pv,1,1,4,1,Robert,Carlson,Fort Washington,United States,PA,19034,schatz@nccn.org,National Comprehensive Cancer Network,NA,nccn.org,Robert Carlson,"Fort Washington, PA, 19034",schatz@nccn.org,National Comprehensive Cancer Network,Trade Association
63,CMS-2017-0156-1586,CMS-2017-0156-1586-0,See attached file(s),3,1,CMS-2017-0156,CMS-2017-0156-DRAFT-1593,NA,0983-AT08,RetireSafe-DC,PUBLIC SUBMISSIONS,Public Comment,Yes,CMS-2017-0156-0046,Posted,01/18/2018,NA,"Hayes, Yolanda K (CMS)",01/16/2018,01/18/2018,No restrictions,NA,NA,NA,NA,1k2-90yl-odyo,1,1,3,1,Thair,Phillips,Washington,United States,DC,20006,tphillips@retiresafe.org,RetireSafe,NA,retiresafe.org,Thair Phillips,"Washington, DC, 20006",tphillips@retiresafe.org,RetireSafe,Beneficiary Advocate
64,CMS-2017-0156-1561,CMS-2017-0156-1561-0,See attached file(s),3,1,CMS-2017-0156,CMS-2017-0156-DRAFT-1568,NA,0983-AT08,The ERISA Industry Committee-DC,PUBLIC SUBMISSIONS,Public Comment,Yes,CMS-2017-0156-0046,Posted,01/18/2018,NA,"Hayes, Yolanda K (CMS)",01/16/2018,01/18/2018,No restrictions,NA,NA,NA,NA,1k2-90yl-9uwt,1,1,3,1,James,Gelfand,Washington,United States,DC,20005,jgelfand@eric.org,The ERISA Industry Committee,NA,eric.org,James Gelfand,"Washington, DC, 20005",jgelfand@eric.org,The ERISA Industry Committee,Trade Association
65,CMS-2017-0156-0056,CMS-2017-0156-0056-0,See attached file(s),3,1,CMS-2017-0156,CMS-2017-0156-DRAFT-0056,NA,0983-AT08,NJ Association of Long Term Care Pharmacy Providers-NJ,PUBLIC SUBMISSIONS,Public Comment,Yes,CMS-2017-0156-0046,Posted,12/26/2017,NA,"Hayes, Yolanda K (CMS)",12/21/2017,12/26/2017,No restrictions,NA,NA,NA,NA,1k1-90h3-wzxr,1,1,4,1,Catherine,Chin,Basking Ridge,United States,NJ,7920,cchin@almangroupllc.com,NJ Association of Long Term Care Pharmacy Providers,NA,almangroupllc.com,Catherine Chin,"Basking Ridge, NJ, 07920",cchin@almangroupllc.com,NJ Association of Long Term Care Pharmacy Providers,Trade Association (LTC)
66,CMS-2017-0156-1552,CMS-2017-0156-1552-0,See attached file(s),3,1,CMS-2017-0156,CMS-2017-0156-DRAFT-1559,NA,0983-AT08,Wenatchee Clinic Pharmacy-WA,PUBLIC SUBMISSIONS,Public Comment,Yes,CMS-2017-0156-0046,Posted,01/18/2018,NA,"Hayes, Yolanda K (CMS)",01/16/2018,01/18/2018,No restrictions,NA,NA,NA,NA,1k2-90yl-tgl8,1,1,3,1,Ryan,Murray,Wenatchee,United States,WA,98801,Ryan@clinic-rx.com,Wenatchee Clinic Pharmacy,NA,clinic-rx.com,Ryan Murray,"Wenatchee, WA, 98801",Ryan@clinic-rx.com,Wenatchee Clinic Pharmacy,Pharmacy
67,CMS-2017-0156-0989,CMS-2017-0156-0989-0,See attached file(s),3,1,CMS-2017-0156,CMS-2017-0156-DRAFT-0990,NA,0983-AT08,American Society of Cataract and Refractive Surgery-VA,PUBLIC SUBMISSIONS,Public Comment,Yes,CMS-2017-0156-0046,Posted,01/16/2018,NA,"Hayes, Yolanda K (CMS)",01/11/2018,01/16/2018,No restrictions,NA,NA,NA,NA,1k2-90v2-zgtn,1,1,3,1,Allison,MAdson,Fairfax,United States,VA,22033,amadson@ascrs.org,American Society of Cataract and Refractive Surgery,NA,ascrs.org,Allison MAdson,"Fairfax, VA, 22033",amadson@ascrs.org,American Society of Cataract and Refractive Surgery,Trade Association (Providers)
69,CMS-2017-0156-1416,CMS-2017-0156-1416-0,See attached file(s),3,1,CMS-2017-0156,CMS-2017-0156-DRAFT-1421,NA,0983-AT08,Tivity Health-TN,PUBLIC SUBMISSIONS,Public Comment,Yes,CMS-2017-0156-0046,Posted,01/17/2018,NA,"Hayes, Yolanda K (CMS)",01/16/2018,01/17/2018,No restrictions,NA,NA,NA,NA,1k2-90yf-xa4u,1,1,4,1,Vicki,Shepard,Franklin,United States,TN,37067,stephanie.curtis@alston.com,Tivity Health,NA,alston.com,Vicki Shepard,"Franklin, TN, 37067",stephanie.curtis@alston.com,Tivity Health,NA
70,CMS-2017-0156-1564,CMS-2017-0156-1564-0,See attached file(s),3,1,CMS-2017-0156,CMS-2017-0156-DRAFT-1571,NA,0983-AT08,UnitedHealth Group-MN,PUBLIC SUBMISSIONS,Public Comment,Yes,CMS-2017-0156-0046,Posted,01/18/2018,NA,"Hayes, Yolanda K (CMS)",01/16/2018,01/18/2018,No restrictions,NA,NA,NA,NA,1k2-90yl-8eld,1,1,3,1,Richard,Migliori,Minnetonka,United States,MN,55343,jesse_p_schoolnik@uhc.com,UnitedHealth Group,NA,uhc.com,Richard Migliori,"Minnetonka, MN, 55343",jesse_p_schoolnik@uhc.com,UnitedHealth Group,Health Plan
72,CMS-2017-0156-1269,CMS-2017-0156-1269-0,See attached file(s),3,1,CMS-2017-0156,CMS-2017-0156-DRAFT-1272,NA,0983-AT08,Health Transformation Alliance-DC,PUBLIC SUBMISSIONS,Public Comment,Yes,CMS-2017-0156-0046,Posted,01/17/2018,NA,"Hayes, Yolanda K (CMS)",01/15/2018,01/17/2018,No restrictions,NA,NA,NA,NA,1k2-90xr-osye,1,1,4,1,Robert,Andrews,"Washington, DC",United States,DC,20009,NA,Health Transformation Alliance,NA,NA,Robert Andrews,"Washington, DC, DC, 20009",NA,Health Transformation Alliance,Trade Association
74,CMS-2017-0156-1191,CMS-2017-0156-1191-0,See attached file(s),3,1,CMS-2017-0156,CMS-2017-0156-DRAFT-1194,NA,0983-AT08,Brad Stapley-UT,PUBLIC SUBMISSIONS,Public Comment,Yes,CMS-2017-0156-0046,Posted,01/16/2018,NA,"Hayes, Yolanda K (CMS)",01/12/2018,01/16/2018,No restrictions,NA,NA,NA,NA,1k2-90vx-ym5n,1,1,3,1,Brad,Stapley,St. George,United States,UT,84770,brad@stapleypharmacy.com,NA,NA,stapleypharmacy.com,Brad Stapley,"St. George, UT, 84770",brad@stapleypharmacy.com,NA,NA
75,CMS-2017-0156-1417,CMS-2017-0156-1417-0,See attached file(s),3,1,CMS-2017-0156,CMS-2017-0156-DRAFT-1422,NA,0983-AT08,National Council for Prescription Drug Programs-AZ,PUBLIC SUBMISSIONS,Public Comment,Yes,CMS-2017-0156-0046,Posted,01/17/2018,NA,"Hayes, Yolanda K (CMS)",01/16/2018,01/17/2018,No restrictions,NA,NA,NA,NA,1k2-90yf-jkai,1,1,4,1,Paul,Wilson,Scottsdale,United States,AZ,85260,pwilson@ncpdp.org,NCPDP,NA,ncpdp.org,Paul Wilson,"Scottsdale, AZ, 85260",pwilson@ncpdp.org,NCPDP,NA
76,CMS-2017-0156-1481,CMS-2017-0156-1481-0,See attached file(s),3,1,CMS-2017-0156,CMS-2017-0156-DRAFT-1486,NA,0983-AT08,Nonprofit Kidney Care Alliance-DC,PUBLIC SUBMISSIONS,Public Comment,Yes,CMS-2017-0156-0046,Posted,01/18/2018,NA,"Hayes, Yolanda K (CMS)",01/16/2018,01/18/2018,No restrictions,NA,NA,NA,NA,1k2-90yj-xtys,1,1,3,1,Kelly,Delmore,Washington,United States,DC,20004,kdelmore@health-law.com,Nonprofit Kidney Care Alliance,NA,health-law.com,Kelly Delmore,"Washington, DC, 20004",kdelmore@health-law.com,Nonprofit Kidney Care Alliance,Beneficiary Advocate
80,CMS-2017-0156-1394,CMS-2017-0156-1394-0,See attached file(s),3,1,CMS-2017-0156,CMS-2017-0156-DRAFT-1399,NA,0983-AT08,LuGina Mendez-Harper-AZ,PUBLIC SUBMISSIONS,Public Comment,Yes,CMS-2017-0156-0046,Posted,01/17/2018,NA,"Hayes, Yolanda K (CMS)",01/16/2018,01/17/2018,No restrictions,NA,NA,NA,NA,1k2-90yd-ny7s,1,1,3,1,LuGina,Mendez-Harper,Phoenix,United States,AZ,85019,lmendezharper@primetherapeutics.com,NA,NA,primetherapeutics.com,LuGina Mendez-Harper,"Phoenix, AZ, 85019",lmendezharper@primetherapeutics.com,NA,PBM
81,CMS-2017-0156-1186,CMS-2017-0156-1186-0,See attached file(s),3,1,CMS-2017-0156,CMS-2017-0156-DRAFT-1189,NA,0983-AT08,Lauren Kyger-DC,PUBLIC SUBMISSIONS,Public Comment,Yes,CMS-2017-0156-0046,Posted,01/16/2018,NA,"Hayes, Yolanda K (CMS)",01/12/2018,01/16/2018,No restrictions,NA,NA,NA,NA,1k2-90vx-iwgn,1,1,3,1,Lauren,Kyger,Washington,United States,DC,20005,kygerl@ada.org,Organized Dentistry Coalition,NA,ada.org,Lauren Kyger,"Washington, DC, 20005",kygerl@ada.org,Organized Dentistry Coalition,Trade Association (Dental)
86,CMS-2017-0156-1527,CMS-2017-0156-1527-0,See attached file(s),3,1,CMS-2017-0156,CMS-2017-0156-DRAFT-1534,NA,0983-AT08,National Association of Manufacturer-DC,PUBLIC SUBMISSIONS,Public Comment,Yes,CMS-2017-0156-0046,Posted,01/18/2018,NA,"Hayes, Yolanda K (CMS)",01/16/2018,01/18/2018,No restrictions,NA,NA,NA,NA,1k2-90yk-mnl3,1,1,3,1,Robyn,Boerstling,Washington,United States,DC,20001,rboerstling@nam.org,National Association of Manufacturers,NA,nam.org,Robyn Boerstling,"Washington, DC, 20001",rboerstling@nam.org,National Association of Manufacturers,Trade Association (Manufacturers)
89,CMS-2017-0156-1613,CMS-2017-0156-1613-0,See attached file(s),3,1,CMS-2017-0156,CMS-2017-0156-DRAFT-1618,NA,0983-AT08,Matthews Drug Store-NC,PUBLIC SUBMISSIONS,Public Comment,Yes,CMS-2017-0156-0046,Posted,01/18/2018,NA,"Hayes, Yolanda K (CMS)",01/16/2018,01/18/2018,No restrictions,NA,NA,NA,NA,1k2-90ym-act5,1,1,3,1,James,Matthews,Clinton,United States,NC,28328,NA,Matthews Drug Store,NA,NA,James Matthews,"Clinton, NC, 28328",NA,Matthews Drug Store,Pharmacy
90,CMS-2017-0156-1497,CMS-2017-0156-1497-0,See attached file(s),3,1,CMS-2017-0156,CMS-2017-0156-DRAFT-1503,NA,0983-AT08,Genoa-OH,PUBLIC SUBMISSIONS,Public Comment,Yes,CMS-2017-0156-0046,Posted,01/18/2018,NA,"Hayes, Yolanda K (CMS)",01/16/2018,01/18/2018,No restrictions,NA,NA,NA,NA,1k2-90yk-ji4j,1,1,3,1,Dale,Masten,NA,United States,OH,45242,dmasten@genoa-qol.com,Genoa,NA,genoa-qol.com,Dale Masten,"OH, 45242",dmasten@genoa-qol.com,Genoa,NA
91,CMS-2017-0156-1635,CMS-2017-0156-1635-0,See attached file(s),3,1,CMS-2017-0156,CMS-2017-0156-DRAFT-1640,NA,0983-AT08,Advocate Health Care--IL,PUBLIC SUBMISSIONS,Public Comment,Yes,CMS-2017-0156-0046,Posted,01/18/2018,NA,"Hayes, Yolanda K (CMS)",01/16/2018,01/18/2018,No restrictions,NA,NA,NA,NA,1k2-90yo-hfcj,1,1,3,1,Shauna,McCarthy,Downers Grove,United States,IL,60654,shauna.mccarthy@advocatehealth.com,Advocate Health Care,NA,advocatehealth.com,Shauna McCarthy,"Downers Grove, IL, 60654",shauna.mccarthy@advocatehealth.com,Advocate Health Care,Beneficiary Advocate
92,CMS-2017-0156-1390,CMS-2017-0156-1390-0,See attached file(s),3,1,CMS-2017-0156,CMS-2017-0156-DRAFT-1395,NA,0983-AT08,"Elder Care and Advanced Illness, Altarum-DC",PUBLIC SUBMISSIONS,Public Comment,Yes,CMS-2017-0156-0046,Posted,01/17/2018,NA,"Hayes, Yolanda K (CMS)",01/16/2018,01/17/2018,No restrictions,NA,NA,NA,NA,1k2-90yd-4gos,1,1,3,1,Joanne,Lynn,Washington,United States,DC,20036,Joanne.Lynn@Altarum.org,"Elder Care and Advanced Illness, Altarum",NA,Altarum.org,Joanne Lynn,"Washington, DC, 20036",Joanne.Lynn@Altarum.org,"Elder Care and Advanced Illness, Altarum",NA
95,CMS-2017-0156-1294,CMS-2017-0156-1294-0,See attached file(s),3,1,CMS-2017-0156,CMS-2017-0156-DRAFT-1298,NA,0983-AT08,Bandar Saleh-MI,PUBLIC SUBMISSIONS,Public Comment,Yes,CMS-2017-0156-0046,Posted,01/17/2018,NA,"Hayes, Yolanda K (CMS)",01/15/2018,01/17/2018,No restrictions,NA,NA,NA,NA,1k2-90xu-f39m,1,1,3,1,Bandar,Saleh,Hamtramck,United States,MI,48212,Bd0484@aol.com,NA,NA,aol.com,Bandar Saleh,"Hamtramck, MI, 48212",Bd0484@aol.com,NA,Other
103,CMS-2017-0156-1483,CMS-2017-0156-1483-0,See attached file(s),3,1,CMS-2017-0156,CMS-2017-0156-DRAFT-1488,NA,0983-AT08,AgeOptions-IL,PUBLIC SUBMISSIONS,Public Comment,Yes,CMS-2017-0156-0046,Posted,01/18/2018,NA,"Hayes, Yolanda K (CMS)",01/16/2018,01/18/2018,No restrictions,NA,NA,NA,NA,1k2-90yj-4qdd,1,1,3,1,Jon,Lavin,Oak Park,United States,IL,60301,jon.lavin@ageoptions.org,AgeOptions,NA,ageoptions.org,Jon Lavin,"Oak Park, IL, 60301",jon.lavin@ageoptions.org,AgeOptions,NA
107,CMS-2017-0156-1595,CMS-2017-0156-1595-0,See attached file(s),3,1,CMS-2017-0156,CMS-2017-0156-DRAFT-1603,NA,0983-AT08,AbbVie-DC,PUBLIC SUBMISSIONS,Public Comment,Yes,CMS-2017-0156-0046,Posted,01/18/2018,NA,"Hayes, Yolanda K (CMS)",01/16/2018,01/18/2018,No restrictions,NA,NA,NA,NA,1k2-90yl-vv30,1,1,3,1,Ashley,Flint,Washington,United States,DC,20005,ashley.flint@abbvie.com,AbbVie,NA,abbvie.com,Ashley Flint,"Washington, DC, 20005",ashley.flint@abbvie.com,AbbVie,Manufacturer
112,CMS-2017-0156-1558,CMS-2017-0156-1558-0,See attached file(s),3,1,CMS-2017-0156,CMS-2017-0156-DRAFT-1565,NA,0983-AT08,Global Healthy Living Foundation-NY,PUBLIC SUBMISSIONS,Public Comment,Yes,CMS-2017-0156-0046,Posted,01/18/2018,NA,"Hayes, Yolanda K (CMS)",01/16/2018,01/18/2018,No restrictions,NA,NA,NA,NA,1k2-90yl-y82b,1,1,3,1,Stephen,Marmaras,Upper Nyack,United States,NY,10960,smarmaras@ghlf.org,Global Healthy Living Foundation,NA,ghlf.org,Stephen Marmaras,"Upper Nyack, NY, 10960",smarmaras@ghlf.org,Global Healthy Living Foundation,Beneficiary Advocate
113,CMS-2017-0156-1568,CMS-2017-0156-1568-0,See attached file(s),3,1,CMS-2017-0156,CMS-2017-0156-DRAFT-1575,NA,0983-AT08,National Council on Aging-VA,PUBLIC SUBMISSIONS,Public Comment,Yes,CMS-2017-0156-0046,Posted,01/18/2018,NA,"Hayes, Yolanda K (CMS)",01/16/2018,01/18/2018,No restrictions,NA,NA,NA,NA,1k2-90yl-prab,1,1,4,1,Samantha,Zenlea,Arlington,United States,VA,22202,samantha.zenlea@ncoa.org,National Council on Aging,NA,ncoa.org,Samantha Zenlea,"Arlington, VA, 22202",samantha.zenlea@ncoa.org,National Council on Aging,Beneficiary Advocate
114,CMS-2017-0156-1621,CMS-2017-0156-1621-0,See attached file(s),3,1,CMS-2017-0156,CMS-2017-0156-DRAFT-1626,NA,0983-AT08,Medica--MN,PUBLIC SUBMISSIONS,Public Comment,Yes,CMS-2017-0156-0046,Posted,01/18/2018,NA,"Hayes, Yolanda K (CMS)",01/16/2018,01/18/2018,No restrictions,NA,NA,NA,NA,1k2-90ym-41ls,1,1,3,1,Anonymous,Anonymous,NA,United States,MN,55305,NA,Medica,NA,NA,Anonymous Anonymous,"MN, 55305",NA,Medica,Health Plan
119,CMS-2017-0156-1305,CMS-2017-0156-1305-0,See attached file(s),3,1,CMS-2017-0156,CMS-2017-0156-DRAFT-1309,NA,0983-AT08,"Duran Central Pharmacy, Inc.-NM",PUBLIC SUBMISSIONS,Public Comment,Yes,CMS-2017-0156-0046,Posted,01/17/2018,NA,"Hayes, Yolanda K (CMS)",01/15/2018,01/17/2018,No restrictions,NA,NA,NA,NA,1k2-90xv-s6in,1,1,3,1,Mona,Ghattas,Albuquerque,United States,NM,87104,monaghattas@me.com,"Duran Central Pharmacy, Inc.",NA,me.com,Mona Ghattas,"Albuquerque, NM, 87104",monaghattas@me.com,"Duran Central Pharmacy, Inc.",Pharmacy
121,CMS-2017-0156-1223,CMS-2017-0156-1223-0,See attached file(s),3,1,CMS-2017-0156,CMS-2017-0156-DRAFT-1227,NA,0983-AT08,EVA Health-CA,PUBLIC SUBMISSIONS,Public Comment,Yes,CMS-2017-0156-0046,Posted,01/16/2018,NA,"Hayes, Yolanda K (CMS)",01/12/2018,01/16/2018,No restrictions,NA,NA,NA,NA,1k2-90w2-hhd0,1,1,3,1,Chad,Nour,COVINA,United States,CA,91723,pharmacist4me@yahoo.com,NA,NA,yahoo.com,Chad Nour,"COVINA, CA, 91723",pharmacist4me@yahoo.com,NA,NA
125,CMS-2017-0156-1628,CMS-2017-0156-1628-0,See attached file(s),3,1,CMS-2017-0156,CMS-2017-0156-DRAFT-1633,NA,0983-AT08,Alliance for Home Dialysis--DC,PUBLIC SUBMISSIONS,Public Comment,Yes,CMS-2017-0156-0046,Posted,01/18/2018,NA,"Hayes, Yolanda K (CMS)",01/16/2018,01/18/2018,No restrictions,NA,NA,NA,NA,1k2-90yn-v843,1,1,4,1,Michelle,Seger,Washington,United States,DC,20002,michelle@homedialysisalliance.org,Alliance for Home Dialysis,NA,homedialysisalliance.org,Michelle Seger,"Washington, DC, 20002",michelle@homedialysisalliance.org,Alliance for Home Dialysis,NA
128,CMS-2017-0156-0032,CMS-2017-0156-0032-0,See attached file(s),3,1,CMS-2017-0156,CMS-2017-0156-DRAFT-0032,NA,0983-AT08,Association for Community Affiliated Plans-DC,PUBLIC SUBMISSIONS,Public Comment,Yes,CMS-2017-0156-0001,Posted,12/11/2017,NA,"Hayes, Yolanda K (CMS)",11/27/2017,12/11/2017,No restrictions,NA,NA,NA,NA,1k1-9015-ja8q,1,1,3,1,Christine,Lynch,Washington,United States,DC,20005,clynch@communityplans.net,ACAP,NA,communityplans.net,Christine Lynch,"Washington, DC, 20005",clynch@communityplans.net,ACAP,Trade Association
130,CMS-2017-0156-1604,CMS-2017-0156-1604-0,See attached file(s),3,1,CMS-2017-0156,CMS-2017-0156-DRAFT-1612,NA,0983-AT08,California Dental Association-CA,PUBLIC SUBMISSIONS,Public Comment,Yes,CMS-2017-0156-0046,Posted,01/18/2018,NA,"Hayes, Yolanda K (CMS)",01/16/2018,01/18/2018,No restrictions,NA,NA,NA,NA,1k2-90ym-zj2j,1,1,3,1,Ann,Milar,SACRAMENTO,United States,CA,95814,ann.milar@cda.org,California Dental Association,NA,cda.org,Ann Milar,"SACRAMENTO, CA, 95814",ann.milar@cda.org,California Dental Association,Trade Association (Dental)
133,CMS-2017-0156-1206,CMS-2017-0156-1206-0,See attached file(s),3,1,CMS-2017-0156,CMS-2017-0156-DRAFT-1209,NA,0983-AT08,Ben Lee-CA,PUBLIC SUBMISSIONS,Public Comment,Yes,CMS-2017-0156-0046,Posted,01/16/2018,NA,"Hayes, Yolanda K (CMS)",01/12/2018,01/16/2018,No restrictions,NA,NA,NA,NA,1k2-90vz-y4hw,1,1,3,1,Ben,Lee,Coalinga,United States,CA,93210,NA,NA,NA,NA,Ben Lee,"Coalinga, CA, 93210",NA,NA,Other
134,CMS-2017-0156-0916,CMS-2017-0156-0916-0,See attached file(s),3,1,CMS-2017-0156,CMS-2017-0156-DRAFT-0916,NA,0983-AT08,National Committee for Quality Assurance-DC,PUBLIC SUBMISSIONS,Public Comment,Yes,CMS-2017-0156-0046,Posted,01/16/2018,NA,"Hayes, Yolanda K (CMS)",01/09/2018,01/16/2018,No restrictions,NA,NA,NA,NA,1k2-90tu-scgq,1,1,3,1,Paul,Cotton,Washington,United States,DC,20005,cotton@ncqa.org,National Committee for Quality Assurance,NA,ncqa.org,Paul Cotton,"Washington, DC, 20005",cotton@ncqa.org,National Committee for Quality Assurance,Trade Association
135,CMS-2017-0156-1550,CMS-2017-0156-1550-0,See attached file(s),3,1,CMS-2017-0156,CMS-2017-0156-DRAFT-1557,NA,0983-AT08,National Association of Health Underwriters-DC,PUBLIC SUBMISSIONS,Public Comment,Yes,CMS-2017-0156-0046,Posted,01/18/2018,NA,"Hayes, Yolanda K (CMS)",01/16/2018,01/18/2018,No restrictions,NA,NA,NA,NA,1k2-90yl-iywm,1,1,3,1,Janet,Trautwein,Washington,United States,DC,20005,jessica@forwardhealthconsulting.com,National Association of Health Underwriters,NA,forwardhealthconsulting.com,Janet Trautwein,"Washington, DC, 20005",jessica@forwardhealthconsulting.com,National Association of Health Underwriters,Trade Association
136,CMS-2017-0156-1573,CMS-2017-0156-1573-0,See attached file(s),3,1,CMS-2017-0156,CMS-2017-0156-DRAFT-1580,NA,0983-AT08,Bristol-Myers Squibb-NJ,PUBLIC SUBMISSIONS,Public Comment,Yes,CMS-2017-0156-0046,Posted,01/18/2018,NA,"Hayes, Yolanda K (CMS)",01/16/2018,01/18/2018,No restrictions,NA,NA,NA,NA,1k2-90yl-azv6,1,1,3,1,Tamar,Thompson,NA,United States,NJ,8648,tamar.thompson@bms.com,Bristol-Myers Squibb,NA,bms.com,Tamar Thompson,"NJ, 08648",tamar.thompson@bms.com,Bristol-Myers Squibb,Manufacturer
138,CMS-2017-0156-0337,CMS-2017-0156-0337-0,Please see attached.,3,1,CMS-2017-0156,CMS-2017-0156-DRAFT-0337,NA,0983-AT08,American Speech-Language-Hearing Association-MD,PUBLIC SUBMISSIONS,Public Comment,Yes,CMS-2017-0156-0046,Posted,12/26/2017,NA,"Hayes, Yolanda K (CMS)",12/22/2017,12/26/2017,No restrictions,NA,NA,NA,NA,1k1-90ho-8q56,1,1,3,1,Gail,"Richard, PhD, CCC-SLP",Rockville,United States,MD,20850-3289,swarren@asha.org,ASHA,NA,asha.org,"Gail Richard, PhD, CCC-SLP","Rockville, MD, 20850-3289",swarren@asha.org,ASHA,NA
141,CMS-2017-0156-1376,CMS-2017-0156-1376-0,See attached file(s),3,1,CMS-2017-0156,CMS-2017-0156-DRAFT-1381,NA,0983-AT08,Jim Vrana-WI,PUBLIC SUBMISSIONS,Public Comment,Yes,CMS-2017-0156-0046,Posted,01/17/2018,NA,"Hayes, Yolanda K (CMS)",01/15/2018,01/17/2018,No restrictions,NA,NA,NA,NA,1k2-90y2-bik3,1,1,3,1,Jim,Vrana,Racine,United States,WI,53402,vranajim@gmail.com,NA,NA,gmail.com,Jim Vrana,"Racine, WI, 53402",vranajim@gmail.com,NA,Other
146,CMS-2017-0156-1609,CMS-2017-0156-1609-0,See attached file(s),3,1,CMS-2017-0156,CMS-2017-0156-DRAFT-1614,NA,0983-AT08,National MS Society-NY,PUBLIC SUBMISSIONS,Public Comment,Yes,CMS-2017-0156-0046,Posted,01/18/2018,NA,"Hayes, Yolanda K (CMS)",01/16/2018,01/18/2018,No restrictions,NA,NA,NA,NA,1k2-90ym-ng11,1,1,3,1,Kimberly,Calder,New York,United States,NY,10017,Kimberly.Calder@nmss.org,National MS Society,NA,nmss.org,Kimberly Calder,"New York, NY, 10017",Kimberly.Calder@nmss.org,National MS Society,Beneficiary Advocate
147,CMS-2017-0156-1520,CMS-2017-0156-1520-0,See attached file(s),3,1,CMS-2017-0156,CMS-2017-0156-DRAFT-1526,NA,0983-AT08,Fallon Health-MA,PUBLIC SUBMISSIONS,Public Comment,Yes,CMS-2017-0156-0046,Posted,01/18/2018,NA,"Hayes, Yolanda K (CMS)",01/16/2018,01/18/2018,No restrictions,NA,NA,NA,NA,1k2-90yk-p03f,1,1,3,1,Keith,Greiner,Worcester,United States,MA,1608,Keith.Greiner@fallonhealth.org,Fallon Health,NA,fallonhealth.org,Keith Greiner,"Worcester, MA, 01608",Keith.Greiner@fallonhealth.org,Fallon Health,Health Plan
149,CMS-2017-0156-1489,CMS-2017-0156-1489-0,See attached file(s),3,1,CMS-2017-0156,CMS-2017-0156-DRAFT-1495,NA,0983-AT08,National Association of Specialty Pharmacy-DC,PUBLIC SUBMISSIONS,Public Comment,Yes,CMS-2017-0156-0046,Posted,01/18/2018,NA,"Hayes, Yolanda K (CMS)",01/16/2018,01/18/2018,No restrictions,NA,NA,NA,NA,1k2-90yk-6dsy,1,1,3,1,Sheila,Arquette,Washington,United States,DC,20001,sarquette@naspnet.org,NA,NA,naspnet.org,Sheila Arquette,"Washington, DC, 20001",sarquette@naspnet.org,NA,Trade Association (Pharmacy)
151,CMS-2017-0156-1471,CMS-2017-0156-1471-0,See attached file(s),3,1,CMS-2017-0156,CMS-2017-0156-DRAFT-1476,NA,0983-AT08,Mark Newsom-DC,PUBLIC SUBMISSIONS,Public Comment,Yes,CMS-2017-0156-0046,Posted,01/18/2018,NA,"Hayes, Yolanda K (CMS)",01/16/2018,01/18/2018,No restrictions,NA,NA,NA,NA,1k2-90yj-onjj,1,1,3,1,Mark,Newsom,Washington,United States,DC,20004,mnewsom@humana.com,NA,NA,humana.com,Mark Newsom,"Washington, DC, 20004",mnewsom@humana.com,NA,Health Plan
155,CMS-2017-0156-1213,CMS-2017-0156-1213-0,See attached file(s),3,1,CMS-2017-0156,CMS-2017-0156-DRAFT-1217,NA,0983-AT08,AMY'S PHARMACY-CA,PUBLIC SUBMISSIONS,Public Comment,Yes,CMS-2017-0156-0046,Posted,01/16/2018,NA,"Hayes, Yolanda K (CMS)",01/12/2018,01/16/2018,No restrictions,NA,NA,NA,NA,1k2-90vz-ie9t,1,1,3,1,AMAL,FAHMY,ARLETA,United States,CA,91331,AMYPHARMACY@OUTLOOK.COM,AMY'S PHARMACY,NA,OUTLOOK.COM,AMAL FAHMY,"ARLETA, CA, 91331",AMYPHARMACY@OUTLOOK.COM,AMY'S PHARMACY,Pharmacy
157,CMS-2017-0156-1242,CMS-2017-0156-1242-0,See attached file(s),3,1,CMS-2017-0156,CMS-2017-0156-DRAFT-1246,NA,0983-AT08,Elizabeth Harmer-PA,PUBLIC SUBMISSIONS,Public Comment,Yes,CMS-2017-0156-0046,Posted,01/16/2018,NA,"Hayes, Yolanda K (CMS)",01/13/2018,01/16/2018,No restrictions,NA,NA,NA,NA,1k2-90wh-kha8,1,1,3,1,Elizabeth,Harmer,Lansdowne,United States,PA,19050,pepepper@rcn.com,IPC,NA,rcn.com,Elizabeth Harmer,"Lansdowne, PA, 19050",pepepper@rcn.com,IPC,NA
158,CMS-2017-0156-1487,CMS-2017-0156-1487-0,See attached file(s),3,1,CMS-2017-0156,CMS-2017-0156-DRAFT-1493,NA,0983-AT08,American Association of Nurse Practitioners-VA,PUBLIC SUBMISSIONS,Public Comment,Yes,CMS-2017-0156-0046,Posted,01/18/2018,NA,"Hayes, Yolanda K (CMS)",01/16/2018,01/18/2018,No restrictions,NA,NA,NA,NA,1k2-90yk-huyy,1,1,4,1,Franklin,Harrington,Alexandria,United States,VA,22314,fharrington@aanp.org,AANP,NA,aanp.org,Franklin Harrington,"Alexandria, VA, 22314",fharrington@aanp.org,AANP,NA
160,CMS-2017-0156-0995,CMS-2017-0156-0995-0,See attached file(s),3,1,CMS-2017-0156,CMS-2017-0156-DRAFT-0996,NA,0983-AT08,TJ Parker-NH,PUBLIC SUBMISSIONS,Public Comment,Yes,CMS-2017-0156-0046,Posted,01/16/2018,NA,"Hayes, Yolanda K (CMS)",01/11/2018,01/16/2018,No restrictions,NA,NA,NA,NA,1k2-90v2-ql0n,1,1,3,1,TJ,Parker,Manchester,United States,NH,3101,tj@pillpack.com,NA,NA,pillpack.com,TJ Parker,"Manchester, NH, 03101",tj@pillpack.com,NA,NA
165,CMS-2017-0156-1326,CMS-2017-0156-1326-0,See attached file(s),3,1,CMS-2017-0156,CMS-2017-0156-DRAFT-1330,NA,0983-AT08,Angie Shirley-AL,PUBLIC SUBMISSIONS,Public Comment,Yes,CMS-2017-0156-0046,Posted,01/17/2018,NA,"Hayes, Yolanda K (CMS)",01/15/2018,01/17/2018,No restrictions,NA,NA,NA,NA,1k2-90xx-2vh3,1,1,3,1,Angie,Shirley,Bessemer,United States,AL,35022,angies@apcinet.com,NA,NA,apcinet.com,Angie Shirley,"Bessemer, AL, 35022",angies@apcinet.com,NA,NA
166,CMS-2017-0156-1396,CMS-2017-0156-1396-0,See attached file(s),3,1,CMS-2017-0156,CMS-2017-0156-DRAFT-1401,NA,0983-AT08,American Academy of Family Physicians-DC,PUBLIC SUBMISSIONS,Public Comment,Yes,CMS-2017-0156-0046,Posted,01/17/2018,NA,"Hayes, Yolanda K (CMS)",01/16/2018,01/17/2018,No restrictions,NA,NA,NA,NA,1k2-90yd-gelf,1,1,3,1,Robert,Bennett,Washington,United States,DC,22202,rbennett@aafp.org,American Academy of Family Physicians,NA,aafp.org,Robert Bennett,"Washington, DC, 22202",rbennett@aafp.org,American Academy of Family Physicians,Trade Association (Providers)
167,CMS-2017-0156-1203,CMS-2017-0156-1203-0,See attached file(s),3,1,CMS-2017-0156,CMS-2017-0156-DRAFT-1206,NA,0983-AT08,Southwest Pharmacy-NV,PUBLIC SUBMISSIONS,Public Comment,Yes,CMS-2017-0156-0046,Posted,01/16/2018,NA,"Hayes, Yolanda K (CMS)",01/12/2018,01/16/2018,No restrictions,NA,NA,NA,NA,1k2-90vy-v2zl,1,1,3,1,JOHN,TRAN,Las VEGAS,United States,NV,89110,SWRXLV@GMAIL.COM,SOUTHWEST PHARMACY,NA,GMAIL.COM,JOHN TRAN,"Las VEGAS, NV, 89110",SWRXLV@GMAIL.COM,SOUTHWEST PHARMACY,Pharmacy
169,CMS-2017-0156-1435,CMS-2017-0156-1435-0,See attached file(s),3,1,CMS-2017-0156,CMS-2017-0156-DRAFT-1440,NA,0983-AT08,Delta Dental Plans Association-DC,PUBLIC SUBMISSIONS,Public Comment,Yes,CMS-2017-0156-0046,Posted,01/17/2018,NA,"Hayes, Yolanda K (CMS)",01/16/2018,01/17/2018,No restrictions,NA,NA,NA,NA,1k2-90yg-zrh7,1,1,3,1,Frank,Kolb,Washington,United States,DC,20001,fkolb@deltadental.com,Delta Dental Plans Association,NA,deltadental.com,Frank Kolb,"Washington, DC, 20001",fkolb@deltadental.com,Delta Dental Plans Association,Trade Association (Dental)
170,CMS-2017-0156-1199,CMS-2017-0156-1199-0,See attached file(s),3,1,CMS-2017-0156,CMS-2017-0156-DRAFT-1202,NA,0983-AT08,Change Healthcare-TN,PUBLIC SUBMISSIONS,Public Comment,Yes,CMS-2017-0156-0046,Posted,01/16/2018,NA,"Hayes, Yolanda K (CMS)",01/12/2018,01/16/2018,No restrictions,NA,NA,NA,NA,1k2-90vy-woll,1,1,3,1,Tim,Jones,Nashville,United States,TN,37214,tim.jones@altegrahealth.com,Change Healthcare,NA,altegrahealth.com,Tim Jones,"Nashville, TN, 37214",tim.jones@altegrahealth.com,Change Healthcare,Health Services
171,CMS-2017-0156-1637,CMS-2017-0156-1637-0,See attached file(s),3,1,CMS-2017-0156,CMS-2017-0156-DRAFT-1642,NA,0983-AT08,American Society of Clinical Oncology--VA,PUBLIC SUBMISSIONS,Public Comment,Yes,CMS-2017-0156-0046,Posted,01/18/2018,NA,"Hayes, Yolanda K (CMS)",01/16/2018,01/18/2018,No restrictions,NA,NA,NA,NA,1k2-90yo-p11a,1,1,4,1,Sybil,Green,Alexandria,United States,VA,22314,sybil.green@asco.org,American Society of Clinical Oncology,NA,asco.org,Sybil Green,"Alexandria, VA, 22314",sybil.green@asco.org,American Society of Clinical Oncology,Trade Association (Providers)
174,CMS-2017-0156-1486,CMS-2017-0156-1486-0,See attached file(s),3,1,CMS-2017-0156,CMS-2017-0156-DRAFT-1492,NA,0983-AT08,"Lilly USA, LLC-IN",PUBLIC SUBMISSIONS,Public Comment,Yes,CMS-2017-0156-0046,Posted,01/18/2018,NA,"Hayes, Yolanda K (CMS)",01/16/2018,01/18/2018,No restrictions,NA,NA,NA,NA,1k2-90yj-svf5,1,1,3,1,Ryan,Urgo,Indianapolis,United States,IN,46225,urgorv@lilly.com,Eli Lilly & Co,NA,lilly.com,Ryan Urgo,"Indianapolis, IN, 46225",urgorv@lilly.com,Eli Lilly &amp; Co,Manufacturer
176,CMS-2017-0156-1218,CMS-2017-0156-1218-0,See attached file(s),3,1,CMS-2017-0156,CMS-2017-0156-DRAFT-1222,NA,0983-AT08,AltaMed Health Services-CA,PUBLIC SUBMISSIONS,Public Comment,Yes,CMS-2017-0156-0046,Posted,01/16/2018,NA,"Hayes, Yolanda K (CMS)",01/12/2018,01/16/2018,No restrictions,NA,NA,NA,NA,1k2-90w0-upqs,1,1,3,1,Berenice,Nuez Constant,Los Angeles,United States,CA,90040,bconstant@altamed.org,AltaMed Health Services,NA,altamed.org,Berenice Nuez Constant,"Los Angeles, CA, 90040",bconstant@altamed.org,AltaMed Health Services,NA
181,CMS-2017-0156-1319,CMS-2017-0156-1319-0,See attached file(s),3,1,CMS-2017-0156,CMS-2017-0156-DRAFT-1323,NA,0983-AT08,Lisa Harvey-McPherson-ME,PUBLIC SUBMISSIONS,Public Comment,Yes,CMS-2017-0156-0046,Posted,01/17/2018,NA,"Hayes, Yolanda K (CMS)",01/15/2018,01/17/2018,No restrictions,NA,NA,NA,NA,1k2-90xw-97o1,1,1,3,1,Lisa,Harvey-McPherson,Brewer,United States,ME,4412,lmcpherson@emhs.org,EMHS,NA,emhs.org,Lisa Harvey-McPherson,"Brewer, ME, 04412",lmcpherson@emhs.org,EMHS,NA
183,CMS-2017-0156-1571,CMS-2017-0156-1571-0,See attached file(s),3,1,CMS-2017-0156,CMS-2017-0156-DRAFT-1578,NA,0983-AT08,Health Care Service Corporation-DC,PUBLIC SUBMISSIONS,Public Comment,Yes,CMS-2017-0156-0046,Posted,01/18/2018,NA,"Hayes, Yolanda K (CMS)",01/16/2018,01/18/2018,No restrictions,NA,NA,NA,NA,1k2-90yl-c8cf,1,1,3,1,Dana,Mott-Bronson,NA,United States,DC,20004,Dana_Mott-Bronson@hcsc.net,Health Care Service Corporation,NA,hcsc.net,Dana Mott-Bronson,"DC, 20004",Dana_Mott-Bronson@hcsc.net,Health Care Service Corporation,Health Plan
184,CMS-2017-0156-1631,CMS-2017-0156-1631-0,See attached file(s),3,1,CMS-2017-0156,CMS-2017-0156-DRAFT-1636,NA,0983-AT08,L.A. Care Health Plan--CA,PUBLIC SUBMISSIONS,Public Comment,Yes,CMS-2017-0156-0046,Posted,01/18/2018,NA,"Hayes, Yolanda K (CMS)",01/16/2018,01/18/2018,No restrictions,NA,NA,NA,NA,1k2-90yn-953e,1,1,4,1,Julianne,Holloway,Los Angeles,United States,CA,90017,jholloway@lacare.org,L.A. Care Health Plan,NA,lacare.org,Julianne Holloway,"Los Angeles, CA, 90017",jholloway@lacare.org,L.A. Care Health Plan,Health Plan
187,CMS-2017-0156-1523,CMS-2017-0156-1523-0,See attached file(s),3,1,CMS-2017-0156,CMS-2017-0156-DRAFT-1530,NA,0983-AT08,DaVita-DC,PUBLIC SUBMISSIONS,Public Comment,Yes,CMS-2017-0156-0046,Posted,01/18/2018,NA,"Hayes, Yolanda K (CMS)",01/16/2018,01/18/2018,No restrictions,NA,NA,NA,NA,1k2-90yk-tsno,1,1,4,1,LeAnne,Zumwalt,Washington,United States,DC,20001,LeAnne.Zumwalt@davita.com,DaVita,NA,davita.com,LeAnne Zumwalt,"Washington, DC, 20001",LeAnne.Zumwalt@davita.com,DaVita,Health Plan
189,CMS-2017-0156-1491,CMS-2017-0156-1491-0,See attached file(s),3,1,CMS-2017-0156,CMS-2017-0156-DRAFT-1497,NA,0983-AT08,MED-Choice Pharmacy-TX,PUBLIC SUBMISSIONS,Public Comment,Yes,CMS-2017-0156-0046,Posted,01/18/2018,NA,"Hayes, Yolanda K (CMS)",01/16/2018,01/18/2018,No restrictions,NA,NA,NA,NA,1k2-90yk-8r3p,1,1,3,1,Susan,Miller,Denison,United States,TX,75020,medchoicepharmacy@cableone.net,MED-Choice Pharmacy,NA,cableone.net,Susan Miller,"Denison, TX, 75020",medchoicepharmacy@cableone.net,MED-Choice Pharmacy,Pharmacy
190,CMS-2017-0156-1484,CMS-2017-0156-1484-0,See attached file(s),3,1,CMS-2017-0156,CMS-2017-0156-DRAFT-1490,NA,0983-AT08,California Health Advocates-CA,PUBLIC SUBMISSIONS,Public Comment,Yes,CMS-2017-0156-0046,Posted,01/18/2018,NA,"Hayes, Yolanda K (CMS)",01/16/2018,01/18/2018,No restrictions,NA,NA,NA,NA,1k2-90yj-7buv,1,1,3,1,Tatiana,Fassieux,Sacramento,United States,CA,95819,tfassieux@cahealthadvocates.org,California Health Advocates,NA,cahealthadvocates.org,Tatiana Fassieux,"Sacramento, CA, 95819",tfassieux@cahealthadvocates.org,California Health Advocates,Beneficiary Advocate
194,CMS-2017-0156-1171,CMS-2017-0156-1171-0,See attached file(s),3,1,CMS-2017-0156,CMS-2017-0156-DRAFT-1172,NA,0983-AT08,The Leukemia & Lymphoma Society-DC,PUBLIC SUBMISSIONS,Public Comment,Yes,CMS-2017-0156-0046,Posted,01/16/2018,NA,"Hayes, Yolanda K (CMS)",01/12/2018,01/16/2018,No restrictions,NA,NA,NA,NA,1k2-90vv-yr5r,1,1,4,1,Bernadette,O'Donoghue,Washington,United States,DC,20002,brian.connell@lls.org,The Leukemia & Lymphoma Society,NA,lls.org,Bernadette O'Donoghue,"Washington, DC, 20002",brian.connell@lls.org,The Leukemia &amp; Lymphoma Society,Beneficiary Advocate
196,CMS-2017-0156-1580,CMS-2017-0156-1580-0,See attached file(s),3,1,CMS-2017-0156,CMS-2017-0156-DRAFT-1587,NA,0983-AT08,The Epilepsy Foundation-MD,PUBLIC SUBMISSIONS,Public Comment,Yes,CMS-2017-0156-0046,Posted,01/18/2018,NA,"Hayes, Yolanda K (CMS)",01/16/2018,01/18/2018,No restrictions,NA,NA,NA,NA,1k2-90yl-4q0q,1,1,3,1,Abbey,Roudebush,Landover,United States,MD,20785,aroudebush@efa.org,The Epilepsy Foundation,NA,efa.org,Abbey Roudebush,"Landover, MD, 20785",aroudebush@efa.org,The Epilepsy Foundation,Beneficiary Advocate
197,CMS-2017-0156-1510,CMS-2017-0156-1510-0,See attached file(s),3,1,CMS-2017-0156,CMS-2017-0156-DRAFT-1516,NA,0983-AT08,Express Scripts-DC,PUBLIC SUBMISSIONS,Public Comment,Yes,CMS-2017-0156-0046,Posted,01/18/2018,NA,"Hayes, Yolanda K (CMS)",01/16/2018,01/18/2018,No restrictions,NA,NA,NA,NA,1k2-90yk-ixn5,1,1,3,1,Sergio,Santiviago,Washington,United States,DC,20001,sasantiviago@express-scripts.com,Express Scripts,NA,express-scripts.com,Sergio Santiviago,"Washington, DC, 20001",sasantiviago@express-scripts.com,Express Scripts,PBM
199,CMS-2017-0156-1399,CMS-2017-0156-1399-0,See attached file(s),3,1,CMS-2017-0156,CMS-2017-0156-DRAFT-1404,NA,0983-AT08,Maryland State Dental Association-MD,PUBLIC SUBMISSIONS,Public Comment,Yes,CMS-2017-0156-0046,Posted,01/17/2018,NA,"Hayes, Yolanda K (CMS)",01/16/2018,01/17/2018,No restrictions,NA,NA,NA,NA,1k2-90ye-p31a,1,1,3,1,Gregory,Buckler,Columbia,United States,MD,21045,greg@msda.com,Maryland,NA,msda.com,Gregory Buckler,"Columbia, MD, 21045",greg@msda.com,Maryland,Trade Association (Dental)
205,CMS-2017-0156-1116,CMS-2017-0156-1116-0,See attached file(s),3,1,CMS-2017-0156,CMS-2017-0156-DRAFT-1117,NA,0983-AT08,MA Executive Office of Health and Human Services-MA,PUBLIC SUBMISSIONS,Public Comment,Yes,CMS-2017-0156-0046,Posted,01/16/2018,NA,"Hayes, Yolanda K (CMS)",01/12/2018,01/16/2018,No restrictions,NA,NA,NA,NA,1k2-90vp-vu3n,1,1,3,1,Mindy,Machera,NA,United States,MA,2108,NA,MA Executive Office of Health and Human Services,NA,NA,Mindy Machera,"MA, 02108",NA,MA Executive Office of Health and Human Services,Other - Gov
208,CMS-2017-0156-1322,CMS-2017-0156-1322-0,See attached file(s),3,1,CMS-2017-0156,CMS-2017-0156-DRAFT-1326,NA,0983-AT08,Douglas Read-TX,PUBLIC SUBMISSIONS,Public Comment,Yes,CMS-2017-0156-0046,Posted,01/17/2018,NA,"Hayes, Yolanda K (CMS)",01/15/2018,01/17/2018,No restrictions,NA,NA,NA,NA,1k2-90xw-njtc,1,1,3,1,Douglas,Read,San Antonio,United States,TX,78204,read.douglas@heb.com,H-E-B,NA,heb.com,Douglas Read,"San Antonio, TX, 78204",read.douglas@heb.com,H-E-B,NA
210,CMS-2017-0156-1131,CMS-2017-0156-1131-0,See attached file(s),3,1,CMS-2017-0156,CMS-2017-0156-DRAFT-1132,NA,0983-AT08,American Dental Association-DC,PUBLIC SUBMISSIONS,Public Comment,Yes,CMS-2017-0156-0046,Posted,01/16/2018,NA,"Hayes, Yolanda K (CMS)",01/12/2018,01/16/2018,No restrictions,NA,NA,NA,NA,1k2-90vs-ng2n,1,1,3,1,Lauren,Kyger,Washington,United States,DC,20005,kygerl@ada.org,American Dental Association,NA,ada.org,Lauren Kyger,"Washington, DC, 20005",kygerl@ada.org,American Dental Association,Trade Association (Dental)
212,CMS-2017-0156-1277,CMS-2017-0156-1277-0,See attached file(s),3,1,CMS-2017-0156,CMS-2017-0156-DRAFT-1280,NA,0983-AT08,"BioScrip, Inc.-CO",PUBLIC SUBMISSIONS,Public Comment,Yes,CMS-2017-0156-0046,Posted,01/17/2018,NA,"Hayes, Yolanda K (CMS)",01/15/2018,01/17/2018,No restrictions,NA,NA,NA,NA,1k2-90xs-kkuh,1,1,3,1,Anonymous,Anonymous,Denver,United States,CO,80202,dfarber@kslaw.com,"BioScrip, Inc.",NA,kslaw.com,Anonymous Anonymous,"Denver, CO, 80202",dfarber@kslaw.com,"BioScrip, Inc.",NA
213,CMS-2017-0156-1325,CMS-2017-0156-1325-0,See attached file(s),3,1,CMS-2017-0156,CMS-2017-0156-DRAFT-1329,NA,0983-AT08,Medigold-MI,PUBLIC SUBMISSIONS,Public Comment,Yes,CMS-2017-0156-0046,Posted,01/17/2018,NA,"Hayes, Yolanda K (CMS)",01/15/2018,01/17/2018,No restrictions,NA,NA,NA,NA,1k2-90xx-8xok,1,1,3,1,Tonya,Wells,Livonia,United States,MI,48152,wellstk@trinity-health.org,Medigold,NA,trinity-health.org,Tonya Wells,"Livonia, MI, 48152",wellstk@trinity-health.org,Medigold,NA
220,CMS-2017-0156-1633,CMS-2017-0156-1633-0,See attached file(s),3,1,CMS-2017-0156,CMS-2017-0156-DRAFT-1638,NA,0983-AT08,Alaskan Native Tribal Health Consortium--AK,PUBLIC SUBMISSIONS,Public Comment,Yes,CMS-2017-0156-0046,Posted,01/18/2018,NA,"Hayes, Yolanda K (CMS)",01/16/2018,01/18/2018,No restrictions,NA,NA,NA,NA,1k2-90yo-eokw,1,1,3,1,Gerald,Moses,NA,United States,AK,99508,eealaivanu@anthc.org,ANTHC,NA,anthc.org,Gerald Moses,"AK, 99508",eealaivanu@anthc.org,ANTHC,Provider
221,CMS-2017-0156-1304,CMS-2017-0156-1304-0,See attached file(s),3,1,CMS-2017-0156,CMS-2017-0156-DRAFT-1308,NA,0983-AT08,Michelle Jacobson-MN,PUBLIC SUBMISSIONS,Public Comment,Yes,CMS-2017-0156-0046,Posted,01/17/2018,NA,"Hayes, Yolanda K (CMS)",01/15/2018,01/17/2018,No restrictions,NA,NA,NA,NA,1k2-90xv-snu1,1,1,3,1,Michelle,Jacobson,Bloomington,United States,MN,55437,Michelle.Jacobson@PrimeTherapeutics.com,NA,NA,PrimeTherapeutics.com,Michelle Jacobson,"Bloomington, MN, 55437",Michelle.Jacobson@PrimeTherapeutics.com,NA,PBM
222,CMS-2017-0156-1225,CMS-2017-0156-1225-0,See attached file(s),3,1,CMS-2017-0156,CMS-2017-0156-DRAFT-1229,NA,0983-AT08,Rosemary Smith-KY,PUBLIC SUBMISSIONS,Public Comment,Yes,CMS-2017-0156-0046,Posted,01/16/2018,NA,"Hayes, Yolanda K (CMS)",01/12/2018,01/16/2018,No restrictions,NA,NA,NA,NA,1k2-90w2-7z8g,1,1,3,1,Rosemary,Smith,Beattyville,United States,KY,41311,rosemary@jordandrug.com,NA,NA,jordandrug.com,Rosemary Smith,"Beattyville, KY, 41311",rosemary@jordandrug.com,NA,NA
223,CMS-2017-0156-1454,CMS-2017-0156-1454-0,See attached file(s),3,1,CMS-2017-0156,CMS-2017-0156-DRAFT-1459,NA,0983-AT08,Mayo Clinic-MN,PUBLIC SUBMISSIONS,Public Comment,Yes,CMS-2017-0156-0046,Posted,01/17/2018,NA,"Hayes, Yolanda K (CMS)",01/16/2018,01/17/2018,No restrictions,NA,NA,NA,NA,1k2-90yi-ob2g,1,1,3,1,Ronald,Grousky,Rochester,United States,MN,55905,grousky.ronald@mayo.edu,Mayo Clinic,NA,mayo.edu,Ronald Grousky,"Rochester, MN, 55905",grousky.ronald@mayo.edu,Mayo Clinic,Provider
225,CMS-2017-0156-0755,CMS-2017-0156-0755-0,See attached file(s),3,1,CMS-2017-0156,CMS-2017-0156-DRAFT-0754,NA,0983-AT08,Anonymous-ID,PUBLIC SUBMISSIONS,Public Comment,Yes,CMS-2017-0156-0046,Posted,01/10/2018,NA,"Braxton, Shawn L (CMS)",01/05/2018,01/10/2018,No restrictions,NA,NA,NA,NA,1k2-90r9-kw2z,1,1,3,1,Anonymous,Anonymous,NA,United States,ID,83712,NA,NA,NA,NA,Anonymous Anonymous,"ID, 83712",NA,NA,Other
226,CMS-2017-0156-1290,CMS-2017-0156-1290-0,See attached file(s),3,1,CMS-2017-0156,CMS-2017-0156-DRAFT-1294,NA,0983-AT08,Tasha Klesk-MN,PUBLIC SUBMISSIONS,Public Comment,Yes,CMS-2017-0156-0046,Posted,01/17/2018,NA,"Hayes, Yolanda K (CMS)",01/15/2018,01/17/2018,No restrictions,NA,NA,NA,NA,1k2-90xu-9kyi,1,1,3,1,Tasha,Klesk,Edina,United States,MN,55435,Tasha.Klesk@PrimeTherapeutics.com,NA,NA,PrimeTherapeutics.com,Tasha Klesk,"Edina, MN, 55435",Tasha.Klesk@PrimeTherapeutics.com,NA,PBM
227,CMS-2017-0156-0945,CMS-2017-0156-0945-0,See attached file(s),3,1,CMS-2017-0156,CMS-2017-0156-DRAFT-0945,NA,0983-AT08,UCARE-MN,PUBLIC SUBMISSIONS,Public Comment,Yes,CMS-2017-0156-0046,Posted,01/16/2018,NA,"Hayes, Yolanda K (CMS)",01/10/2018,01/16/2018,No restrictions,NA,NA,NA,NA,1k2-90ue-aofd,1,1,3,1,Tracy,Hoisington,NA,United States,MN,55413,NA,UCare,NA,NA,Tracy Hoisington,"MN, 55413",NA,UCare,Health Plan
229,CMS-2017-0156-1281,CMS-2017-0156-1281-0,See attached file(s),3,1,CMS-2017-0156,CMS-2017-0156-DRAFT-1284,NA,0983-AT08,Emelia Gomez-IL,PUBLIC SUBMISSIONS,Public Comment,Yes,CMS-2017-0156-0046,Posted,01/17/2018,NA,"Hayes, Yolanda K (CMS)",01/15/2018,01/17/2018,No restrictions,NA,NA,NA,NA,1k2-90xt-m2f9,1,1,3,1,Emelia,Gomez,Chicago,United States,IL,60625,emelia.gomez@localhealthrx.com,Hwang Pharmacy,NA,localhealthrx.com,Emelia Gomez,"Chicago, IL, 60625",emelia.gomez@localhealthrx.com,Hwang Pharmacy,Pharmacy
230,CMS-2017-0156-1559,CMS-2017-0156-1559-0,See attached file(s),3,1,CMS-2017-0156,CMS-2017-0156-DRAFT-1566,NA,0983-AT08,"The Compliance Team , Inc.-PA",PUBLIC SUBMISSIONS,Public Comment,Yes,CMS-2017-0156-0046,Posted,01/18/2018,NA,"Hayes, Yolanda K (CMS)",01/16/2018,01/18/2018,No restrictions,NA,NA,NA,NA,1k2-90yl-bigj,1,1,3,1,Steve,Simmerman,Spring House,United States,PA,19477,ssimmerman@thecomplianceteam.org,NA,NA,thecomplianceteam.org,Steve Simmerman,"Spring House, PA, 19477",ssimmerman@thecomplianceteam.org,NA,NA
231,CMS-2017-0156-1474,CMS-2017-0156-1474-0,See attached file(s),3,1,CMS-2017-0156,CMS-2017-0156-DRAFT-1479,NA,0983-AT08,Idaho Department of Health and Welfare-ID,PUBLIC SUBMISSIONS,Public Comment,Yes,CMS-2017-0156-0046,Posted,01/18/2018,NA,"Hayes, Yolanda K (CMS)",01/16/2018,01/18/2018,No restrictions,NA,NA,NA,NA,1k2-90yj-w0cj,1,1,4,1,Alexandra,Fernandez,Boise,United States,ID,83705,alexandra.fernandez@dhw.idaho.gov,Idaho Department of Health and Welfare,NA,dhw.idaho.gov,Alexandra Fernandez,"Boise, ID, 83705",alexandra.fernandez@dhw.idaho.gov,Idaho Department of Health and Welfare,Other - Gov
234,CMS-2017-0156-1608,CMS-2017-0156-1608-0,See attached file(s),3,1,CMS-2017-0156,CMS-2017-0156-DRAFT-1365,NA,0983-AT08,Southn Park Pharmacy-WA,PUBLIC SUBMISSIONS,Public Comment,Yes,CMS-2017-0156-0046,Posted,01/18/2018,NA,"Hayes, Yolanda K (CMS)",01/15/2018,01/18/2018,No restrictions,NA,NA,NA,NA,1k2-90xz-ciao,1,1,3,1,Kenneth,Paskett,Port Orchard,United States,WA,98366,kenrx1@wavecable.com,Southn Park Pharmacy,NA,wavecable.com,Kenneth Paskett,"Port Orchard, WA, 98366",kenrx1@wavecable.com,Southn Park Pharmacy,Pharmacy
235,CMS-2017-0156-1211,CMS-2017-0156-1211-0,See attached file(s),3,1,CMS-2017-0156,CMS-2017-0156-DRAFT-1214,NA,0983-AT08,Union Drug-IA,PUBLIC SUBMISSIONS,Public Comment,Yes,CMS-2017-0156-0046,Posted,01/16/2018,NA,"Hayes, Yolanda K (CMS)",01/12/2018,01/16/2018,No restrictions,NA,NA,NA,NA,1k2-90vz-8esy,1,1,3,1,Steven,Metcalf,West Union,United States,IA,52175,smetcalf@alpinecom.net,Union Drug,NA,alpinecom.net,Steven Metcalf,"West Union, IA, 52175",smetcalf@alpinecom.net,Union Drug,NA
236,CMS-2017-0156-1308,CMS-2017-0156-1308-0,See attached file(s),3,1,CMS-2017-0156,CMS-2017-0156-DRAFT-1312,NA,0983-AT08,Santiago Gonzalez-NM,PUBLIC SUBMISSIONS,Public Comment,Yes,CMS-2017-0156-0046,Posted,01/17/2018,NA,"Hayes, Yolanda K (CMS)",01/15/2018,01/17/2018,No restrictions,NA,NA,NA,NA,1k2-90xv-i14e,1,1,3,1,Santiago,Gonzalez,Albuquerque,United States,NM,87109,santiago.gonzales@primetherapeutics.com,NA,NA,primetherapeutics.com,Santiago Gonzalez,"Albuquerque, NM, 87109",santiago.gonzales@primetherapeutics.com,NA,PBM
238,CMS-2017-0156-1445,CMS-2017-0156-1445-0,See attached file(s),3,1,CMS-2017-0156,CMS-2017-0156-DRAFT-1450,NA,0983-AT08,eHealth Inc.-DC,PUBLIC SUBMISSIONS,Public Comment,Yes,CMS-2017-0156-0046,Posted,01/17/2018,NA,"Hayes, Yolanda K (CMS)",01/16/2018,01/17/2018,No restrictions,NA,NA,NA,NA,1k2-90yh-gon0,1,1,4,1,John,Desser,Washington,United States,DC,20036,john.desser@ehealth.com,eHealth Inc.,NA,ehealth.com,John Desser,"Washington, DC, 20036",john.desser@ehealth.com,eHealth Inc.,NA
240,CMS-2017-0156-1333,CMS-2017-0156-1333-0,See attached letter.,3,1,CMS-2017-0156,CMS-2017-0156-DRAFT-1337,NA,0983-AT08,Connecticut State Dental Association-CT,PUBLIC SUBMISSIONS,Public Comment,Yes,CMS-2017-0156-0046,Posted,01/17/2018,NA,"Hayes, Yolanda K (CMS)",01/15/2018,01/17/2018,No restrictions,NA,NA,NA,NA,1k2-90xx-6w7b,1,1,3,1,Kristina,Diamond,Southington,United States,CT,6489,kdiamond@csda.com,Connecticut State Dental Association,NA,csda.com,Kristina Diamond,"Southington, CT, 06489",kdiamond@csda.com,Connecticut State Dental Association,Trade Association (Dental)
242,CMS-2017-0156-1212,CMS-2017-0156-1212-0,See attached file(s),3,1,CMS-2017-0156,CMS-2017-0156-DRAFT-1216,NA,0983-AT08,Craig Willimann-MO,PUBLIC SUBMISSIONS,Public Comment,Yes,CMS-2017-0156-0046,Posted,01/16/2018,NA,"Hayes, Yolanda K (CMS)",01/12/2018,01/16/2018,No restrictions,NA,NA,NA,NA,1k2-90vz-1uq4,1,1,3,1,Craig,Willimann,New Haven,United States,MO,63068,prattrx@fidnet.com,NA,NA,fidnet.com,Craig Willimann,"New Haven, MO, 63068",prattrx@fidnet.com,NA,NA
243,CMS-2017-0156-1532,CMS-2017-0156-1532-0,See attached file(s),3,1,CMS-2017-0156,CMS-2017-0156-DRAFT-1539,NA,0983-AT08,Medicare Rights Center-NY,PUBLIC SUBMISSIONS,Public Comment,Yes,CMS-2017-0156-0046,Posted,01/18/2018,NA,"Hayes, Yolanda K (CMS)",01/16/2018,01/18/2018,No restrictions,NA,NA,NA,NA,1k2-90yk-oiam,1,1,3,1,Casey,Schwarz,266 W37th St,United States,NY,10018,cschwarz@medicarerights.org,Medicare Rights Center,NA,medicarerights.org,Casey Schwarz,"266 W37th St, NY, 10018",cschwarz@medicarerights.org,Medicare Rights Center,Beneficiary Advocate
247,CMS-2017-0156-1502,CMS-2017-0156-1502-0,See attached file(s),3,1,CMS-2017-0156,CMS-2017-0156-DRAFT-1508,NA,0983-AT08,"Commonwealth Care Alliance, Inc.-MA",PUBLIC SUBMISSIONS,Public Comment,Yes,CMS-2017-0156-0046,Posted,01/18/2018,NA,"Hayes, Yolanda K (CMS)",01/16/2018,01/18/2018,No restrictions,NA,NA,NA,NA,1k2-90yk-ha52,1,1,3,1,Ken,Preede,Boston,United States,MA,2108,kpreede@commonwealthcare.org,"Commonwealth Care Alliance, Inc.",NA,commonwealthcare.org,Ken Preede,"Boston, MA, 02108",kpreede@commonwealthcare.org,"Commonwealth Care Alliance, Inc.",Trade Association
248,CMS-2017-0156-1624,CMS-2017-0156-1624-0,See attached file(s),3,1,CMS-2017-0156,CMS-2017-0156-DRAFT-1629,NA,0983-AT08,Star Pharmacy--MI,PUBLIC SUBMISSIONS,Public Comment,Yes,CMS-2017-0156-0046,Posted,01/18/2018,NA,"Hayes, Yolanda K (CMS)",01/16/2018,01/18/2018,No restrictions,NA,NA,NA,NA,1k2-90ym-nn58,1,1,3,1,Shah,Bhuiyan,Warren,United States,MI,48091,starpharmacymi@gmail.com,NA,NA,gmail.com,Shah Bhuiyan,"Warren, MI, 48091",starpharmacymi@gmail.com,NA,Other
250,CMS-2017-0156-1525,CMS-2017-0156-1525-0,See attached file(s),3,1,CMS-2017-0156,CMS-2017-0156-DRAFT-1532,NA,0983-AT08,"Highmark, Inc.-PA",PUBLIC SUBMISSIONS,Public Comment,Yes,CMS-2017-0156-0046,Posted,01/18/2018,NA,"Hayes, Yolanda K (CMS)",01/16/2018,01/18/2018,No restrictions,NA,NA,NA,NA,1k2-90yk-5xs8,1,1,3,1,Amy,Sawyer,Pittsburgh,United States,PA,15222,amy.wallacesawyer@highmark.com,"Highmark, Inc.",NA,highmark.com,Amy Sawyer,"Pittsburgh, PA, 15222",amy.wallacesawyer@highmark.com,"Highmark, Inc.",Health Plan
252,CMS-2017-0156-1456,CMS-2017-0156-1456-0,See attached file(s),3,1,CMS-2017-0156,CMS-2017-0156-DRAFT-1461,NA,0983-AT08,American Hospital Association-DC,PUBLIC SUBMISSIONS,Public Comment,Yes,CMS-2017-0156-0046,Posted,01/17/2018,NA,"Hayes, Yolanda K (CMS)",01/16/2018,01/17/2018,No restrictions,NA,NA,NA,NA,1k2-90yi-4plt,1,1,3,1,Molly,Smith,Washington,United States,DC,20001,mollysmith@aha.org,American Hospital Association,NA,aha.org,Molly Smith,"Washington, DC, 20001",mollysmith@aha.org,American Hospital Association,Trade Association (Providers)
255,CMS-2017-0156-1565,CMS-2017-0156-1565-0,Please see attached.,3,1,CMS-2017-0156,CMS-2017-0156-DRAFT-1572,NA,0983-AT08,National Community Pharmacists Association-VA,PUBLIC SUBMISSIONS,Public Comment,Yes,CMS-2017-0156-0046,Posted,01/18/2018,NA,"Hayes, Yolanda K (CMS)",01/16/2018,01/18/2018,No restrictions,NA,NA,NA,NA,1k2-90yl-k7vm,1,1,3,1,Kala,Shankle,Alexandria,United States,VA,22314,kala.shankle@ncpanet.org,National Community Pharmacists Association,NA,ncpanet.org,Kala Shankle,"Alexandria, VA, 22314",kala.shankle@ncpanet.org,National Community Pharmacists Association,Trade Association (Pharmacy)
256,CMS-2017-0156-1627,CMS-2017-0156-1627-0,See attached file(s),3,1,CMS-2017-0156,CMS-2017-0156-DRAFT-1632,NA,0983-AT08,Seeber's Pharmacy--WA,PUBLIC SUBMISSIONS,Public Comment,Yes,CMS-2017-0156-0046,Posted,01/18/2018,NA,"Hayes, Yolanda K (CMS)",01/16/2018,01/18/2018,No restrictions,NA,NA,NA,NA,1k2-90yn-1hft,1,1,3,1,Greg,Seeber,Newport,United States,WA,99156,gseeber@povn.com,Seeber's Pharmacy,NA,povn.com,Greg Seeber,"Newport, WA, 99156",gseeber@povn.com,Seeber's Pharmacy,Pharmacy
257,CMS-2017-0156-1434,CMS-2017-0156-1434-0,See attached file(s),3,1,CMS-2017-0156,CMS-2017-0156-DRAFT-1439,NA,0983-AT08,The Pew Charitable Trusts-DC,PUBLIC SUBMISSIONS,Public Comment,Yes,CMS-2017-0156-0046,Posted,01/17/2018,NA,"Hayes, Yolanda K (CMS)",01/16/2018,01/17/2018,No restrictions,NA,NA,NA,NA,1k2-90yg-dulx,1,1,4,1,Cynthia,Reilly,Washington DC,United States,DC,20004,creilly@pewtrusts.org,The Pew Charitable Trusts,NA,pewtrusts.org,Cynthia Reilly,"Washington DC, DC, 20004",creilly@pewtrusts.org,The Pew Charitable Trusts,NA
259,CMS-2017-0156-1457,CMS-2017-0156-1457-0,See attached file(s),3,1,CMS-2017-0156,CMS-2017-0156-DRAFT-1462,NA,0983-AT08,CVS Health-DC,PUBLIC SUBMISSIONS,Public Comment,Yes,CMS-2017-0156-0046,Posted,01/17/2018,NA,"Hayes, Yolanda K (CMS)",01/16/2018,01/17/2018,No restrictions,NA,NA,NA,NA,1k2-90yi-f48z,1,1,3,1,Jennifer,Hitchon,Washington,United States,DC,20004,jennifer.hitchon@cvshealth.com,CVS Health,NA,cvshealth.com,Jennifer Hitchon,"Washington, DC, 20004",jennifer.hitchon@cvshealth.com,CVS Health,PBM/Pharmacy/Health Plan
263,CMS-2017-0156-1291,CMS-2017-0156-1291-0,See attached file(s),3,1,CMS-2017-0156,CMS-2017-0156-DRAFT-1295,NA,0983-AT08,Allison Erickson-MN,PUBLIC SUBMISSIONS,Public Comment,Yes,CMS-2017-0156-0046,Posted,01/17/2018,NA,"Hayes, Yolanda K (CMS)",01/15/2018,01/17/2018,No restrictions,NA,NA,NA,NA,1k2-90xu-640k,1,1,3,1,Allison,Erickson,Edina,United States,MN,55435,aerickson@primetherapeutics.com,NA,NA,primetherapeutics.com,Allison Erickson,"Edina, MN, 55435",aerickson@primetherapeutics.com,NA,PBM
265,CMS-2017-0156-1275,CMS-2017-0156-1275-0,See attached file(s),3,1,CMS-2017-0156,CMS-2017-0156-DRAFT-1278,NA,0983-AT08,PPG Script Inc dba Rx Xpress Health Mart Pharmacy-PA,PUBLIC SUBMISSIONS,Public Comment,Yes,CMS-2017-0156-0046,Posted,01/17/2018,NA,"Hayes, Yolanda K (CMS)",01/15/2018,01/17/2018,No restrictions,NA,NA,NA,NA,1k2-90xs-93vg,1,1,3,1,Pamela,Burns-Grisnik,Grove City,United States,PA,16127,rxoffice@zoominternet.net,PPG Script Inc dba Rx Xpress Health Mart Pharmacy,NA,zoominternet.net,Pamela Burns-Grisnik,"Grove City, PA, 16127",rxoffice@zoominternet.net,PPG Script Inc dba Rx Xpress Health Mart Pharmacy,NA
266,CMS-2017-0156-1442,CMS-2017-0156-1442-0,See attached file(s),3,1,CMS-2017-0156,CMS-2017-0156-DRAFT-1447,NA,0983-AT08,Christina Macias-AZ,PUBLIC SUBMISSIONS,Public Comment,Yes,CMS-2017-0156-0046,Posted,01/17/2018,NA,"Hayes, Yolanda K (CMS)",01/16/2018,01/17/2018,No restrictions,NA,NA,NA,NA,1k2-90yh-ixgx,1,1,3,1,Christina,Macias,Phoenix,United States,AZ,85040,MaciasC1@aetna.com,NA,NA,aetna.com,Christina Macias,"Phoenix, AZ, 85040",MaciasC1@aetna.com,NA,NA
267,CMS-2017-0156-1555,CMS-2017-0156-1555-0,See attached file(s),3,1,CMS-2017-0156,CMS-2017-0156-DRAFT-1562,NA,0983-AT08,Medicaid Health Plans of America-DC,PUBLIC SUBMISSIONS,Public Comment,Yes,CMS-2017-0156-0046,Posted,01/18/2018,NA,"Hayes, Yolanda K (CMS)",01/16/2018,01/18/2018,No restrictions,NA,NA,NA,NA,1k2-90yl-rqhb,1,1,3,1,Kirby,Greissing,NW,United States,DC,20036,kgreissing@mhpa.org,Medicaid Health Plans of America,NA,mhpa.org,Kirby Greissing,"NW, DC, 20036",kgreissing@mhpa.org,Medicaid Health Plans of America,Trade Association
270,CMS-2017-0156-1431,CMS-2017-0156-1431-0,See attached file(s),3,1,CMS-2017-0156,CMS-2017-0156-DRAFT-1436,NA,0983-AT08,Pharmacyplus-NM,PUBLIC SUBMISSIONS,Public Comment,Yes,CMS-2017-0156-0046,Posted,01/17/2018,NA,"Hayes, Yolanda K (CMS)",01/16/2018,01/17/2018,No restrictions,NA,NA,NA,NA,1k2-90yg-a8em,1,1,3,1,George,Sandoval,Albuquerque,United States,NM,87114,Pharmacyplusbern@msn.com,NA,NA,msn.com,George Sandoval,"Albuquerque, NM, 87114",Pharmacyplusbern@msn.com,NA,NA
273,CMS-2017-0156-1448,CMS-2017-0156-1448-0,See attached file(s),3,1,CMS-2017-0156,CMS-2017-0156-DRAFT-1453,NA,0983-AT08,American Society of Health System Pharmacists-MD,PUBLIC SUBMISSIONS,Public Comment,Yes,CMS-2017-0156-0046,Posted,01/17/2018,NA,"Hayes, Yolanda K (CMS)",01/16/2018,01/17/2018,No restrictions,NA,NA,NA,NA,1k2-90yh-7frb,1,1,4,1,Jillanne,Schulte Wall,Bethesda,United States,MD,20814,jschulte@ashp.org,ASHP,NA,ashp.org,Jillanne Schulte Wall,"Bethesda, MD, 20814",jschulte@ashp.org,ASHP,NA
275,CMS-2017-0156-1239,CMS-2017-0156-1239-0,See attached file(s),3,1,CMS-2017-0156,CMS-2017-0156-DRAFT-1243,NA,0983-AT08,Hussein Safawi-MI,PUBLIC SUBMISSIONS,Public Comment,Yes,CMS-2017-0156-0046,Posted,01/16/2018,NA,"Hayes, Yolanda K (CMS)",01/13/2018,01/16/2018,No restrictions,NA,NA,NA,NA,1k2-90we-r9ca,1,1,3,1,Hussein,Safawi,Detroit,United States,MI,48235,express_meds@yahoo.com,NA,NA,yahoo.com,Hussein Safawi,"Detroit, MI, 48235",express_meds@yahoo.com,NA,NA
277,CMS-2017-0156-0291,CMS-2017-0156-0291-0,Please see attached,3,1,CMS-2017-0156,CMS-2017-0156-DRAFT-0291,NA,0983-AT08,Mental Health America-VA,PUBLIC SUBMISSIONS,Public Comment,Yes,CMS-2017-0156-0046,Posted,12/26/2017,NA,"Hayes, Yolanda K (CMS)",12/21/2017,12/26/2017,No restrictions,NA,NA,NA,NA,1k1-90ha-bty2,1,1,3,1,Nathaniel,Counts,Alexandria,United States,VA,22314,ncounts@mentalhealthamerica.net,Mental Health America,NA,mentalhealthamerica.net,Nathaniel Counts,"Alexandria, VA, 22314",ncounts@mentalhealthamerica.net,Mental Health America,Beneficiary Advocate
278,CMS-2017-0156-1226,CMS-2017-0156-1226-0,See attached file(s),3,1,CMS-2017-0156,CMS-2017-0156-DRAFT-1230,NA,0983-AT08,OC Pharmacy-CA,PUBLIC SUBMISSIONS,Public Comment,Yes,CMS-2017-0156-0046,Posted,01/16/2018,NA,"Hayes, Yolanda K (CMS)",01/12/2018,01/16/2018,No restrictions,NA,NA,NA,NA,1k2-90w2-86vw,1,1,3,1,omeed,Askari,San Juan Capistrano,United States,CA,92675,omeed@ocpharmacy.net,OC Pharmacy,NA,ocpharmacy.net,omeed Askari,"San Juan Capistrano, CA, 92675",omeed@ocpharmacy.net,OC Pharmacy,Pharmacy
285,CMS-2017-0156-1313,CMS-2017-0156-1313-0,See attached file(s),3,1,CMS-2017-0156,CMS-2017-0156-DRAFT-1317,NA,0983-AT08,Shannon Kampa-MN,PUBLIC SUBMISSIONS,Public Comment,Yes,CMS-2017-0156-0046,Posted,01/17/2018,NA,"Hayes, Yolanda K (CMS)",01/15/2018,01/17/2018,No restrictions,NA,NA,NA,NA,1k2-90xw-ervo,1,1,3,1,Shannon,Kampa,Bloomington,United States,MN,55437,SKampa@primetherapeutics.com,NA,NA,primetherapeutics.com,Shannon Kampa,"Bloomington, MN, 55437",SKampa@primetherapeutics.com,NA,PBM
287,CMS-2017-0156-1630,CMS-2017-0156-1630-0,See attached file(s),3,1,CMS-2017-0156,CMS-2017-0156-DRAFT-1635,NA,0983-AT08,Iowa Dental Association--IA,PUBLIC SUBMISSIONS,Public Comment,Yes,CMS-2017-0156-0046,Posted,01/18/2018,NA,"Hayes, Yolanda K (CMS)",01/16/2018,01/18/2018,No restrictions,NA,NA,NA,NA,1k2-90yn-3qur,1,1,3,1,Anonymous,Anonymous,Des Moines,United States,IA,50309,cownie@brownwinick.com,Iowa Dental Association,NA,brownwinick.com,Anonymous Anonymous,"Des Moines, IA, 50309",cownie@brownwinick.com,Iowa Dental Association,Trade Association (Dental)
290,CMS-2017-0156-1286,CMS-2017-0156-1286-0,See attached file(s),3,1,CMS-2017-0156,CMS-2017-0156-DRAFT-1289,NA,0983-AT08,Abigail Stoddard-MN,PUBLIC SUBMISSIONS,Public Comment,Yes,CMS-2017-0156-0046,Posted,01/17/2018,NA,"Hayes, Yolanda K (CMS)",01/15/2018,01/17/2018,No restrictions,NA,NA,NA,NA,1k2-90xt-cp2a,1,1,3,1,Abigail,Stoddard,Minneapolis,United States,MN,55419,astoddard@primetherapeutics.com,NA,NA,primetherapeutics.com,Abigail Stoddard,"Minneapolis, MN, 55419",astoddard@primetherapeutics.com,NA,PBM
8,CMS-2017-0156-1649,CMS-2017-0156-1649-0,See attached,2,1,CMS-2017-0156,CMS-2017-0156-DRAFT-1654,NA,0983-AT08,National Coalition on Health Care--DC,PUBLIC SUBMISSIONS,Public Comment,Yes,CMS-2017-0156-0046,Posted,01/18/2018,NA,"Hayes, Yolanda K (CMS)",01/16/2018,01/18/2018,No restrictions,NA,NA,NA,NA,1k2-90yq-puyr,1,1,3,1,Larry,McNeely,Washington,United States,DC,20005,lmcneely@nchc.org,National Coalition on Health Care,NA,nchc.org,Larry McNeely,"Washington, DC, 20005",lmcneely@nchc.org,National Coalition on Health Care,Policy and Research
13,CMS-2017-0156-1612,CMS-2017-0156-1612-0,"See attached
",2,1,CMS-2017-0156,CMS-2017-0156-DRAFT-1617,NA,0983-AT08,MN Department Human Services--MN,PUBLIC SUBMISSIONS,Public Comment,Yes,CMS-2017-0156-0046,Posted,01/18/2018,NA,"Hayes, Yolanda K (CMS)",01/16/2018,01/18/2018,No restrictions,NA,NA,NA,NA,1k2-90ym-gpkc,1,1,3,1,Gretchen,Ulbee,St. Paul,United States,MN,55164,gretchen.ulbee@state.mn,MN Department Human Services,NA,state.mn,Gretchen Ulbee,"St. Paul, MN, 55164",gretchen.ulbee@state.mn,MN Department Human Services,Other - Gov
59,CMS-2017-0156-1662,CMS-2017-0156-1662-0,See Attached,2,1,CMS-2017-0156,CMS-2017-0156-DRAFT-1665,NA,0983-AT08,Biosimilars Forum-DC,PUBLIC SUBMISSIONS,NA,Yes,CMS-2017-0156-0046,Posted,01/19/2018,NA,"Hayes, Yolanda K (CMS)",01/19/2018,01/19/2018,No restrictions,NA,NA,NA,CMS-4182-P,1k2-910e-sz7g,1,1,NA,1,NA,NA,NA,United States,DC,20006,NA,Biosimilars Forum,NA,NA,NA,"DC, 20006",NA,Biosimilars Forum,NA
68,CMS-2017-0156-1668,CMS-2017-0156-1668-0,See Attached,2,1,CMS-2017-0156,CMS-2017-0156-DRAFT-1672,NA,0983-AT08,National Grange-DC,PUBLIC SUBMISSIONS,NA,Yes,CMS-2017-0156-0046,Posted,01/19/2018,NA,"Hayes, Yolanda K (CMS)",01/19/2018,01/19/2018,No restrictions,NA,NA,NA,CMS-4182-P,1k2-910f-qkla,1,1,NA,1,NA,NA,NA,United States,DC,20006,NA,The National Grange,NA,NA,NA,"DC, 20006",NA,The National Grange,Beneficiary Advocate
77,CMS-2017-0156-1584,CMS-2017-0156-1584-0,See attached,2,1,CMS-2017-0156,CMS-2017-0156-DRAFT-1591,NA,0983-AT08,QualChoice Health-MN,PUBLIC SUBMISSIONS,Public Comment,Yes,CMS-2017-0156-0046,Posted,01/18/2018,NA,"Hayes, Yolanda K (CMS)",01/16/2018,01/18/2018,No restrictions,NA,NA,NA,NA,1k2-90yl-oe5g,1,1,3,1,David,Walsh,Eden Prairie,United States,MN,55344,david.walsh@qualchoicehealth.com,QualChoice Health,NA,qualchoicehealth.com,David Walsh,"Eden Prairie, MN, 55344",david.walsh@qualchoicehealth.com,QualChoice Health,Health Plan
79,CMS-2017-0156-1640,CMS-2017-0156-1640-0,See attached.,2,1,CMS-2017-0156,CMS-2017-0156-DRAFT-1645,NA,0983-AT08,Alliance of Specialty Medicine--DC,PUBLIC SUBMISSIONS,Public Comment,Yes,CMS-2017-0156-0046,Posted,01/18/2018,NA,"Hayes, Yolanda K (CMS)",01/16/2018,01/18/2018,No restrictions,NA,NA,NA,NA,1k2-90yp-4so9,1,1,3,1,Emily,Graham,Washington,United States,DC,20016,egraham@hhs.com,Alliance of Specialty Medicine,NA,hhs.com,Emily Graham,"Washington, DC, 20016",egraham@hhs.com,Alliance of Specialty Medicine,Trade Association
83,CMS-2017-0156-1663,CMS-2017-0156-1663-0,See Attached,2,1,CMS-2017-0156,CMS-2017-0156-DRAFT-1666,NA,0983-AT08,Brian Babin-DC (form ltr-9),PUBLIC SUBMISSIONS,NA,Yes,CMS-2017-0156-0046,Posted,01/19/2018,NA,"Hayes, Yolanda K (CMS)",01/19/2018,01/19/2018,No restrictions,NA,NA,NA,CMS-4182-P,1k2-910f-248s,1,1,NA,9,NA,NA,NA,United States,DC,20515,NA,Congress of the United States,NA,NA,NA,"DC, 20515",NA,Congress of the United States,Other - Gov
139,CMS-2017-0156-1355,CMS-2017-0156-1355-0,See attached.,2,1,CMS-2017-0156,CMS-2017-0156-DRAFT-1359,NA,0983-AT08,American Academy of Allergy Asthma and Immunology-WI,PUBLIC SUBMISSIONS,Public Comment,Yes,CMS-2017-0156-0046,Posted,01/17/2018,NA,"Hayes, Yolanda K (CMS)",01/15/2018,01/17/2018,No restrictions,NA,NA,NA,NA,1k2-90xy-pdfg,1,1,3,1,Sheila,Heitzig,Milwaukee,United States,WI,53202,sheitzig@aaaai.org,American Academy of Allergy Asthma and Immunology,NA,aaaai.org,Sheila Heitzig,"Milwaukee, WI, 53202",sheitzig@aaaai.org,American Academy of Allergy Asthma and Immunology,Trade Association (Providers)
168,CMS-2017-0156-1664,CMS-2017-0156-1664-0,See Attached,2,1,CMS-2017-0156,CMS-2017-0156-DRAFT-1667,NA,0983-AT08,Kansas Independent Pharmacy Service Corporation-KS,PUBLIC SUBMISSIONS,NA,Yes,CMS-2017-0156-0046,Posted,01/19/2018,NA,"Hayes, Yolanda K (CMS)",01/19/2018,01/19/2018,No restrictions,NA,NA,NA,CMS-4182-P,1k2-910f-n8mp,1,1,NA,1,NA,NA,NA,United States,KS,66614,NA,Kansas Independent Pharmacy Service Corporation,NA,NA,NA,"KS, 66614",NA,Kansas Independent Pharmacy Service Corporation,Trade Association
178,CMS-2017-0156-0608,CMS-2017-0156-0608-0,See attached,2,1,CMS-2017-0156,CMS-2017-0156-DRAFT-0607,NA,0983-AT08,Medicare Payment Advisory Commission-DC,PUBLIC SUBMISSIONS,Public Comment,Yes,CMS-2017-0156-0046,Posted,01/05/2018,NA,"Braxton, Shawn L (CMS)",01/03/2018,01/05/2018,No restrictions,NA,NA,NA,NA,1k2-90pu-pj1i,1,1,3,1,Francis J.,Crosson,Washington,United States,DC,20001,jmathews@medpac.gov,Medicare Payment Advisory Commission,NA,medpac.gov,Francis J. Crosson,"Washington, DC, 20001",jmathews@medpac.gov,Medicare Payment Advisory Commission,Policy and Research
195,CMS-2017-0156-0033,CMS-2017-0156-0033-0,See Attached,2,1,CMS-2017-0156,CMS-2017-0156-DRAFT-0033,NA,0983-AT08,Laurel Hines-OR,PUBLIC SUBMISSIONS,NA,Yes,CMS-2017-0156-0001,Posted,12/11/2017,NA,"Hayes, Yolanda K (CMS)",11/28/2017,12/11/2017,No restrictions,NA,NA,NA,NA,1k1-901s-79l7,1,1,NA,1,NA,NA,NA,United States,OR,97306,NA,na,NA,NA,NA,"OR, 97306",NA,na,Other
202,CMS-2017-0156-1665,CMS-2017-0156-1665-0,See Attached,2,1,CMS-2017-0156,CMS-2017-0156-DRAFT-1668,NA,0983-AT08,Ohio Department of Medicaid-OH,PUBLIC SUBMISSIONS,NA,Yes,CMS-2017-0156-0046,Posted,01/19/2018,NA,"Hayes, Yolanda K (CMS)",01/19/2018,01/19/2018,No restrictions,NA,NA,NA,CMS-4182-P,1k2-910f-eb9u,1,1,NA,1,NA,NA,NA,United States,OH,43215,NA,Ohio Department of Medicaid,NA,NA,NA,"OH, 43215",NA,Ohio Department of Medicaid,Other - Gov
203,CMS-2017-0156-1666,CMS-2017-0156-1666-0,See Attached,2,1,CMS-2017-0156,CMS-2017-0156-DRAFT-1670,NA,0983-AT08,"Triple S Advantage, Inc.-Puerto Rico",PUBLIC SUBMISSIONS,NA,Yes,CMS-2017-0156-0046,Posted,01/19/2018,NA,"Hayes, Yolanda K (CMS)",01/19/2018,01/19/2018,No restrictions,NA,NA,NA,CMS-4182-P,1k2-910f-fd1d,1,1,NA,1,NA,NA,NA,United States,PR,922,NA,"Triple-S Advantage, Inc.",NA,NA,NA,"PR, 00922",NA,"Triple-S Advantage, Inc.",Health Plan
206,CMS-2017-0156-1323,CMS-2017-0156-1323-0,See attached.,2,1,CMS-2017-0156,CMS-2017-0156-DRAFT-1327,NA,0983-AT08,American College of Mohs Surgery-WI,PUBLIC SUBMISSIONS,Public Comment,Yes,CMS-2017-0156-0046,Posted,01/17/2018,NA,"Hayes, Yolanda K (CMS)",01/15/2018,01/17/2018,No restrictions,NA,NA,NA,NA,1k2-90xw-f7r9,1,1,3,1,Emily,Graham,Milwaukee,United States,WI,53202,egraham@hhs.com,American College of Mohs Surgery,NA,hhs.com,Emily Graham,"Milwaukee, WI, 53202",egraham@hhs.com,American College of Mohs Surgery,Trade Association (Providers)
214,CMS-2017-0156-1638,CMS-2017-0156-1638-0,See attached.,2,1,CMS-2017-0156,CMS-2017-0156-DRAFT-1643,NA,0983-AT08,National Organization of Rheumatology Managers--NC,PUBLIC SUBMISSIONS,Public Comment,Yes,CMS-2017-0156-0046,Posted,01/18/2018,NA,"Hayes, Yolanda K (CMS)",01/16/2018,01/18/2018,No restrictions,NA,NA,NA,NA,1k2-90yo-nn5r,1,1,3,1,Andrea,Zlatkus,Wilmington,United States,NC,28405,andrea.zlatkus@gmail.com,National Organization of Rheumatology Managers,NA,gmail.com,Andrea Zlatkus,"Wilmington, NC, 28405",andrea.zlatkus@gmail.com,National Organization of Rheumatology Managers,Trade Association
239,CMS-2017-0156-1667,CMS-2017-0156-1667-0,See Attached,2,1,CMS-2017-0156,CMS-2017-0156-DRAFT-1671,NA,0983-AT08,Pennsylvania Pharmacists Association-PA,PUBLIC SUBMISSIONS,NA,Yes,CMS-2017-0156-0046,Posted,01/19/2018,NA,"Hayes, Yolanda K (CMS)",01/19/2018,01/19/2018,No restrictions,NA,NA,NA,CMS-4182-P,1k2-910f-80u4,1,1,NA,1,NA,NA,NA,United States,PA,17101,NA,Pennsylvania Pharmacists Association,NA,NA,NA,"PA, 17101",NA,Pennsylvania Pharmacists Association,Trade Association
251,CMS-2017-0156-1591,CMS-2017-0156-1591-0,See attached.,2,1,CMS-2017-0156,CMS-2017-0156-DRAFT-1598,NA,0983-AT08,Baker Donelson-DC,PUBLIC SUBMISSIONS,Public Comment,Yes,CMS-2017-0156-0046,Posted,01/18/2018,NA,"Hayes, Yolanda K (CMS)",01/16/2018,01/18/2018,No restrictions,NA,NA,NA,NA,1k2-90yl-7v64,1,1,3,1,Stephen,Azia,Washington,United States,DC,20001,sazia@bakerdonelson.com,Baker Donelson,NA,bakerdonelson.com,Stephen Azia,"Washington, DC, 20001",sazia@bakerdonelson.com,Baker Donelson,Policy and Research
262,CMS-2017-0156-1321,CMS-2017-0156-1321-0,See attached.,2,1,CMS-2017-0156,CMS-2017-0156-DRAFT-1325,NA,0983-AT08,Oncology Nursing Society-PA,PUBLIC SUBMISSIONS,Public Comment,Yes,CMS-2017-0156-0046,Posted,01/17/2018,NA,"Hayes, Yolanda K (CMS)",01/15/2018,01/17/2018,No restrictions,NA,NA,NA,NA,1k2-90xw-e5og,1,1,3,1,Dede,Sweeney,Pittsburgh,United States,PA,15275,dsweeney@ons.org,Oncology Nursing Society,NA,ons.org,Dede Sweeney,"Pittsburgh, PA, 15275",dsweeney@ons.org,Oncology Nursing Society,Trade Association
284,CMS-2017-0156-1357,CMS-2017-0156-1357-0,See attached.,2,1,CMS-2017-0156,CMS-2017-0156-DRAFT-1361,NA,0983-AT08,Sheila Heitzig-WI,PUBLIC SUBMISSIONS,Public Comment,Yes,CMS-2017-0156-0046,Posted,01/17/2018,NA,"Hayes, Yolanda K (CMS)",01/15/2018,01/17/2018,No restrictions,NA,NA,NA,NA,1k2-90xz-3azt,1,1,3,1,Sheila,Heitzig,Milwaukee,United States,WI,53202,sheitzig@aaaai.org,American Academy of Allergy Asthma and Immunology,NA,aaaai.org,Sheila Heitzig,"Milwaukee, WI, 53202",sheitzig@aaaai.org,American Academy of Allergy Asthma and Immunology,Trade Association (Providers)
